About Us About Us

REIMBURSEMENT

REIMBURSEMENT

Reimbursement

Edwards Lifesciences is committed to supporting our customers with reimbursement resources to assist with coverage, coding, and reimbursement for our products. We have several tools below which may assist you in determining the appropriate code(s) to utilize when billing for products and procedures as well as the nationally averaged reimbursement amounts.

HCPCS C Code Finder

The Health Care Common Procedural Coding System (HCPCS) C Code Finder allows you to find the appropriate HCPCS C Code, if applicable, for a specific Edwards product. C codes are used in conjunction with the Medicare prospective payment system for outpatient hospital procedures only. C codes do not apply to inpatient surgical procedures, but should be added to the hospital’s chargemaster to report device costs used in the outpatient setting. Medicare created C codes to track device cost information for future APC rate-setting purposes.

Please enter the Edwards model number

Facility and Physician Billing Guides

These billing guides are intended to provide information to clinicians regarding appropriate coding, coverage, and payment for procedures performed with the Edwards Lifesciences products. These guides contain information regarding most commonly billed CPT, ICD-10, and HCPCS coding, as well as typical DRG payments for procedures related to our products.

THV Replacement Technologies

2016 Facility and Physician Billing Guide

Facilities and Physicians use Current Procedural Terminology (CPT1) codes to bill for procedures and services. Each CPT code is assigned unique relative value units (RVUs), which are used to determine payment by the Centers for Medicare and Medicaid Services (CMS). All the CPT codes used to bill for TAVR procedures are listed below.

CPT Code1,2Description2016 National Avg. Physician Payment (Final JAN-DEC)Early Physician Payment (Modifier-62)*2016 Facility RVUS
33361 Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; percutaneous femoral artery approach $1,421 $888 39.65
33362 Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; open femoral artery approach $1,553 $971 43.36
33363 Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; open axillary artery approach $1,614 $1,009 45.04
33364 Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; open iliac artery approach $1,692 $1,057 47.22
33365 Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; transaortic approach (e.g., median sternotomy, mediastinotomy) $1,862 $1,164 51.98
33366 Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; transapical exposure (e.g., left thoracotomy) $2,015 $1,259 56.24
Add-on Codes
33367+ Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; cardiopulmonary bypass support with percutaneous peripheral arterial and venous cannulation (e.g., femoral vessels) (list separately in addition to code for primary procedure) $655 NA 18.27
33368+ Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; cardiopulmonary bypass support with open peripheral arterial and venous cannulation (e.g., femoral, iliac, axillary vessels) (list separately in addition to code for primary procedure) $785 NA 21.91
33369+ Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; cardiopulmonary bypass support with central arterial and venous cannulation (e.g., aorta, right atrium, pulmonary artery) (list separately in addition to code for primary procedure) $1,037 NA 28.95
Note: *As per the CMS’s NCD for TAVR, TAVR is a two-physician (IC & CS) procedure. Medicare payment for each physician is 62.5% of the established national average payment 8. +33367,33368 and 33369 are add-on codes which does not require modifier 62 hence each physician payment of 62.5% does not apply.
Note: Medicare will only pay TAVR physician claims with these CPT codes when billed with the Place of Service (POS) code 21 (Inpatient Hospital), modifier 62 (two surgeons/ co-surgeons), modifier Q0 (zero) signifying CED participation (qualifying registry or qualified clinical study) and ICD-10 secondary diagnosis code Z00.6 (Encounter for examination for normal comparison and control in clinical research program) Medicare requires reporting of the Clinical Trial (CT) number on the claim form. For example, the CT number for the TVT Registry is CT01737528 and the PARTNER II Trial is CT01314313. Medicare may return other claims as unprocessable. * Codes 33361-33369 have a 0 day global period; Codes 33361, 33362, 33363, 33364, 33365, 33366, 33367, 33368 and 33369 do not include cardiac catheterization [93451-93572] when performed at the time of the procedure for diagnostic purposes prior to aortic valve replacement. Codes 33361, 33362, 33363, 33364, 33365, 33366, 33367, 33368 and 33369 include all other catheterization[s], temporary pacing, intraprocedural contrast injection[s], fluoroscopic radiological supervision and interpretation, and imaging guidance, which are not reported separately when performed to complete the aortic valve procedure.
Additional Notes1

33361-33369 Transcatheter Aortic Valve Replacement

INCLUDES:
  • Access and Implantation of the aortic valve (33361-33366)
  • Access sheath placement
  • Advancement of valve delivery system
  • Arteriotomy closure
  • Balloon aortic valvuloplasty
  • Cardiac or open arterial approach
  • Deployment of valve
  • Percutaneous access
  • Temporary pacemaker
  • Valve repositioning when necessary
  • Radiology procedures:
    • Angiography during and after procedure
    • Assessment of access site for closure
    • Documentation of completion of the intervention
    • Guidances for valve placement
    • Supervision and interpretation
EXCLUDES:
  • Percutaneous coronary interventional procedures
  • Transvascular ventricular support (33967, 33970, 33973, 33975-33976, 33990-33993, 33999)
  • Code also add-on codes for cardiopulmonary bypass, when appropriate (33367-33369)
  • Code also cardiac catheterization services for purposes other than TAVR/TAVI
  • Code also diagnostic coronary angiography at a different session from the interventional procedure
  • Code also diagnostic coronary angiography at the same time as TAVR/TAVI when:
    • A previous study is available, but documentation states the patient’s condition has changed since the previous study, visualization of the anatomy/pathology is inadequate, or a change occurs during the procedure warranting additional evaluation of an area outside the current target area
    • No previous catheter-based coronary angiography study is available, and a full diagnostic study is performed, with the decision to perform the intervention based on that study
  • Code also modifier 59 when diagnostic coronary angiography procedures are performed as separate and distinct procedural services on the same day or session as TAVR/TAVI
  • Code also modifier 62 as well as al TAVI/TAVR procedures require the work of two physicians
  • Do not report separately when included in the TAVR/TAVI service (93452-93453, 93458-93461, 933567)

Medicare inpatient hospital reimbursement is based upon the Medicare Severity Diagnostic-Related Group (MS-DRG) classification system, which assigns MS-DRGs based on ICD-9-CM diagnosis and procedure codes. The following codes generally describe diagnosis and procedures associated with the use of the Edwards SAPIEN 3 transcatheter heart valve.

ICD-9-CM3 Diagnosis CodeDescription
421.1 Aortic valve disorders
ICD-10-CM9 Code (effective Oct. 1st, 2015)Description
I35.0 Nonrheumatic aortic (valve) stenosis
ICD-9-CM3 Procedure CodesDescription
35.05 Endovascular replacement of aortic valve
35.06 Transapical replacement of aortic valve
ICD-10-CM9 Code (effective Oct. 1st, 2015)Description
02RF38Z Replacement of Aortic Valve with Zooplastic Tissue, Percutaneous Approach
02RF38H Replacement of Aortic Valve with Zooplastic Tissue, Transapical, Percutaneous Approach

Pursuant to the final rule for the FY 2015 hospital Inpatient Prospective Payment System (IPPS), CMS created new MS-DRGs for endovascular cardiac valve replacements, effective October 1, 2014.

MS-DRG5DescriptionFY 2016 Relative WeightFY 2016 National Average Payment7FY 2016 Geometric Mean-LOS
266 Endovascular Cardiac Valve Replacement with MCC 8.5986 $50,772 7.3
267 Endovascular Cardiac Valve Replacement without MCC 6.5575 $38,720 4.4

Note: Medicare will only pay TAVR facility claims with these ICD-10-CM codes when billed with the ICD-10 secondary diagnosis code Z00.6 (Encounter for examination for normal comparison and control in clinical research program) and condition code 30 (qualifying clinical trial). Medicare will return all other claims as unprocessable.

Principal Diagnosis for Valve-in-Valve with the Edwards SAPIEN XT Transcatheter Heart Valve

Depending on the circumstances, there are several ICD-10-CM diagnosis codes that could be used as the principal diagnosis when the encounter is specifically for performing a valve-in-valve procedure at a different operative encounter from the prior valve placement. From a coding perspective, the options are following.

ScenarioICD-10 Diagnosis CodeICD-10 Code Description
If the previously placed valve was malpositioned or became displaced T82.222A Displacement of biological heart valve graft, initial encounter
If the previously placed valve developed stenosis prematurely T82.223A Stenosis of cardiac prosthetic devices, implants and grafts, initial encounter
If the previously placed valve developed regurgitation prematurely T82.223A Leakage of biological heart valve graft, initial encounter
If the previously placed valve developed stenosis or regurgitation as an expected occurrence as it degenerates toward valve end-of-life T82.223A Encounter for adjustment and management of other cardiac device

EDWARDS SAPIEN XT TRANSCATHETER HEART VALVE WITH THE NOVAFLEX+ DELIVERY SYSTEM

Indications: The Edwards SAPIEN XT transcatheter heart valve is indicated for use in patients with symptomatic heart disease due to either severe native calcific aortic stenosis or failure (stenosed, insufficient, or combined) of a surgical bioprosthetic aortic valve who are judged by a heart team, including a cardiac surgeon, to be at high or greater risk for open surgical therapy (i.e., Society of Thoracic Surgeons operative risk score ³ 8% or at a ³ 15% risk of mortality at 30 days).

Contraindications: The THV and delivery systems are contraindicated in patients who cannot tolerate an anticoagulation/antiplatelet regimen or who have active bacterial endocarditis or other active infections.

Warnings: Observation of the pacing lead throughout the procedure is essential to avoid the potential risk of pacing lead perforation. There is an increased risk of stroke in transcatheter aortic valve replacement procedures, as compared to balloon aortic valvuloplasty or other standard treatments. The devices are designed, intended, and distributed for single use only. Do not resterilize or reuse the devices. There are no data to support the sterility, nonpyrogenicity, and functionality of the devices after reprocessing. Care should be exercised when sizing the native annulus or surgical valve; implanting a THV that is too small may lead to paravalvular leak, migration or embolization, whereas implanting a THV that is too large may lead to residual gradient (patient-prosthesis mismatch) or annular rupture. Accelerated deterioration of the THV may occur in patients with an altered calcium metabolism. Prior to delivery, the THV must remain hydrated at all times and cannot be exposed to solutions other than its shipping storage solution and sterile physiologic rinsing solution. THV leaflets mishandled or damaged during any part of the procedure will require replacement of the THV. Caution should be exercised in implanting a THV in patients with clinically significant coronary artery disease. Patients with pre-existing mitral valve devices should be carefully assessed prior to implantation of the THV to ensure proper THV positioning and deployment. Do not use the THV if the tamper evident seal is broken, the storage solution does not completely cover the THV, the temperature indicator has been activated, the THV is damaged, or the expiration date has elapsed. Do not mishandle the NovaFlex+ delivery system or use it if the packaging or any components are not sterile, have been opened or are damaged (e.g. kinked or stretched), or the expiration date has elapsed. Use of excessive contrast media may lead to renal failure. Measure the patient’s creatinine level prior to the procedure. Contrast media usage should be monitored. Patient injury could occur if the delivery system is not un-flexed prior to removal. Care should be exercised in patients with hypersensitivities to cobalt, nickel, chromium, molybdenum, titanium, manganese, silicon, and/or polymeric materials. The procedure should be conducted under fluoroscopic guidance. Some fluoroscopically guided procedures are associated with a risk of radiation injury to the skin. These injuries may be painful, disfiguring, and long-lasting. THV recipients should be maintained on anticoagulant/antiplatelet therapy, except when contraindicated, as determined by their physician. This device has not been tested for use without anticoagulation. Do not add or apply antibiotics to the storage solution, rinse solutions, or to the THV.

Precautions: Long-term durability has not been established for the THV. Regular medical follow-up is advised to evaluate THV performance. Glutaraldehyde may cause irritation of the skin, eyes, nose and throat. Avoid prolonged or repeated exposure to, or breathing of, the solution. Use only with adequate ventilation. If skin contact occurs, immediately flush the affected area with water; in the event of contact with eyes, seek immediate medical attention. For more information about glutaraldehyde exposure, refer to the Material Safety Data Sheet available from Edwards Lifesciences. To maintain proper valve leaflet coaptation, do not overinflate the deployment balloon. Appropriate antibiotic prophylaxis is recommended post-procedure in patients at risk for prosthetic valve infection and endocarditis. Safety, effectiveness, and durability have not been established for THV in THV procedures. Safety and effectiveness have not been established for patients with the following characteristics/ comorbidities: non-calcified aortic annulus, severe ventricular dysfunction with ejection fraction < 20%, congenital unicuspid or congenital bicuspid aortic valve, mixed aortic valve disease (aortic stenosis and aortic regurgitation with predominant aortic regurgitation > 3+), pre-existing prosthetic ring in any position, severe mitral annular calcification (MAC), severe (> 3+) mitral insufficiency, or Gorlin syndrome, blood dyscrasias defined as: leukopenia (WBC < 3000 cells/mL), acute anemia (Hb < 9 g/dL), thrombocytopenia (platelet count <50,000 cells/mL), or history of bleeding diathesis or coagulopathy, hypertrophic cardiomyopathy with or without obstruction (HOCM), echocardiographic evidence of intracardiac mass, thrombus, or vegetation, a known hypersensitivity or contraindication to aspirin, heparin, ticlopidine (Ticlid™), or clopidogrel (Plavix™), or sensitivity to contrast media, which cannot be adequately premedicated, significant aortic disease, including abdominal aortic or thoracic aneurysm defined as maximal luminal diameter 5 cm or greater; marked tortuosity (hyperacute bend), aortic arch atheroma (especially if thick [> 5 mm], protruding, or ulcerated) or narrowing (especially with calcification and surface irregularities) of the abdominal or thoracic aorta, severe “unfolding” and tortuosity of the thoracic aorta, access characteristics that would preclude safe placement of 16F, 18F, or 20F Edwards expandable introducer sheath set, such as severe obstructive calcification, severe tortuosity or diameter less than 6 mm, 6.5 mm, or 7 mm, respectively, bulky calcified aortic valve leaflets in close proximity to coronary ostia, a concomitant paravalvular leak where the surgical bioprosthesis is not securely fixed in the native annulus or is not structurally intact (e.g. wireform frame fracture), and a partially detached leaflet of the surgical bioprosthesis that in the aortic position may obstruct a coronary ostium. The safety and effectiveness have not been established for implanting the THV inside a stented bioprosthetic valve < 21 mm (labeled size) or an unstented bioprosthetic aortic valve. Residual mean gradient may be higher in a “TAV-in-SAV” configuration than that observed following implantation of the THV inside a native aortic annulus using the same size device. Patients with elevated mean gradient post procedure should be carefully followed. It is important that the manufacturer, model and size of the preexisting surgical bioprosthetic aortic valve be determined, so that the appropriate THV can be implanted and a prosthesis-patient mismatch be avoided. Additionally, pre-procedure imaging modalities must be employed to make as accurate a determination of the internal orifice as possible.

Potential Adverse Events: Potential risks associated with the overall procedure including potential access complications associated with standard cardiac catheterization, balloon valvuloplasty, the potential risks of conscious sedation and/or general anesthesia, and the use of angiography: death; stroke/transient ischemic attack, clusters or neurological deficit; paralysis; permanent disability; respiratory insufficiency or respiratory failure; hemorrhage requiring transfusion or intervention; cardiovascular injury including perforation or dissection of vessels, ventricle, myocardium or valvular structures that may require intervention; pericardial effusion or cardiac tamponade; embolization including air, calcific valve material or thrombus; infection including septicemia and endocarditis; heart failure; myocardial infarction; renal insufficiency or renal failure; conduction system defect which may require a permanent pacemaker; arrhythmia; retroperitoneal bleed; AV fistula or pseudoaneurysm; reoperation; ischemia or nerve injury; restenosis; pulmonary edema; pleural effusion; bleeding; anemia; abnormal lab values (including electrolyte imbalance); hypertension or hypotension; allergic reaction to anesthesia, contrast media, or device materials; hematoma; syncope; pain or changes at the access site; exercise intolerance or weakness; inflammation; angina; heart murmur; fever. Additional potential risks associated with the use of the THV, delivery system, and/or accessories include: cardiac arrest; cardiogenic shock; emergency cardiac surgery; cardiac failure or low cardiac output; coronary flow obstruction/transvalvular flow disturbance; device thrombosis requiring intervention; valve thrombosis; device embolization; device migration or malposition requiring intervention; valve deployment in unintended location; valve stenosis; structural valve deterioration (wear, fracture, calcification, leaflet tear/tearing from the stent posts, leaflet retraction, suture line disruption of components of a prosthetic valve, thickening, stenosis); device degeneration; paravalvular or transvalvular leak; valve regurgitation; hemolysis; device explants; nonstructural dysfunction; mechanical failure of delivery system, and/or accessories, non-emergent reoperation.

EDWARDS EXPANDABLE INTRODUCER SHEATH SET

Indications: The Edwards expandable introducer sheath is indicated for the introduction and removal of devices used with the Edwards SAPIEN XT transcatheter heart valve.

Contraindications: This product is contraindicated for tortuous or calcified vessels that would prevent safe entry of the introducer and sheath.

Warnings: The devices are designed, intended, and distributed for single use only. Do not resterilize or reuse the devices. There is no data to support the sterility, nonpyrogenicity, and functionality of the devices after reprocessing. The Edwards expandable introducer sheath set must be used with a compatible 0.035” guidewire.

Precautions: Do not use the introducer sheath set if the packaging sterile barriers and any components have been opened or damaged. The Edwards Expandable Sheath temporarily enlarges to allow the passage of devices; ensure that the vasculature can accommodate the maximum diameter of the expanded sheath. When inserting, manipulating or withdrawing a device through the expandable sheath, always maintain sheath position. When puncturing, suturing or incising the tissue near the sheath, use caution to avoid damage to the sheath.

Potential Adverse Events: Complications associated with standard catheterization and use of angiography include, but are not limited to, injury including perforation or dissection of vessels, thrombosis, and/or plaque dislodgement which may result in emboli formation, distal vessel obstruction, stroke, infection, and/or death.

EDWARDS SAPIEN XT TRANSCATHETER HEART VALVE WITH THE ASCENDRA+ DELIVERY SYSTEM

Indications: The Edwards SAPIEN XT transcatheter heart valve is indicated for use in patients with symptomatic heart disease due to either severe native calcific aortic stenosis or failure (stenosed, insufficient, or combined) of a surgical bioprosthetic aortic valve who are judged by a heart team, including a cardiac surgeon, to be at high or greater risk for open surgical therapy (i.e., Society of Thoracic Surgeons operative risk score ³ 8% or at a ³ 15% risk of mortality at 30 days).

Contraindications: The THV and delivery systems are contraindicated in patients who cannot tolerate an anticoagulation/antiplatelet regimen or who have active bacterial endocarditis or other active infections.

Warnings: Observation of the pacing lead throughout the procedure is essential to avoid the potential risk of pacing lead perforation. There is an increased risk of stroke in transcatheter aortic valve replacement procedures, as compared to balloon aortic valvuloplasty or other standard treatments. The devices are designed, intended, and distributed for single use only. Do not resterilize or reuse the devices. There are no data to support the sterility, nonpyrogenicity, and functionality of the devices after reprocessing. Care should be exercised when sizing the native annulus or surgical valve; implanting a THV that is too small may lead to paravalvular leak, migration or embolization, whereas implanting a THV that is too large may lead to residual gradient (patient-prosthesis mismatch) or annular rupture. Accelerated deterioration of the THV may occur in patients with an altered calcium metabolism. Prior to delivery, the THV must remain hydrated at all times and cannot be exposed to solutions other than its shipping storage solution and sterile physiologic rinsing solution. THV leaflets mishandled or damaged during any part of the procedure will require replacement of the THV. Caution should be exercised in implanting a THV in patients with clinically significant coronary artery disease. Patients with pre-existing mitral valve devices should be carefully assessed prior to implantation of the THV to ensure proper THV positioning and deployment. Patients presenting with combination AV low flow, low gradient should undergo additional evaluation to establish the degree of aortic stenosis. Do not use the THV if the tamper evident seal is broken, the storage solution does not completely cover the THV, the temperature indicator has been activated, the THV is damaged, or the expiration date has elapsed. Do not mishandle the Ascendra+ delivery system or use it if the packaging or any components are not sterile, have been opened or are damaged (e.g. kinked or stretched), or the expiration date has elapsed. Care should be exercised in patients with hypersensitivities to cobalt, nickel, chromium, molybdenum, titanium, manganese, silicon, and/or polymeric materials. The procedure should be conducted under fluoroscopic guidance. Some fluoroscopically guided procedures are associated with a risk of radiation injury to the skin. These injuries may be painful, disfiguring, and long-lasting. THV recipients should be maintained on anticoagulant/antiplatelet therapy, except when contraindicated, as determined by their physician. This device has not been tested for use without anticoagulation. Do not add or apply antibiotics to the storage solution, rinse solutions, or to the THV.

Precautions: Long-term durability has not been established for the THV. Regular medical follow-up is advised to evaluate THV performance. Glutaraldehyde may cause irritation of the skin, eyes, nose and throat. Avoid prolonged or repeated exposure to, or breathing of, the solution. Use only with adequate ventilation. If skin contact occurs, immediately flush the affected area with water; in the event of contact with eyes, seek immediate medical attention. For more information about glutaraldehyde exposure, refer to the Material Safety Data Sheet available from Edwards Lifesciences. To maintain proper valve leaflet coaptation, do not overinflate the deployment balloon. Appropriate antibiotic prophylaxis is recommended post-procedure in patients at risk for prosthetic valve infection and endocarditis. Safety, effectiveness, and durability have not been established for THV in THV procedures. Safety and effectiveness have not been established for patients with the following characteristics/ comorbidities: Non-calcified aortic annulus, severe ventricular dysfunction with ejection fraction < 20%, congenital unicuspid or congenital bicuspid aortic valve, mixed aortic valve disease (aortic stenosis and aortic regurgitation with predominant aortic regurgitation > 3+), pre-existing prosthetic ring in any position, severe mitral annular calcification (MAC), severe (> 3+) mitral insufficiency, or Gorlin syndrome, blood dyscrasias defined as: leukopenia (WBC < 3000 cells/mL), acute anemia (Hb < 9 g/dL), thrombocytopenia (platelet count <50,000 cells/mL), or history of bleeding diathesis or coagulopathy, hypertrophic cardiomyopathy with or without obstruction (HOCM), echocardiographic evidence of intracardiac mass, thrombus, or vegetation, a known hypersensitivity or contraindication to aspirin, heparin, ticlopidine (Ticlid™), or clopidogrel (Plavix™), or sensitivity to contrast media, which cannot be adequately premedicated, excessive calcification of vessel at access site, bulky calcified aortic valve leaflets in close proximity to coronary ostia, a concomitant paravalvular leak where the surgical bioprosthesis is not securely fixed in the native annulus or is not structurally intact (e.g. wireform frame fracture), and a partially detached leaflet of the surgical bioprosthesis that in the aortic position may obstruct a coronary ostium. The safety and effectiveness have not been established for implanting the THV inside a stented bioprosthetic valve < 21 mm (labeled size) or an unstented bioprosthetic aortic valve. Residual mean gradient may be higher in a “TAV-in-SAV” configuration than that observed following implantation of the THV inside a native aortic annulus using the same size device. Patients with elevated mean gradient post procedure should be carefully followed. It is important that the manufacturer, model and size of the preexisting surgical bioprosthetic aortic valve be determined, so that the appropriate THV can be implanted and a prosthesis-patient mismatch be avoided. Additionally, pre-procedure imaging modalities must be employed to make as accurate a determination of the internal orifice as possible.

Potential Adverse Events: Potential risks associated with the overall procedure including potential access complications associated with standard cardiac catheterization, balloon valvuloplasty, the potential risks of conscious sedation and/or general anesthesia, and the use of angiography: death; stroke/transient ischemic attack, clusters or neurological deficit; paralysis; permanent disability; respiratory insufficiency or respiratory failure; hemorrhage requiring transfusion or intervention; cardiovascular injury including perforation or dissection of vessels, ventricle, myocardium or valvular structures that may require intervention; pericardial effusion or cardiac tamponade; embolization including air, calcific valve material or thrombus; infection including septicemia and endocarditis; heart failure; myocardial infarction; renal insufficiency or renal failure; conduction system defect which may require a permanent pacemaker; arrhythmia; retroperitoneal bleed; AV fistula or pseudoaneurysm; reoperation; ischemia or nerve injury; restenosis; pulmonary edema; pleural effusion; bleeding; anemia; abnormal lab values (including electrolyte imbalance); hypertension or hypotension; allergic reaction to anesthesia, contrast media, or device materials; hematoma; syncope; pain or changes at the access site; exercise intolerance or weakness; inflammation; angina; heart murmur; fever. Additional potential risks associated with the use of the THV, delivery system, and/or accessories include: cardiac arrest; cardiogenic shock; emergency cardiac surgery; cardiac failure or low cardiac output; coronary flow obstruction/transvalvular flow disturbance; device thrombosis requiring intervention; valve thrombosis; device embolization; device migration or malposition requiring intervention; valve deployment in unintended location; valve stenosis; structural valve deterioration (wear, fracture, calcification, leaflet tear/tearing from the stent posts, leaflet retraction, suture line disruption of components of a prosthetic valve, thickening, stenosis); device degeneration; paravalvular or transvalvular leak; valve regurgitation; hemolysis; device explants; nonstructural dysfunction; mechanical failure of delivery system, and/or accessories; non-emergent reoperation.

ASCENDRA+ INTRODUCER SHEATH SET

Indications: The Ascendra+ introducer sheath set is indicated for the introduction and removal of devices used with the Edwards SAPIEN XT transcatheter heart valve.

Contraindications: No known contraindications.

Warnings: The devices are designed, intended, and distributed for single use only. Do not resterilize or reuse the devices. There are no data to support the sterility, nonpyrogenicity, and functionality of the devices after reprocessing. Do not mishandle the device or use it if the packaging or any components are not sterile, have been opened or are damaged (e.g. kinked or stretched), or the expiration date has elapsed. Should not be used in patients with left ventricular aneurysm. The Ascendra+ introducer sheath set must be used with a 0.035” guidewire.

Precautions: No known precautions.

Potential Adverse Events: Complications associated with cardiac surgical intervention and use of angiography include, but are not limited to, allergic reaction to anesthesia or to contrast media, injury including myocardial injury, thrombus formation, and plaque dislodgement which may result in myocardial infarction, arrhythmia, stroke, and/or death. Reference the Edwards SAPIEN XT transcatheter heart valve with the Ascendra+ delivery system Instructions for Use for a full list of potential adverse events.

EDWARDS CRIMPER

Indications: The Edwards crimper is indicated for use in preparing the Edwards SAPIEN XT transcatheter heart valve for implantation.

Contraindications: No known contraindications.

Warnings: The device is designed, intended, and distributed for single use only. Do not resterilize or reuse the device. There are no data to support the sterility, nonpyrogenicity, and functionality of the device after reprocessing. Do not mishandle the device. Do not use the device if the packaging or any components are not sterile, have been opened or are damaged, or the expiration date has elapsed.

Precautions: For special considerations associated with the use of this device prior to THV implantation, refer to the SAPIEN XT transcatheter heart valve Instructions for Use.

Potential Adverse Events: No known potential adverse events.

EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE WITH THE EDWARDS COMMANDER DELIVERY SYSTEM

Indications: The Edwards SAPIEN 3 transcatheter heart valve (THV), model 9600TFX, and accessories are indicated for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic stenosis who are judged by a heart team, including a cardiac surgeon, to be at high or greater risk for open surgical therapy (i.e., Society of Thoracic Surgeons operative risk score ³ 8% or at a ³ 15% risk of mortality at 30 days).

Contraindications: The THV and delivery systems are contraindicated in patients who cannot tolerate an anticoagulation/antiplatelet regimen or who have active bacterial endocarditis or other active infections.

Warnings: Observation of the pacing lead throughout the procedure is essential to avoid the potential risk of pacing lead perforation. There is an increased risk of stroke in transcatheter aortic valve replacement procedures, as compared to balloon aortic valvuloplasty or other standard treatments. The devices are designed, intended, and distributed for single use only. Do not resterilize or reuse the devices. There are no data to support the sterility, nonpyrogenicity, and functionality of the devices after reprocessing. Incorrect sizing of the THV may lead to paravalvular leak, migration, embolization, and/or annular rupture. Accelerated deterioration of the THV may occur in patients with an altered calcium metabolism. Prior to delivery, the THV must remain hydrated at all times and cannot be exposed to solutions other than its shipping storage solution and sterile physiologic rinsing solution. THV leaflets mishandled or damaged during any part of the procedure will require replacement of the THV. Caution should be exercised in implanting a THV in patients with clinically significant coronary artery disease. Patients with pre-existing mitral valve devices should be carefully assessed prior to implantation of the THV to ensure proper THV positioning and deployment. Do not mishandle the delivery system or use it if the packaging or any components are not sterile, have been opened or are damaged (e.g., kinked or stretched), or if the expiration date has elapsed. Use of excessive contrast media may lead to renal failure. Measure the patient’s creatinine level prior to the procedure. Contrast media usage should be monitored. Patient injury could occur if the delivery system is not un-flexed prior to removal. Care should be exercised in patients with hypersensitivities to cobalt, nickel, chromium, molybdenum, titanium, manganese, silicon, and/ or polymeric materials. The procedure should be conducted under fluoroscopic guidance. Some fluoroscopically guided procedures are associated with a risk of radiation injury to the skin. These injuries may be painful, disfiguring, and long-lasting. THV recipients should be maintained on anticoagulant/antiplatelet therapy, except when contraindicated, as determined by their physician. This device has not been tested for use without anticoagulation.

Precautions: Long-term durability has not been established for the THV. Regular medical follow-up is advised to evaluate THV performance. Glutaraldehyde may cause irritation of the skin, eyes, nose, and throat. Avoid prolonged or repeated exposure to, or breathing of, the solution. To maintain proper valve leaflet coaptation, do not overinflate the deployment balloon. Appropriate antibiotic prophylaxis is recommended post-procedure in patients at risk for prosthetic valve infection and endocarditis. Safety, effectiveness, and durability have not been established for valve-in-valve procedures. Safety and effectiveness have not been established for patients with the following characteristics/comorbidities: non-calcified aortic annulus; severe ventricular dysfunction with ejection fraction < 20%; congenital unicuspid or congenital bicuspid aortic valve; mixed aortic valve disease (aortic stenosis and aortic regurgitation with predominant aortic regurgitation > 3+); pre-existing prosthetic heart valve or prosthetic ring in any position; severe mitral annular calcification (MAC), severe (> 3+) mitral insufficiency, or Gorlin syndrome; blood dyscrasias defined as leukopenia (WBC < 3000 cells/mL), acute anemia (Hb < 9 g/dL), thrombocytopenia (platelet count < 50,000 cells/mL), or history of bleeding diathesis or coagulopathy; hypertrophic cardiomyopathy with or without obstruction (HOCM); echocardiographic evidence of intracardiac mass, thrombus, or vegetation; a known hypersensitivity or contraindication to aspirin, heparin, ticlopidine (Ticlid), or clopidogrel (Plavix), or sensitivity to contrast media, which cannot be adequately premedicated; significant aortic disease, including abdominal aortic or thoracic aneurysm defined as maximal luminal diameter 5 cm or greater, marked tortuosity (hyperacute bend), aortic arch atheroma (especially if thick [> 5 mm], protruding, or ulcerated) or narrowing (especially with calcification and surface irregularities) of the abdominal or thoracic aorta, severe “unfolding” and tortuosity of the thoracic aorta; access characteristics that would preclude safe placement of 14F or 16F Edwards eSheath introducer set, such as severe obstructive calcification, severe tortuosity, or diameter less than 5.5 mm or 6 mm, respectively; or bulky calcified aortic valve leaflets in close proximity to coronary ostia.

Potential Adverse Events: Potential risks associated with the overall procedure including potential access complications associated with standard cardiac catheterization, balloon valvuloplasty, the potential risks of conscious sedation and/or general anesthesia, and the use of angiography: death; stroke/transient ischemic attack, clusters, or neurological deficit; paralysis; permanent disability; respiratory insufficiency or respiratory failure; hemorrhage requiring transfusion or intervention; cardiovascular injury including perforation or dissection of vessels, ventricle, myocardium, or valvular structures that may require intervention; pericardial effusion or cardiac tamponade; embolization including air, calcific valve material, or thrombus; infection including septicemia and endocarditis; heart failure; myocardial infarction; renal insufficiency or renal failure; conduction system defect which may require a permanent pacemaker; arrhythmia; retroperitoneal bleed; AV fistula or pseudoaneurysm; reoperation; ischemia or nerve injury; restenosis; pulmonary edema; pleural effusion; bleeding; anemia; abnormal lab values (including electrolyte imbalance); hypertension or hypotension; allergic reaction to anesthesia, contrast media, or device materials; hematoma; syncope; pain or changes at the access site; exercise intolerance or weakness; inflammation; angina; heart murmur; and fever. Additional potential risks associated with the use of the THV, delivery system, and/or accessories include: cardiac arrest; cardiogenic shock; emergency cardiac surgery; cardiac failure or low cardiac output; coronary flow obstruction/transvalvular flow disturbance; device thrombosis requiring intervention; valve thrombosis; device embolization; device migration or malposition requiring intervention; valve deployment in unintended location; valve stenosis; structural valve deterioration (wear, fracture, calcification, leaflet tear/tearing from the stent posts, leaflet retraction, suture line disruption of components of a prosthetic valve, thickening, stenosis); device degeneration; paravalvular or transvalvular leak; valve regurgitation; hemolysis; device explants; nonstructural dysfunction; mechanical failure of delivery system and/or accessories; and non-emergent reoperation.

 

 

Reimbursement Hotline: 1-800-471-9387

DISCLAIMER

Reimbursement information provided by Edwards Lifesciences is gathered from third-party sources and is presented for informational purposes only. Edwards makes no representation, warranty or guarantee as to the timeliness, accuracy or completeness of the information and such information is not, and should not be construed as reimbursement, coding or legal advice. Any and all references to reimbursement codes are provided as examples only and are not intended to be a recommendation or advice as to the appropriate code for the a particular patient, diagnosis, product or procedure or a guarantee or promise of coverage or payment, nor does Edwards Lifesciences warranty that codes listed are appropriate in all related clinical scenarios. It is the responsibility of the provider to determine if coverage exists and what requirements are necessary for submitting a proper claim for reimbursement to a health plan or payer, including the appropriate code(s) for products provided or services rendered. Laws, regulations, and payer policies concerning reimbursement are complex and change frequently; service providers are responsible for all decisions relating to coding and reimbursement submissions. Medicare’s Correct Coding Initiative and commercial payer policies are reviewed and updated several times each year. Accordingly, Edwards strongly recommends consultation with payers, reimbursement specialists and/or legal counsel regarding appropriate product or procedure codes, coverage, and reimbursement matters.

References
  1. Current Procedure Terminology (CPT) copyright 2014, American Medical Association (AMA). All rights reserved. CPT is a registered trademark of the AMA. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein. Applicable FARS/DFARS restrictions apply to government use.
  2. Not all codes provided are applicable for the clinical scenarios in which Edwards Lifesciences’ Transcatheter Heart Valve technologies are used. The provider is responsible for selecting the most appropriate code(s) for the patient’s clinical presentation. When diagnostic services are performed, it may be appropriate to add applicable codes according to the service provided following the correct coding guidelines. Services that are considered a component of another procedure may not always be coded and billed separately.
  3. International Classification of Diseases, 9th Revision, Clinical Modification 6th Edition, 2015 ICD-9-CM for hospitals, volume 1, 2, & 3.
  4. Centers for Medicare & Medicaid Services (CMS). Updates and Revisions to ICD-9-CM Procedure Codes (Addendum). FY 2012 Medicare Addendum, ICD-9-CM Volume 3, Procedures. 26 October 2011. http://www.cms.gov/icd9providerdiagnosticcodes/04_addendum.asp and http://www.cms.gov/ICD9ProviderDiagnosticCodes/Downloads/FY2012_Addenda.pdf. CMS MLN Matters MM7897, National Coverage Determination (NCD) for Transcatheter Aortic Valve Replacement (TAVR), Revised 25 September, 2012 http://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNMattersArticles/downloads/MM7897.pdf CMS MLN Matters MM8255, NCD for TAVR- Implementation of Mandatory Reporting of Clinical Trial Number. Revised July, 2013 http://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNMattersArticles/downloads/MM8255.pdf
  5. DRG Expert: A Comprehensive Guidebook to the DRG Classification System, 31st Edition, 2015.
  6. Centers for Medicare and Medicaid Services, Physician Fee Schedule Relative Value Files http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/Physicia FeeSched/PFS-Relative-Value-Files.html. Accessed 10-31-2015
  7. CMS IPPS FY2016 Final Rule The FY2016 Final Average standardized amount is $5904.74
  8. Medicare Access and CHIP Authorization Act of 2015- Public Law 114-10-APR. 16,2015.
  9. International Classification of Diseases, 10th Revision, Clinical Modification 2015 ICD-10-CM for hospitals, volume 1, 2, & 3.
Heart Valve Technologies

2016 Facility and Physician Screening Guide and Facility Patient Coding Guide

View the PDF of the Patient Coding Guide

2016 Facility and Physician Billing Guide

Clinicians use Current Procedural Terminology (CPT)1 codes to bill for procedures and services. Each CPT code is assigned unique relative value units (RVUs), which are used to determine payment by the Centers for Medicare & Medicaid Services (CMS) and other payers. Some commonly billed CPT codes used to describe procedures related to Edwards Lifesciences’ Heart Valve technologies are listed below.2 This list may not be comprehensive or complete. These procedures may be subject to the CMS multiple procedure reduction rule. When applicable, a payment reduction of 50% is applied to all payment amounts except the procedure with the greatest RVUs, which is paid at 100% unless exempt by CPT instructions or payer policy.

CPT Code Description Medicare National Average Physician Payment3
Facility Setting
33400 Valvuloplasty, aortic valve; open, with cardiopulmonary bypass $2,372
33401 Valvuloplasty, aortic valve; open, with inflow occlusion $1,504
33403 Valvuloplasty, aortic valve; using transventricular dilation, with cardiopulmonary bypass $1,545
33405 Replacement, aortic valve, with cardiopulmonary bypass; with prosthetic valve other than homograft or stentless valve $2,365
33406 Replacement, aortic valve, with cardiopulmonary bypass; with allograft valve (freehand) $2,999
33410 Replacement, aortic valve, with cardiopulmonary bypass; with stentless tissue valve $2,641
33411 Replacement, aortic valve; with aortic annulus enlargement, noncoronary sinus $3,498
33412 Replacement, aortic valve; with transventricular aortic annulus enlargement (Konno procedure) $3,309
33413 Replacement, aortic valve; by translocation of autologous pulmonary valve with allograft replacement of pulmonary valve (Ross procedure) $3,391
33420 Valvotomy, mitral valve; closed heart $1,520
33422 Valvotomy, mitral valve; open heart, with cardiopulmonary bypass $1,743
33425 Valvuloplasty, mitral valve, with cardiopulmonary bypass $2,850
33426 Valvuloplasty, mitral valve, with cardiopulmonary bypass; with prosthetic ring $2,482
33427 Valvuloplasty, mitral valve, with cardiopulmonary bypass; radical reconstruction, with or without ring $2,547
33430 Replacement, mitral valve, with cardiopulmonary bypass $2,916
33460 Valvectomy, tricuspid valve, with cardiopulmonary bypass $2,545
33463 Valvuloplasty, tricuspid valve; without ring insertion $3,221
33464 Valvuloplasty, tricuspid valve; with ring insertion $2,544
33465 Replacement, tricuspid valve, with cardiopulmonary bypass $2,873
33468 Tricuspid valve repositioning and plication for Ebstein anomaly $2,571
33999 Unlisted procedure, cardiac surgery Contractor priced
92986 Percutaneous balloon valvuloplasty; aortic valve $1,386
92987 Percutaneous balloon valvuloplasty; mitral valve $1,429
CPT Code Description Medicare National Average Physician Payment3
Facility Setting
33510 Coronary artery bypass, vein only; single coronary venous graft $2,013
33511 Coronary artery bypass, vein only; 2 coronary venous grafts $2,213
33512 Coronary artery bypass, vein only; 3 coronary venous grafts $2,515
33513 Coronary artery bypass, vein only; 4 coronary venous grafts $2,588
33514 Coronary artery bypass, vein only; 5 coronary venous grafts $2,724
33516 Coronary artery bypass, vein only; 6 or more coronary venous grafts $2,845
33517 Coronary artery bypass, using venous graft(s) and arterial graft(s); single vein graft (List separately in addition to code for primary procedure) $195
33518 Coronary artery bypass, using venous graft(s) and arterial graft(s); 2 venous grafts (List separately in addition to code for primary procedure) $430
33519 Coronary artery bypass, using venous graft(s) and arterial graft(s); 3 venous grafts (List separately in addition to code for primary procedure) $568
33521 Coronary artery bypass, using venous graft(s) and arterial graft(s);4 venous grafts (List separately in addition to code for primary procedure) $681
33522 Coronary artery bypass, using venous graft(s) and arterial graft(s); 5 venous grafts (List separately in addition to code for primary procedure) $764
33523 Coronary artery bypass, using venous graft(s) and arterial graft(s); 6 or more venous grafts (List separately in addition to code for primary procedure) $869
33530 Reoperation, coronary artery bypass procedure or valve procedure, more than 1 month after original operation (List separately in addition to code for primary procedure) $549
33533 Coronary artery bypass, using arterial graft(s); single arterial graft $1,947
33534 Coronary artery bypass, using arterial graft(s); 2 coronary arterial grafts $2,291
33535 Coronary artery bypass, using arterial graft(s); 3 coronary arterial grafts $2,555
33536 Coronary artery bypass, using arterial graft(s); 4 or more coronary arterial grafts $2,754
35600 Harvest of upper extremity artery, 1 segment, for coronary artery bypass procedure (List separately in addition to code for primary procedure) $267
CPT Code Description Medicare National Average Physician Payment3
Facility Setting
36013 Introduction of catheter, right heart or main pulmonary artery4 $131
36200 Introduction of catheter, aorta4 $160
36620 Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous4 $53
93318 - 26 Echocardiography, transesophageal (TEE) for monitoring purposes, including probe placement, real time 2D image acquisition and interpretation leading to ongoing (continuous) assessment of (dynamically changing) cardiac pumping function and to therapeutic measures on an immediate time basis5 $119
93503 Insertion and placement of flow directed catheter (e.g., Swan-Ganz catheter) for monitoring purposes $132

Medicare reimburses inpatient hospital services under the Inpatient Prospective Payment System (IPPS), which bases payment on Medicare Severity-Diagnosis Related Groups (MS-DRGs). All services and supplies provided during the inpatient admission are bundled into a single MS-DRG payment rate for each patient regardless of the length of stay, intensity of treatments, or number of procedures performed. MS-DRG assignment is usually determined based on the patient’s primary diagnosis or procedure performed, as indicated by the ICD-10-PCS codes on the billing form.

MS-DRG6DescriptionFY2017 Medicare National Average Payment
Valve Repair/Replacement Procedures
216 Cardiac valve procedures and other major cardiothoracic procedures with cardiac catheterization with MCC $57,511
217 Cardiac valve procedures and other major cardiothoracic procedures with cardiac catheterization with CC $37,688
218 Cardiac valve procedures and other major cardiothoracic procedures with cardiac catheterization without MCC or CC $33,800
219 Cardiac valve procedures and other major cardiothoracic procedures without cardiac catheterization with MCC $45,985
220 Cardiac valve procedures and other major cardiothoracic procedures without cardiac catheterization with CC $30,744
221 Cardiac valve procedures and other major cardiothoracic procedures without cardiac catheterization without MCC or CC $27,494
CABG Procedures
231 Coronary bypass with PTCA with MCC $48,102
232 Coronary bypass with PTCA without MCC $35,109
233 Coronary bypass with cardiac catheterization with MCC $44,652
234 Coronary bypass with cardiac catheterization without MCC $29,533
235 Coronary bypass without cardiac catheterization with MCC $34,376
236 Coronary bypass without cardiac catheterization without MCC $22,971

Medicare inpatient hospital reimbursement is based upon the Medicare Severity-Diagnosis Related Group (MS-DRG) classification system, which assigns MS-DRGs based on the International Classification of Diseases, Tenth Revision, Procedure Coding System. The compliance date for mandatory use of ICD-10 codes was October 1, 20157, and this guide provides the cross-over codes for reference only.

ICD-10-PCS
Section and Body System10
ICD-10-PCS Procedure Code10Description
New Technology Group 2 - Cardiovascular System

Procedure codes specifically to be used with EDWARDS INTUITY Elite valve system
X2RF032 Replacement, Zooplastic Tissue, Rapid Deployment Technique, Open Approach
X2RF332 Replacement, Zooplastic Tissue, Rapid Deployment Technique, Percutaneous Approach
X2RF432 Replacement, Zooplastic Tissue, Rapid Deployment Technique, Percutaneous Endoscopic Approach
ICD-9-CM Procedure Code9DescriptionICD-10-PCS Procedure Code10Description
35.00 Closed heart valvotomy, unspecified valve 02NF3ZZ Release Aortic Valve, Percutaneous Approach
02NF4ZZ Release Aortic Valve, Percutaneous Endoscopic Approach
02NG3ZZ Release Mitral Valve, Percutaneous Approach
02NG4ZZ Release Mitral Valve, Percutaneous Endoscopic Approach
02NH3ZZ Release Pulmonary Valve, Percutaneous Approach
02NH4ZZ Release Pulmonary Valve, Percutaneous Endoscopic Approach
02NJ3ZZ Release Tricuspid Valve, Percutaneous Approach
02NJ4ZZ Release Tricuspid Valve, Percutaneous Endoscopic Approach
35.01 Closed heart valvotomy, aortic valve 02CF3ZZ Extirpation of Matter from Aortic Valve, Percutaneous Approach
02CF4ZZ Extirpation of Matter from Aortic Valve, Percutaneous Endoscopic Approach
02NF3ZZ Release Aortic Valve, Percutaneous Approach
02NF4ZZ Release Aortic Valve, Percutaneous Endoscopic Approach
35.02 Closed heart valvotomy, mitral valve 02CG3ZZ Extirpation of Matter from Mitral Valve, Percutaneous Approach
02CG4ZZ Extirpation of Matter from Mitral Valve, Percutaneous Endoscopic Approach
02NG3ZZ Release Mitral Valve, Percutaneous Approach
02NG4ZZ Release Mitral Valve, Percutaneous Endoscopic Approach
35.03 Closed heart valvotomy, pulmonary valve 02CH3ZZ Extirpation of Matter from Pulmonary Valve, Percutaneous Approach
02CH4ZZ Extirpation of Matter from Pulmonary Valve, Percutaneous Endoscopic Approach
02NH3ZZ Release Pulmonary Valve, Percutaneous Approach
02NH4ZZ Release Pulmonary Valve, Percutaneous Endoscopic Approach
35.04 Closed heart valvotomy, tricuspid valve 02CJ3ZZ Extirpation of Matter from Tricuspid Valve, Percutaneous Approach
02CJ4ZZ Extirpation of Matter from Tricuspid Valve, Percutaneous Endoscopic Approach
02NJ3ZZ Release Tricuspid Valve, Percutaneous Approach
02NJ4ZZ Release Tricuspid Valve, Percutaneous Endoscopic Approach
35.10 Open heart valvuloplasty without replacement, unspecified valve 02QF0ZZ Repair Aortic Valve, Open Approach
02QG0ZZ Repair Mitral Valve, Open Approach
02QH0ZZ Repair Pulmonary Valve, Open Approach
02QJ0ZZ Repair Tricuspid Valve, Open Approach
35.11 Open heart valvuloplasty of aortic valve without replacement 027F04Z Dilation of Aortic Valve with Drug-eluting Intraluminal Device, Open Approach
027F0DZ Dilation of Aortic Valve with Intraluminal Device, Open Approach
027F0ZZ Dilation of Aortic Valve, Open Approach
02NF0ZZ Release Aortic Valve, Open Approach
02QF0ZZ Repair Aortic Valve, Open Approach
35.12 Open heart valvuloplasty of mitral valve without replacement 027G04Z Dilation of Mitral Valve with Drug-eluting Intraluminal Device, Open Approach
027G0DZ Dilation of Mitral Valve with Intraluminal Device, Open Approach
027G0ZZ Dilation of Mitral Valve, Open Approach
02NG0ZZ Release Mitral Valve, Open Approach
02QG0ZZ Repair Mitral Valve, Open Approach
35.13 Open heart valvuloplasty of pulmonary valve without replacement 027H04Z Dilation of Pulmonary Valve with Drug-eluting Intraluminal Device, Open Approach
027H0DZ Dilation of Pulmonary Valve with Intraluminal Device, Open Approach
027H0ZZ Dilation of Pulmonary Valve, Open Approach
02NH0ZZ Release Pulmonary Valve, Open Approach
02QH0ZZ Repair Pulmonary Valve, Open Approach
35.14 Open heart valvuloplasty of tricuspid valve without replacement 027J04Z Dilation of Tricuspid Valve with Drug-eluting Intraluminal Device, Open Approach
027J0DZ Dilation of Tricuspid Valve with Intraluminal Device, Open Approach
027J0ZZ Dilation of Tricuspid Valve, Open Approach
02NJ0ZZ Release Tricuspid Valve, Open Approach
02QJ0ZZ Repair Tricuspid Valve, Open Approach
35.20 Open and other replacement of unspecified heart valve 02RF07Z Replacement of Aortic Valve with Autologous Tissue Substitute, Open Approach
02RF08Z Replacement of Aortic Valve with Zooplastic Tissue, Open Approach
02RF0JZ Replacement of Aortic Valve with Synthetic Substitute, Open Approach
02RF0KZ Replacement of Aortic Valve with Nonautologous Tissue Substitute, Open Approach
02RF47Z Replacement of Aortic Valve with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
02RF48Z Replacement of Aortic Valve with Zooplastic Tissue, Percutaneous Endoscopic Approach
02RF4JZ Replacement of Aortic Valve with Synthetic Substitute, Percutaneous Endoscopic Approach
02RF4KZ Replacement of Aortic Valve with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02RG07Z Replacement of Mitral Valve with Autologous Tissue Substitute, Open Approach
02RG08Z Replacement of Mitral Valve with Zooplastic Tissue, Open Approach
02RG0JZ Replacement of Mitral Valve with Synthetic Substitute, Open Approach
02RG0KZ Replacement of Mitral Valve with Nonautologous Tissue Substitute, Open Approach
02RG47Z Replacement of Mitral Valve with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
02RG48Z Replacement of Mitral Valve with Zooplastic Tissue, Percutaneous Endoscopic Approach
02RG4JZ Replacement of Mitral Valve with Synthetic Substitute, Percutaneous Endoscopic Approach
02RG4KZ Replacement of Mitral Valve with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02RH07Z Replacement of Pulmonary Valve with Autologous Tissue Substitute, Open Approach
02RH08Z Replacement of Pulmonary Valve with Zooplastic Tissue, Open Approach
02RH0JZ Replacement of Pulmonary Valve with Synthetic Substitute, Open Approach
02RH0KZ Replacement of Pulmonary Valve with Nonautologous Tissue Substitute, Open Approach
02RH47Z Replacement of Pulmonary Valve with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
02RH48Z Replacement of Pulmonary Valve with Zooplastic Tissue, Percutaneous Endoscopic Approach
02RH4JZ Replacement of Pulmonary Valve with Synthetic Substitute, Percutaneous Endoscopic Approach
02RH4KZ Replacement of Pulmonary Valve with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02RJ07Z Replacement of Tricuspid Valve with Autologous Tissue Substitute, Open Approach
02RJ08Z Replacement of Tricuspid Valve with Zooplastic Tissue, Open Approach
02RJ0JZ Replacement of Tricuspid Valve with Synthetic Substitute, Open Approach
02RJ0KZ Replacement of Tricuspid Valve with Nonautologous Tissue Substitute, Open Approach
02RJ47Z Replacement of Tricuspid Valve with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
02RJ48Z Replacement of Tricuspid Valve with Zooplastic Tissue, Percutaneous Endoscopic Approach
02RJ4JZ Replacement of Tricuspid Valve with Synthetic Substitute, Percutaneous Endoscopic Approach
02RJ4KZ Replacement of Tricuspid Valve with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
35.21 Open and other replacement of aortic valve with tissue graft 02RF07Z Replacement of Aortic Valve with Autologous Tissue Substitute, Open Approach
02RF08Z Replacement of Aortic Valve with Zooplastic Tissue, Open Approach
02RF0KZ Replacement of Aortic Valve with Nonautologous Tissue Substitute, Open Approach
02RF47Z Replacement of Aortic Valve with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
02RF48Z Replacement of Aortic Valve with Zooplastic Tissue, Percutaneous Endoscopic Approach
02RF4KZ Replacement of Aortic Valve with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
35.22 Open and other replacement of aortic valve 02RF0JZ Replacement of Aortic Valve with Synthetic Substitute, Open Approach
02RF4JZ Replacement of Aortic Valve with Synthetic Substitute, Percutaneous Endoscopic Approach
35.23 Open and other replacement of mitral valve with tissue graft 02RG07Z Replacement of Mitral Valve with Autologous Tissue Substitute, Open Approach
02RG08Z Replacement of Mitral Valve with Zooplastic Tissue, Open Approach
02RG0KZ Replacement of Mitral Valve with Nonautologous Tissue Substitute, Open Approach
02RG37Z Replacement of Mitral Valve with Autologous Tissue Substitute, Percutaneous Approach
02RG38Z Replacement of Mitral Valve with Zooplastic Tissue, Percutaneous Approach
02RG3KZ Replacement of Mitral Valve with Nonautologous Tissue Substitute, Percutaneous Approach
02RG47Z Replacement of Mitral Valve with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
02RG48Z Replacement of Mitral Valve with Zooplastic Tissue, Percutaneous Endoscopic Approach
02RG4KZ Replacement of Mitral Valve with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
35.24 Open and other replacement of mitral valve 02RG0JZ Replacement of Mitral Valve with Synthetic Substitute, Open Approach
02RG3JZ Replacement of Mitral Valve with Synthetic Substitute, Percutaneous Approach
02RG4JZ Replacement of Mitral Valve with Synthetic Substitute, Percutaneous Endoscopic Approach
35.26 Open and other replacement of pulmonary valve 02RH0JZ Replacement of Pulmonary Valve with Synthetic Substitute, Open Approach
02RH4JZ Replacement of Pulmonary Valve with Synthetic Substitute, Percutaneous Endoscopic Approach
35.27 Open and other replacement of tricuspid valve with tissue graft 02RJ07Z Replacement of Tricuspid Valve with Autologous Tissue Substitute, Open Approach
02RJ08Z Replacement of Tricuspid Valve with Zooplastic Tissue, Open Approach
02RJ0KZ Replacement of Tricuspid Valve with Nonautologous Tissue Substitute, Open Approach
02RJ47Z Replacement of Tricuspid Valve with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
02RJ48Z Replacement of Tricuspid Valve with Zooplastic Tissue, Percutaneous Endoscopic Approach
02RJ4KZ Replacement of Tricuspid Valve with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
35.28 Open and other replacement of tricuspid valve 02RJ0JZ Replacement of Tricuspid Valve with Synthetic Substitute, Open Approach
02RJ4JZ Replacement of Tricuspid Valve with Synthetic Substitute, Percutaneous Endoscopic Approach
35.33 Annuloplasty 02QF0ZZ Repair Aortic Valve, Open Approach
02QF3ZZ Repair Aortic Valve, Percutaneous Approach
02QF4ZZ Repair Aortic Valve, Percutaneous Approach
02QG0ZZ Repair Mitral Valve, Open Approach
02QG3ZZ Repair Mitral Valve, Percutaneous Approach
02QG4ZZ Repair Mitral Valve, Percutaneous Endoscopic Approach
02QH0ZZ Repair Pulmonary Valve, Open Approach
02QH3ZZ Repair Pulmonary Valve, Percutaneous Approach
02QH4ZZ Repair Pulmonary Valve, Percutaneous Endoscopic Approach
02QJ0ZZ Repair Tricuspid Valve, Open Approach
02QJ3ZZ Repair Tricuspid Valve, Percutaneous Approach
02QJ4ZZ Repair Tricuspid Valve, Percutaneous Endoscopic Approach
02UF07Z Supplement Aortic Valve with Autologous Tissue Substitute, Open Approach
02UF08Z Supplement Aortic Valve with Zooplastic Tissue, Open Approach
02UF0JZ Supplement Aortic Valve with Synthetic Substitute, Open Approach
02UF0KZ Supplement Aortic Valve with Nonautologous Tissue Substitute, Open Approach
02UF37Z Supplement Aortic Valve with Autologous Tissue Substitute, Percutaneous Approach
02UF38Z Supplement Aortic Valve with Zooplastic Tissue, Percutaneous Approach
02UF3JZ Supplement Aortic Valve with Synthetic Substitute, Percutaneous Approach
02UF3KZ Supplement Aortic Valve with Nonautologous Tissue Substitute, Percutaneous Approach
02UF47Z Supplement Aortic Valve with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
02UF48Z Supplement Aortic Valve with Zooplastic Tissue, Percutaneous Endoscopic Approach
02UF4JZ Supplement Aortic Valve with Synthetic Substitute, Percutaneous Endoscopic Approach
02UF4KZ Supplement Aortic Valve with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02UG07Z Supplement Mitral Valve with Autologous Tissue Substitute, Open Approach
02UG08Z Supplement Mitral Valve with Zooplastic Tissue, Open Approach
02UG0JZ Supplement Mitral Valve with Synthetic Substitute, Open Approach
02UG0KZ Supplement Mitral Valve with Nonautologous Tissue Substitute, Open Approach
02UG37Z Supplement Mitral Valve with Autologous Tissue Substitute, Percutaneous Approach
02UG38Z Supplement Mitral Valve with Zooplastic Tissue, Percutaneous Approach
02UG3JZ Supplement Mitral Valve with Synthetic Substitute, Percutaneous Approach
02UG3KZ Supplement Mitral Valve with Nonautologous Tissue Substitute, Percutaneous Approach
02UG47Z Supplement Mitral Valve with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
02UG48Z Supplement Mitral Valve with Zooplastic Tissue, Percutaneous Endoscopic Approach
02UG4JZ Supplement Mitral Valve with Synthetic Substitute, Percutaneous Endoscopic Approach
02UG4KZ Supplement Mitral Valve with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02UH07Z Supplement Pulmonary Valve with Autologous Tissue Substitute, Open Approach
02UH08Z Supplement Pulmonary Valve with Zooplastic Tissue, Open Approach
02UH0JZ Supplement Pulmonary Valve with Synthetic Substitute, Open Approach
02UH0KZ Supplement Pulmonary Valve with Nonautologous Tissue Substitute, Open Approach
02UH37Z Supplement Pulmonary Valve with Autologous Tissue Substitute, Percutaneous Approach
02UH38Z Supplement Pulmonary Valve with Zooplastic Tissue, Percutaneous Approach
02UH3JZ Supplement Pulmonary Valve with Synthetic Substitute, Percutaneous Approach
02UH3KZ Supplement Pulmonary Valve with Nonautologous Tissue Substitute, Percutaneous Approach
02UH47Z Supplement Pulmonary Valve with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
02UH48Z Supplement Pulmonary Valve with Zooplastic Tissue, Percutaneous Endoscopic Approach
02UH4JZ Supplement Pulmonary Valve with Synthetic Substitute, Percutaneous Endoscopic Approach
02UH4KZ Supplement Pulmonary Valve with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02UJ07Z Supplement Tricuspid Valve with Autologous Tissue Substitute, Open Approach
02UJ08Z Supplement Tricuspid Valve with Zooplastic Tissue, Open Approach
02UJ0JZ Supplement Tricuspid Valve with Synthetic Substitute, Open Approach
02UJ0KZ Supplement Tricuspid Valve with Nonautologous Tissue Substitute, Open Approach
02UJ37Z Supplement Tricuspid Valve with Autologous Tissue Substitute, Percutaneous Approach
02UJ38Z Supplement Tricuspid Valve with Zooplastic Tissue, Percutaneous Approach
02UJ3JZ Supplement Tricuspid Valve with Synthetic Substitute, Percutaneous Approach
02UJ3KZ Supplement Tricuspid Valve with Nonautologous Tissue Substitute, Percutaneous Approach
02UJ47Z Supplement Tricuspid Valve with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
02UJ48Z Supplement Tricuspid Valve with Zooplastic Tissue, Percutaneous Endoscopic Approach
02UJ4JZ Supplement Tricuspid Valve with Synthetic Substitute, Percutaneous Endoscopic Approach
02UJ4KZ Supplement Tricuspid Valve with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
35.99 Other operations on valves of heart 02CF0ZZ Extirpation of Matter from Aortic Valve, Open Approach
02CG0ZZ Extirpation of Matter from Mitral Valve, Open Approach
02CH0ZZ Extirpation of Matter from Pulmonary Valve, Open Approach
02CJ0ZZ Extirpation of Matter from Tricuspid Valve, Open Approach
02QF0ZZ Repair Aortic Valve, Open Approach
02QG0ZZ Repair Mitral Valve, Open Approach
02QH0ZZ Repair Pulmonary Valve, Open Approach
02QJ0ZZ Repair Tricuspid Valve, Open Approach
02TH0ZZ Resection of Pulmonary Valve, Open Approach
02TH3ZZ Resection of Pulmonary Valve, Percutaneous Approach
02TH4ZZ Resection of Pulmonary Valve, Percutaneous Endoscopic Approach
37.68 Insertion of percutaneous external heart assist device 02HA3RZ Insertion of External Heart Assist System into Heart, Percutaneous Approach
5A02116 Assistance with Cardiac Output using Other Pump, Intermittent
5A0211D Assistance with Cardiac Output using Impeller Pump, Intermittent
5A02216 Assistance with Cardiac Output using Other Pump, Continuous
5A0221D Assistance with Cardiac Output using Impeller Pump, Continuous
38.45 Resection of vessel with replacement, thoracic vessels 02RP07Z Replacement of Pulmonary Trunk with Autologous Tissue Substitute, Open Approach
02RP08Z Replacement of Pulmonary Trunk with Zooplastic Tissue, Open Approach
02RP0JZ Replacement of Pulmonary Trunk with Synthetic Substitute, Open Approach
02RP0KZ Replacement of Pulmonary Trunk with Nonautologous Tissue Substitute, Open Approach
02RP47Z Replacement of Pulmonary Trunk with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
02RP48Z Replacement of Pulmonary Trunk with Zooplastic Tissue, Percutaneous Endoscopic Approach
02RP4JZ Replacement of Pulmonary Trunk with Synthetic Substitute, Percutaneous Endoscopic Approach
02RP4KZ Replacement of Pulmonary Trunk with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02RQ07Z Replacement of Right Pulmonary Artery with Autologous Tissue Substitute, Open Approach
02RQ08Z Replacement of Right Pulmonary Artery with Zooplastic Tissue, Open Approach
02RQ0JZ Replacement of Right Pulmonary Artery with Synthetic Substitute, Open Approach
02RQ0KZ Replacement of Right Pulmonary Artery with Nonautologous Tissue Substitute, Open Approach
02RQ47Z Replacement of Right Pulmonary Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
02RQ48Z Replacement of Right Pulmonary Artery with Zooplastic Tissue, Percutaneous Endoscopic Approach
02RQ4JZ Replacement of Right Pulmonary Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
02RQ4KZ Replacement of Right Pulmonary Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02RR07Z Replacement of Left Pulmonary Artery with Autologous Tissue Substitute, Open Approach
02RR08Z Replacement of Left Pulmonary Artery with Zooplastic Tissue, Open Approach
02RR0JZ Replacement of Left Pulmonary Artery with Synthetic Substitute, Open Approach
02RR0KZ Replacement of Left Pulmonary Artery with Nonautologous Tissue Substitute, Open Approach
02RR47Z Replacement of Left Pulmonary Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
02RR48Z Replacement of Left Pulmonary Artery with Zooplastic Tissue, Percutaneous Endoscopic Approach
02RR4JZ Replacement of Left Pulmonary Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
02RR4KZ Replacement of Left Pulmonary Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02RS07Z Replacement of Right Pulmonary Vein with Autologous Tissue Substitute, Open Approach
02RS08Z Replacement of Right Pulmonary Vein with Zooplastic Tissue, Open Approach
02RS0JZ Replacement of Right Pulmonary Vein with Synthetic Substitute, Open Approach
02RS0KZ Replacement of Right Pulmonary Vein with Nonautologous Tissue Substitute, Open Approach
02RS47Z Replacement of Right Pulmonary Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
02RS48Z Replacement of Right Pulmonary Vein with Zooplastic Tissue, Percutaneous Endoscopic Approach
02RS4JZ Replacement of Right Pulmonary Vein with Synthetic Substitute, Percutaneous Endoscopic Approach
02RS4KZ Replacement of Right Pulmonary Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02RT07Z Replacement of Left Pulmonary Vein with Autologous Tissue Substitute, Open Approach
02RT08Z Replacement of Left Pulmonary Vein with Zooplastic Tissue, Open Approach
02RT0JZ Replacement of Left Pulmonary Vein with Synthetic Substitute, Open Approach
02RT0KZ Replacement of Left Pulmonary Vein with Nonautologous Tissue Substitute, Open Approach
02RT47Z Replacement of Left Pulmonary Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
02RT48Z Replacement of Left Pulmonary Vein with Zooplastic Tissue, Percutaneous Endoscopic Approach
02RT4JZ Replacement of Left Pulmonary Vein with Synthetic Substitute, Percutaneous Endoscopic Approach
02RT4KZ Replacement of Left Pulmonary Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02RV07Z Replacement of Superior Vena Cava with Autologous Tissue Substitute, Open Approach
02RV08Z Replacement of Superior Vena Cava with Zooplastic Tissue, Open Approach
02RV0JZ Replacement of Superior Vena Cava with Synthetic Substitute, Open Approach
02RV0KZ Replacement of Superior Vena Cava with Nonautologous Tissue Substitute, Open Approach
02RV47Z Replacement of Superior Vena Cava with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
02RV48Z Replacement of Superior Vena Cava with Zooplastic Tissue, Percutaneous Endoscopic Approach
02RV4JZ Replacement of Superior Vena Cava with Synthetic Substitute, Percutaneous Endoscopic Approach
02RV4KZ Replacement of Superior Vena Cava with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02RW07Z Replacement of Thoracic Aorta with Autologous Tissue Substitute, Open Approach
02RW08Z Replacement of Thoracic Aorta with Zooplastic Tissue, Open Approach
02RW0JZ Replacement of Thoracic Aorta with Synthetic Substitute, Open Approach
02RW0KZ Replacement of Thoracic Aorta with Nonautologous Tissue Substitute, Open Approach
02RW48Z Replacement of Thoracic Aorta with Zooplastic Tissue, Percutaneous Endoscopic Approach
02RW48Z Replacement of Thoracic Aorta with Zooplastic Tissue, Percutaneous Endoscopic Approach
02RW4JZ Replacement of Thoracic Aorta with Synthetic Substitute, Percutaneous Endoscopic Approach
02RW4KZ Replacement of Thoracic Aorta with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
03R007Z Replacement of Right Internal Mammary Artery with Autologous Tissue Substitute, Open Approach
03R00JZ Replacement of Right Internal Mammary Artery with Synthetic Substitute, Open Approach
03R00KZ Replacement of Right Internal Mammary Artery with Nonautologous Tissue Substitute, Open Approach
03R047Z Replacement of Right Internal Mammary Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
03R04JZ Replacement of Right Internal Mammary Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
03R04KZ Replacement of Right Internal Mammary Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
03R107Z Replacement of Left Internal Mammary Artery with Autologous Tissue Substitute, Open Approach
03R10JZ Replacement of Left Internal Mammary Artery with Synthetic Substitute, Open Approach
03R10KZ Replacement of Left Internal Mammary Artery with Nonautologous Tissue Substitute, Open Approach
03R147Z Replacement of Left Internal Mammary Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
03R14JZ Replacement of Left Internal Mammary Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
03R14KZ Replacement of Left Internal Mammary Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
03R207Z Replacement of Innominate Artery with Autologous Tissue Substitute, Open Approach
03R20JZ Replacement of Innominate Artery with Synthetic Substitute, Open Approach
03R20KZ Replacement of Innominate Artery with Nonautologous Tissue Substitute, Open Approach
03R247Z Replacement of Innominate Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
03R24JZ Replacement of Innominate Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
03R24KZ Replacement of Innominate Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
03R307Z Replacement of Right Subclavian Artery with Autologous Tissue Substitute, Open Approach
03R30JZ Replacement of Right Subclavian Artery with Synthetic Substitute, Open Approach
03R30KZ Replacement of Right Subclavian Artery with Nonautologous Tissue Substitute, Open Approach
03R347Z Replacement of Right Subclavian Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
03R34JZ Replacement of Right Subclavian Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
03R34KZ Replacement of Right Subclavian Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
03R407Z Replacement of Left Subclavian Artery with Autologous Tissue Substitute, Open Approach
03R40JZ Replacement of Left Subclavian Artery with Synthetic Substitute, Open Approach
03R40KZ Replacement of Left Subclavian Artery with Nonautologous Tissue Substitute, Open Approach
03R447Z Replacement of Left Subclavian Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
03R44JZ Replacement of Left Subclavian Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
03R44KZ Replacement of Left Subclavian Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
05R007Z Replacement of Azygos Vein with Autologous Tissue Substitute, Open Approach
05R00JZ Replacement of Azygos Vein with Synthetic Substitute, Open Approach
05R00KZ Replacement of Azygos Vein with Nonautologous Tissue Substitute, Open Approach
05R047Z Replacement of Azygos Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
05R04JZ Replacement of Azygos Vein with Synthetic Substitute, Percutaneous Endoscopic Approach
05R04KZ Replacement of Azygos Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
05R107Z Replacement of Hemiazygos Vein with Autologous Tissue Substitute, Open Approach
05R10JZ Replacement of Hemiazygos Vein with Synthetic Substitute, Open Approach
05R10KZ Replacement of Hemiazygos Vein with Nonautologous Tissue Substitute, Open Approach
05R147Z Replacement of Hemiazygos Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
05R14JZ Replacement of Hemiazygos Vein with Synthetic Substitute, Percutaneous Endoscopic Approach
05R14KZ Replacement of Hemiazygos Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
05R307Z Replacement of Right Innominate Vein with Autologous Tissue Substitute, Open Approach
05R30JZ Replacement of Right Innominate Vein with Synthetic Substitute, Open Approach
05R30KZ Replacement of Right Innominate Vein with Nonautologous Tissue Substitute, Open Approach
05R347Z Replacement of Right Innominate Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
05R34JZ Replacement of Right Innominate Vein with Synthetic Substitute, Percutaneous Endoscopic Approach
05R34KZ Replacement of Right Innominate Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
05R407Z Replacement of Left Innominate Vein with Autologous Tissue Substitute, Open Approach
05R407Z Replacement of Left Innominate Vein with Autologous Tissue Substitute, Open Approach
05R40JZ Replacement of Left Innominate Vein with Synthetic Substitute, Open Approach
05R40JZ Replacement of Left Innominate Vein with Synthetic Substitute, Open Approach
05R40KZ Replacement of Left Innominate Vein with Nonautologous Tissue Substitute, Open Approach
05R40KZ Replacement of Left Innominate Vein with Nonautologous Tissue Substitute, Open Approach
05R447Z Replacement of Left Innominate Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
05R447Z Replacement of Left Innominate Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
05R44JZ Replacement of Left Innominate Vein with Synthetic Substitute, Percutaneous Endoscopic Approach
05R44JZ Replacement of Left Innominate Vein with Synthetic Substitute, Percutaneous Endoscopic Approach
05R44KZ Replacement of Left Innominate Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
05R44KZ Replacement of Left Innominate Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
05R607Z Replacement of Left Subclavian Vein with Autologous Tissue Substitute, Open Approach
05R60JZ Replacement of Left Subclavian Vein with Synthetic Substitute, Open Approach
05R60KZ Replacement of Left Subclavian Vein with Nonautologous Tissue Substitute, Open Approach
05R647Z Replacement of Left Subclavian Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
05R64JZ Replacement of Left Subclavian Vein with Synthetic Substitute, Percutaneous Endoscopic Approach
05R64KZ Replacement of Left Subclavian Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
38.91 Arterial catheterization 02HP03Z Insertion of Infusion Device into Pulmonary Trunk, Open Approach
02HP33Z Insertion of Infusion Device into Pulmonary Trunk, Percutaneous Approach
02HP43Z Insertion of Infusion Device into Pulmonary Trunk, Percutaneous Endoscopic Approach
02HQ03Z Insertion of Infusion Device into Right Pulmonary Artery, Open Approach
02HQ33Z Insertion of Infusion Device into Right Pulmonary Artery, Percutaneous Approach
02HQ43Z Insertion of Infusion Device into Right Pulmonary Artery, Percutaneous Endoscopic Approach
02HR03Z Insertion of Infusion Device into Left Pulmonary Artery, Open Approach
02HR33Z Insertion of Infusion Device into Left Pulmonary Artery, Percutaneous Approach
02HR43Z Insertion of Infusion Device into Left Pulmonary Artery, Percutaneous Endoscopic Approach
02HW03Z Insertion of Infusion Device into Thoracic Aorta, Open Approach
02HW33Z Insertion of Infusion Device into Thoracic Aorta, Percutaneous Approach
02HW43Z Insertion of Infusion Device into Thoracic Aorta, Percutaneous Endoscopic Approach
03H003Z Insertion of Infusion Device into Right Internal Mammary Artery, Open Approach
03H033Z Insertion of Infusion Device into Right Internal Mammary Artery, Percutaneous Approach
03H043Z Insertion of Infusion Device into Right Internal Mammary Artery, Percutaneous Endoscopic Approach
03H103Z Insertion of Infusion Device into Left Internal Mammary Artery, Open Approach
03H133Z Insertion of Infusion Device into Left Internal Mammary Artery, Percutaneous Approach
03H143Z Insertion of Infusion Device into Left Internal Mammary Artery, Percutaneous Endoscopic Approach
03H203Z Insertion of Infusion Device into Innominate Artery, Open Approach
03H233Z Insertion of Infusion Device into Innominate Artery, Percutaneous Approach
03H243Z Insertion of Infusion Device into Innominate Artery, Percutaneous Endoscopic Approach
03H303Z Insertion of Infusion Device into Right Subclavian Artery, Open Approach
03H333Z Insertion of Infusion Device into Right Subclavian Artery, Percutaneous Approach
03H343Z Insertion of Infusion Device into Right Subclavian Artery, Percutaneous Endoscopic Approach
03H403Z Insertion of Infusion Device into Left Subclavian Artery, Open Approach
03H433Z Insertion of Infusion Device into Left Subclavian Artery, Percutaneous Approach
03H443Z Insertion of Infusion Device into Left Subclavian Artery, Percutaneous Endoscopic Approach
03H503Z Insertion of Infusion Device into Right Axillary Artery, Open Approach
03H533Z Insertion of Infusion Device into Right Axillary Artery, Percutaneous Approach
03H543Z Insertion of Infusion Device into Right Axillary Artery, Percutaneous Endoscopic Approach
03H603Z Insertion of Infusion Device into Left Axillary Artery, Open Approach
03H633Z Insertion of Infusion Device into Left Axillary Artery, Percutaneous Approach
03H643Z Insertion of Infusion Device into Left Axillary Artery, Percutaneous Endoscopic Approach
03H703Z Insertion of Infusion Device into Right Brachial Artery, Open Approach
03H733Z Insertion of Infusion Device into Right Brachial Artery, Percutaneous Approach
03H743Z Insertion of Infusion Device into Right Brachial Artery, Percutaneous Endoscopic Approach
03H803Z Insertion of Infusion Device into Left Brachial Artery, Open Approach
03H833Z Insertion of Infusion Device into Left Brachial Artery, Percutaneous Approach
03H843Z Insertion of Infusion Device into Left Brachial Artery, Percutaneous Endoscopic Approach
03H903Z Insertion of Infusion Device into Right Ulnar Artery, Open Approach
03H933Z Insertion of Infusion Device into Right Ulnar Artery, Percutaneous Approach
03H943Z Insertion of Infusion Device into Right Ulnar Artery, Percutaneous Endoscopic Approach
03HA03Z Insertion of Infusion Device into Left Ulnar Artery, Open Approach
03HA33Z Insertion of Infusion Device into Left Ulnar Artery, Percutaneous Approach
03HA43Z Insertion of Infusion Device into Left Ulnar Artery, Percutaneous Endoscopic Approach
03HB03Z Insertion of Infusion Device into Right Radial Artery, Open Approach
03HB33Z Insertion of Infusion Device into Right Radial Artery, Percutaneous Approach
03HB43Z Insertion of Infusion Device into Right Radial Artery, Percutaneous Endoscopic Approach
03HC03Z Insertion of Infusion Device into Left Radial Artery, Open Approach
03HC33Z Insertion of Infusion Device into Left Radial Artery, Percutaneous Approach
03HC43Z Insertion of Infusion Device into Left Radial Artery, Percutaneous Endoscopic Approach
03HD03Z Insertion of Infusion Device into Right Hand Artery, Open Approach
03HD33Z Insertion of Infusion Device into Right Hand Artery, Percutaneous Approach
03HD43Z Insertion of Infusion Device into Right Hand Artery, Percutaneous Endoscopic Approach
03HF03Z Insertion of Infusion Device into Left Hand Artery, Open Approach
03HF33Z Insertion of Infusion Device into Left Hand Artery, Percutaneous Approach
03HF43Z Insertion of Infusion Device into Left Hand Artery, Percutaneous Endoscopic Approach
03HG03Z Insertion of Infusion Device into Intracranial Artery, Open Approach
03HG33Z Insertion of Infusion Device into Intracranial Artery, Percutaneous Approach
03HG43Z Insertion of Infusion Device into Intracranial Artery, Percutaneous Endoscopic Approach
03HH03Z Insertion of Infusion Device into Right Common Carotid Artery, Open Approach
03HH33Z Insertion of Infusion Device into Right Common Carotid Artery, Percutaneous Approach
03HH43Z Insertion of Infusion Device into Right Common Carotid Artery, Percutaneous Endoscopic Approach
03HJ03Z Insertion of Infusion Device into Left Common Carotid Artery, Open Approach
03HJ33Z Insertion of Infusion Device into Left Common Carotid Artery, Percutaneous Approach
03HJ43Z Insertion of Infusion Device into Left Common Carotid Artery, Percutaneous Endoscopic Approach
03HK03Z Insertion of Infusion Device into Right Internal Carotid Artery, Open Approach
03HK33Z Insertion of Infusion Device into Right Internal Carotid Artery, Percutaneous Approach
03HK43Z Insertion of Infusion Device into Right Internal Carotid Artery, Percutaneous Endoscopic Approach
03HL03Z Insertion of Infusion Device into Left Internal Carotid Artery, Open Approach
03HL33Z Insertion of Infusion Device into Left Internal Carotid Artery, Percutaneous Approach
03HL43Z Insertion of Infusion Device into Left Internal Carotid Artery, Percutaneous Endoscopic Approach
03HM03Z Insertion of Infusion Device into Right External Carotid Artery, Open Approach
03HM33Z Insertion of Infusion Device into Right External Carotid Artery, Percutaneous Approach
03HM43Z Insertion of Infusion Device into Right External Carotid Artery, Percutaneous Endoscopic Approach
03HN03Z Insertion of Infusion Device into Left External Carotid Artery, Open Approach
03HN33Z Insertion of Infusion Device into Left External Carotid Artery, Percutaneous Approach
03HN43Z Insertion of Infusion Device into Left External Carotid Artery, Percutaneous Endoscopic Approach
03HP03Z Insertion of Infusion Device into Right Vertebral Artery, Open Approach
03HP33Z Insertion of Infusion Device into Right Vertebral Artery, Percutaneous Approach
03HP43Z Insertion of Infusion Device into Right Vertebral Artery, Percutaneous Endoscopic Approach
03HQ03Z Insertion of Infusion Device into Left Vertebral Artery, Open Approach
03HQ33Z Insertion of Infusion Device into Left Vertebral Artery, Percutaneous Approach
03HQ43Z Insertion of Infusion Device into Left Vertebral Artery, Percutaneous Endoscopic Approach
03HR03Z Insertion of Infusion Device into Face Artery, Open Approach
03HR33Z Insertion of Infusion Device into Face Artery, Percutaneous Approach
03HR43Z Insertion of Infusion Device into Face Artery, Percutaneous Endoscopic Approach
03HS03Z Insertion of Infusion Device into Right Temporal Artery, Open Approach
03HS33Z Insertion of Infusion Device into Right Temporal Artery, Percutaneous Approach
03HS43Z Insertion of Infusion Device into Right Temporal Artery, Percutaneous Endoscopic Approach
03HT03Z Insertion of Infusion Device into Left Temporal Artery, Open Approach
03HT33Z Insertion of Infusion Device into Left Temporal Artery, Percutaneous Approach
03HT43Z Insertion of Infusion Device into Left Temporal Artery, Percutaneous Endoscopic Approach
03HU03Z Insertion of Infusion Device into Right Thyroid Artery, Open Approach
03HU33Z Insertion of Infusion Device into Right Thyroid Artery, Percutaneous Approach
03HU43Z Insertion of Infusion Device into Right Thyroid Artery, Percutaneous Endoscopic Approach
03HV03Z Insertion of Infusion Device into Left Thyroid Artery, Open Approach
03HV33Z Insertion of Infusion Device into Left Thyroid Artery, Percutaneous Approach
03HV43Z Insertion of Infusion Device into Left Thyroid Artery, Percutaneous Endoscopic Approach
03HY03Z Insertion of Infusion Device into Upper Artery, Open Approach
03HY33Z Insertion of Infusion Device into Upper Artery, Percutaneous Approach
03HY43Z Insertion of Infusion Device into Upper Artery, Percutaneous Endoscopic Approach
04H003Z Insertion of Infusion Device into Abdominal Aorta, Open Approach
04H033Z Insertion of Infusion Device into Abdominal Aorta, Percutaneous Approach
04H043Z Insertion of Infusion Device into Abdominal Aorta, Percutaneous Endoscopic Approach
04H103Z Insertion of Infusion Device into Celiac Artery, Open Approach
04H133Z Insertion of Infusion Device into Celiac Artery, Percutaneous Approach
04H143Z Insertion of Infusion Device into Celiac Artery, Percutaneous Endoscopic Approach
04H203Z Insertion of Infusion Device into Gastric Artery, Open Approach
04H233Z Insertion of Infusion Device into Gastric Artery, Percutaneous Approach
04H243Z Insertion of Infusion Device into Gastric Artery, Percutaneous Endoscopic Approach
04H303Z Insertion of Infusion Device into Hepatic Artery, Open Approach
04H333Z Insertion of Infusion Device into Hepatic Artery, Percutaneous Approach
04H343Z Insertion of Infusion Device into Hepatic Artery, Percutaneous Endoscopic Approach
04H403Z Insertion of Infusion Device into Splenic Artery, Open Approach
04H433Z Insertion of Infusion Device into Splenic Artery, Percutaneous Approach
04H443Z Insertion of Infusion Device into Splenic Artery, Percutaneous Endoscopic Approach
04H503Z Insertion of Infusion Device into Superior Mesenteric Artery, Open Approach
04H533Z Insertion of Infusion Device into Superior Mesenteric Artery, Percutaneous Approach
04H543Z Insertion of Infusion Device into Superior Mesenteric Artery, Percutaneous Endoscopic Approach
04H603Z Insertion of Infusion Device into Right Colic Artery, Open Approach
04H633Z Insertion of Infusion Device into Right Colic Artery, Percutaneous Approach
04H643Z Insertion of Infusion Device into Right Colic Artery, Percutaneous Endoscopic Approach
04H703Z Insertion of Infusion Device into Left Colic Artery, Open Approach
04H733Z Insertion of Infusion Device into Left Colic Artery, Percutaneous Approach
04H743Z Insertion of Infusion Device into Left Colic Artery, Percutaneous Endoscopic Approach
04H803Z Insertion of Infusion Device into Middle Colic Artery, Open Approach
04H833Z Insertion of Infusion Device into Middle Colic Artery, Percutaneous Approach
04H843Z Insertion of Infusion Device into Middle Colic Artery, Percutaneous Endoscopic Approach
04H903Z Insertion of Infusion Device into Right Renal Artery, Open Approach
04H933Z Insertion of Infusion Device into Right Renal Artery, Percutaneous Approach
04H943Z Insertion of Infusion Device into Right Renal Artery, Percutaneous Endoscopic Approach
04HA33Z Insertion of Infusion Device into Left Renal Artery, Open Approach
02QJ4ZZ Insertion of Infusion Device into Left Renal Artery, Percutaneous Approach
04HA43Z Insertion of Infusion Device into Left Renal Artery, Percutaneous Endoscopic Approach
04HB03Z Insertion of Infusion Device into Inferior Mesenteric Artery, Open Approach
04HB33Z Insertion of Infusion Device into Inferior Mesenteric Artery, Percutaneous Approach
04HB43Z Insertion of Infusion Device into Inferior Mesenteric Artery, Percutaneous Endoscopic Approach
04HC03Z Insertion of Infusion Device into Right Common Iliac Artery, Open Approach
04HC33Z Insertion of Infusion Device into Right Common Iliac Artery, Percutaneous Approach
04HC43Z Insertion of Infusion Device into Right Common Iliac Artery, Percutaneous Endoscopic Approach
04HD03Z Insertion of Infusion Device into Left Common Iliac Artery, Open Approach
04HD33Z Insertion of Infusion Device into Left Common Iliac Artery, Percutaneous Approach
04HD43Z Insertion of Infusion Device into Left Common Iliac Artery, Percutaneous Endoscopic Approach
04HE03Z Insertion of Infusion Device into Right Internal Iliac Artery, Open Approach
04HE33Z Insertion of Infusion Device into Right Internal Iliac Artery, Percutaneous Approach
04HE43Z Insertion of Infusion Device into Right Internal Iliac Artery, Percutaneous Endoscopic Approach
04HF03Z Insertion of Infusion Device into Left Internal Iliac Artery, Open Approach
04HF33Z Insertion of Infusion Device into Left Internal Iliac Artery, Percutaneous Approach
04HF43Z Insertion of Infusion Device into Left Internal Iliac Artery, Percutaneous Endoscopic Approach
04HH03Z Insertion of Infusion Device into Right External Iliac Artery, Open Approach
04HH33Z Insertion of Infusion Device into Right External Iliac Artery, Percutaneous Approach
04HH43Z Insertion of Infusion Device into Right External Iliac Artery, Percutaneous Endoscopic Approach
04HJ03Z Insertion of Infusion Device into Left External Iliac Artery, Open Approach
04HJ33Z Insertion of Infusion Device into Left External Iliac Artery, Percutaneous Approach
04HJ43Z Insertion of Infusion Device into Left External Iliac Artery, Percutaneous Endoscopic Approach
04HK03Z Insertion of Infusion Device into Right Femoral Artery, Open Approach
04HK33Z Insertion of Infusion Device into Right Femoral Artery, Percutaneous Approach
04HK43Z Insertion of Infusion Device into Right Femoral Artery, Percutaneous Endoscopic Approach
04HL03Z Insertion of Infusion Device into Left Femoral Artery, Open Approach
04HL33Z Insertion of Infusion Device into Left Femoral Artery, Percutaneous Approach
04HL43Z Insertion of Infusion Device into Left Femoral Artery, Percutaneous Endoscopic Approach
04HM03Z Insertion of Infusion Device into Right Popliteal Artery, Open Approach
04HM33Z Insertion of Infusion Device into Right Popliteal Artery, Percutaneous Approach
04HM43Z Insertion of Infusion Device into Right Popliteal Artery, Percutaneous Endoscopic Approach
04HN03Z Insertion of Infusion Device into Left Popliteal Artery, Open Approach
04HN33Z Insertion of Infusion Device into Left Popliteal Artery, Percutaneous Approach
04HN43Z Insertion of Infusion Device into Left Popliteal Artery, Percutaneous Endoscopic Approach
04HP03Z Insertion of Infusion Device into Right Anterior Tibial Artery, Open Approach
04HP33Z Insertion of Infusion Device into Right Anterior Tibial Artery, Percutaneous Approach
04HP43Z Insertion of Infusion Device into Right Anterior Tibial Artery, Percutaneous Endoscopic Approach
04HQ03Z Insertion of Infusion Device into Left Anterior Tibial Artery, Open Approach
04HQ33Z Insertion of Infusion Device into Left Anterior Tibial Artery, Percutaneous Approach
04HQ43Z Insertion of Infusion Device into Left Anterior Tibial Artery, Percutaneous Endoscopic Approach
04HR03Z Insertion of Infusion Device into Right Posterior Tibial Artery, Open Approach
04HR33Z Insertion of Infusion Device into Right Posterior Tibial Artery, Percutaneous Approach
04HR43Z Insertion of Infusion Device into Right Posterior Tibial Artery, Percutaneous Endoscopic Approach
04HS03Z Insertion of Infusion Device into Left Posterior Tibial Artery, Open Approach
04HS33Z Insertion of Infusion Device into Left Posterior Tibial Artery, Percutaneous Approach
04HS43Z Insertion of Infusion Device into Left Posterior Tibial Artery, Percutaneous Endoscopic Approach
04HT03Z Insertion of Infusion Device into Right Peroneal Artery, Open Approach
04HT33Z Insertion of Infusion Device into Right Peroneal Artery, Percutaneous Approach
04HT43Z Insertion of Infusion Device into Right Peroneal Artery, Percutaneous Endoscopic Approach
04HU03Z Insertion of Infusion Device into Left Peroneal Artery, Open Approach
04HU33Z Insertion of Infusion Device into Left Peroneal Artery, Percutaneous Approach
04HU43Z Insertion of Infusion Device into Left Peroneal Artery, Percutaneous Endoscopic Approach
02NH3ZZ Release Pulmonary Valve, Percutaneous Approach
02NH4ZZ Release Pulmonary Valve, Percutaneous Endoscopic Approach
04HV03Z Insertion of Infusion Device into Right Foot Artery, Open Approach
04HV33Z Insertion of Infusion Device into Right Foot Artery, Percutaneous Approach
04HV43Z Insertion of Infusion Device into Right Foot Artery, Percutaneous Endoscopic Approach
04HW03Z Insertion of Infusion Device into Left Foot Artery, Open Approach
04HW33Z Insertion of Infusion Device into Left Foot Artery, Percutaneous Approach
04HW43Z Insertion of Infusion Device into Left Foot Artery, Percutaneous Endoscopic Approach
04HY03Z Insertion of Infusion Device into Lower Artery, Open Approach
04HY33Z Insertion of Infusion Device into Lower Artery, Percutaneous Approach
04HY43Z Insertion of Infusion Device into Lower Artery, Percutaneous Endoscopic Approach
39.73 Endovascular implantation of graft in thoracic aorta 02UW3JZ Supplement Thoracic Aorta with Synthetic Substitute, Percutaneous Approach
02UW4JZ Supplement Thoracic Aorta with Synthetic Substitute, Percutaneous Endoscopic Approach
02VW0DZ Restriction of Thoracic Aorta with Intraluminal Device, Open Approach
02VW3DZ Restriction of Thoracic Aorta with Intraluminal Device, Percutaneous Approach
02VW4DZ Restriction of Thoracic Aorta with Intraluminal Device, Percutaneous Endoscopic Approach
88.72 Diagnostic ultrasound of heart B240YZZ Ultrasonography of Single Coronary Artery using Other Contrast
B240ZZ4 Ultrasonography of Single Coronary Artery, Transesophageal
B240ZZZ Ultrasonography of Single Coronary Artery
B241YZZ Ultrasonography of Multiple Coronary Arteries using Other Contrast
B241ZZ4 Ultrasonography of Multiple Coronary Arteries, Transesophageal
B241ZZZ Ultrasonography of Multiple Coronary Arteries
B244YZZ Ultrasonography of Right Heart using Other Contrast
B244ZZ4 Ultrasonography of Right Heart, Transesophageal
B244ZZZ Ultrasonography of Right Heart
B245YZZ Ultrasonography of Left Heart using Other Contrast
B245ZZ4 Ultrasonography of Left Heart, Transesophageal
B245ZZZ Ultrasonography of Left Heart
B246YZZ Ultrasonography of Right and Left Heart using Other Contrast
B246ZZ4 Ultrasonography of Right and Left Heart, Transesophageal
B246ZZZ Ultrasonography of Right and Left Heart
B24BYZZ Ultrasonography of Heart with Aorta using Other Contrast
B24BZZ4 Ultrasonography of Heart with Aorta, Transesophageal
B24BZZZ Ultrasonography of Heart with Aorta
B24CYZZ Ultrasonography of Pericardium using Other Contrast
B24CZZ4 Ultrasonography of Pericardium, Transesophageal
B24CZZZ Ultrasonography of Pericardium
B24DYZZ Ultrasonography of Pediatric Heart using Other Contrast
B24DZZ4 Ultrasonography of Pediatric Heart, Transesophageal
B24DZZZ Ultrasonography of Pediatric Heart
ICD-9-CM Procedure Code9DescriptionICD-10-PCS Procedure Code10Description
36.10 Aortocoronary bypass for heart revascularization, not otherwise specified 0210093 Bypass Coronary Artery, One Site from Coronary Artery with Autologous Venous Tissue, Open Approach
0210493 Bypass Coronary Artery, One Site from Coronary Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach
02100A3 Bypass Coronary Artery, One Site from Coronary Artery with Autologous Arterial Tissue, Open Approach
02100J3 Bypass Coronary Artery, One Site from Coronary Artery with Synthetic Substitute, Open Approach
02100K3 Bypass Coronary Artery, One Site from Coronary Artery with Nonautologous Tissue Substitute, Open Approach
02100Z3 Bypass Coronary Artery, One Site from Coronary Artery, Open Approach
02104A3 Bypass Coronary Artery, One Site from Coronary Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
02104J3 Bypass Coronary Artery, One Site from Coronary Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
02104K3 Bypass Coronary Artery, One Site from Coronary Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02104Z3 Bypass Coronary Artery, One Site from Coronary Artery, Percutaneous Endoscopic Approach
36.11 (Aorto)coronary bypass of one coronary artery 021009W Bypass Coronary Artery, One Site from Aorta with Autologous Venous Tissue, Open Approach
02100AW Bypass Coronary Artery, One Site from Aorta with Autologous Arterial Tissue, Open Approach
02100JW Bypass Coronary Artery, One Site from Aorta with Synthetic Substitute, Open Approach
02100KW Bypass Coronary Artery, One Site from Aorta with Nonautologous Tissue Substitute, Open Approach
021049W Bypass Coronary Artery, One Site from Aorta with Autologous Venous Tissue, Percutaneous Endoscopic Approach
02104AW Bypass Coronary Artery, One Site from Aorta with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
02104JW Bypass Coronary Artery, One Site from Aorta with Synthetic Substitute, Percutaneous Endoscopic Approach
02104KW Bypass Coronary Artery, One Site from Aorta with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
36.12 (Aorto)coronary bypass of two coronary artery 021109W Bypass Coronary Artery, Two Sites from Aorta with Autologous Venous Tissue, Open Approach
02110AW Bypass Coronary Artery, Two Sites from Aorta with Autologous Arterial Tissue, Open Approach
02110JW Bypass Coronary Artery, Two Sites from Aorta with Synthetic Substitute, Open Approach
02110KW Bypass Coronary Artery, Two Sites from Aorta with Nonautologous Tissue Substitute, Open Approach
021149W Bypass Coronary Artery, Two Sites from Aorta with Autologous Venous Tissue, Percutaneous Endoscopic Approach
02114AW Bypass Coronary Artery, Two Sites from Aorta with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
02114JW Bypass Coronary Artery, Two Sites from Aorta with Synthetic Substitute, Percutaneous Endoscopic Approach
02114KW Bypass Coronary Artery, Two Sites from Aorta with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
36.13 (Aorto)coronary bypass of three coronary artery 021209W Bypass Coronary Artery, Three Sites from Aorta with Autologous Venous Tissue, Open Approach
02120AW Bypass Coronary Artery, Three Sites from Aorta with Autologous Arterial Tissue, Open Approach
02120JW Bypass Coronary Artery, Three Sites from Aorta with Synthetic Substitute, Open Approach
02120KW Bypass Coronary Artery, Three Sites from Aorta with Nonautologous Tissue Substitute, Open Approach
021249W Bypass Coronary Artery, Three Sites from Aorta with Autologous Venous Tissue, Percutaneous Endoscopic Approach
02124AW Bypass Coronary Artery, Three Sites from Aorta with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
02124JW Bypass Coronary Artery, Three Sites from Aorta with Synthetic Substitute, Percutaneous Endoscopic Approach
02124KW Bypass Coronary Artery, Three Sites from Aorta with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
36.14 (Aorto)coronary bypass of four or more coronary artery 021309W Bypass Coronary Artery, Four or More Sites from Aorta with Autologous Venous Tissue, Open Approach
02130AW Bypass Coronary Artery, Four or More Sites from Aorta with Autologous Arterial Tissue, Open Approach
02130JW Bypass Coronary Artery, Four or More Sites from Aorta with Synthetic Substitute, Open Approach
02130KW Bypass Coronary Artery, Four or More Sites from Aorta with Nonautologous Tissue Substitute, Open Approach
021349W Bypass Coronary Artery, Four or More Sites from Aorta with Autologous Venous Tissue, Percutaneous Endoscopic Approach
02134AW Bypass Coronary Artery, Four or More Sites from Aorta with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
02134JW Bypass Coronary Artery, Four or More Sites from Aorta with Synthetic Substitute, Percutaneous Endoscopic Approach
02134KW Bypass Coronary Artery, Four or More Sites from Aorta with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
36.15 Single internal mammary-coronary artery bypass 0210098 Bypass Coronary Artery, One Site from Right Internal Mammary with Autologous Venous Tissue, Open Approach
0210099 Bypass Coronary Artery, One Site from Left Internal Mammary with Autologous Venous Tissue, Open Approach
0210498 Bypass Coronary Artery, One Site from Right Internal Mammary with Autologous Venous Tissue, Percutaneous Endoscopic Approach
0210499 Bypass Coronary Artery, One Site from Left Internal Mammary with Autologous Venous Tissue, Percutaneous Endoscopic Approach
021009C Bypass Coronary Artery, One Site from Thoracic Artery with Autologous Venous Tissue, Open Approach
02100A8 Bypass Coronary Artery, One Site from Right Internal Mammary with Autologous Arterial Tissue, Open Approach
02100A9 Bypass Coronary Artery, One Site from Left Internal Mammary with Autologous Arterial Tissue, Open Approach
02100AC Bypass Coronary Artery, One Site from Thoracic Artery with Autologous Arterial Tissue, Open Approach
02100J8 Bypass Coronary Artery, One Site from Right Internal Mammary with Synthetic Substitute, Open Approach
02100J9 Bypass Coronary Artery, One Site from Left Internal Mammary with Synthetic Substitute, Open Approach
02100JC Bypass Coronary Artery, One Site from Thoracic Artery with Synthetic Substitute, Open Approach
02100K8 Bypass Coronary Artery, One Site from Right Internal Mammary with Nonautologous Tissue Substitute, Open Approach
02100K9 Bypass Coronary Artery, One Site from Left Internal Mammary with Nonautologous Tissue Substitute, Open Approach
02100KC Bypass Coronary Artery, One Site from Thoracic Artery with Nonautologous Tissue Substitute, Open Approach
02100Z8 Bypass Coronary Artery, One Site from Right Internal Mammary, Open Approach
02100Z9 Bypass Coronary Artery, One Site from Left Internal Mammary, Open Approach
02100ZC Bypass Coronary Artery, One Site from Thoracic Artery, Open Approach
021049C Bypass Coronary Artery, One Site from Thoracic Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach
02104A8 Bypass Coronary Artery, One Site from Right Internal Mammary with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
02104A9 Bypass Coronary Artery, One Site from Left Internal Mammary with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
02104AC Bypass Coronary Artery, One Site from Thoracic Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
02104J8 Bypass Coronary Artery, One Site from Right Internal Mammary with Synthetic Substitute, Percutaneous Endoscopic Approach
02104J9 Bypass Coronary Artery, One Site from Left Internal Mammary with Synthetic Substitute, Percutaneous Endoscopic Approach
02104JC Bypass Coronary Artery, One Site from Thoracic Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
02104K8 Bypass Coronary Artery, One Site from Right Internal Mammary with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02104K9 Bypass Coronary Artery, One Site from Left Internal Mammary with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02104KC Bypass Coronary Artery, One Site from Thoracic Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02104Z8 Bypass Coronary Artery, One Site from Right Internal Mammary, Percutaneous Endoscopic Approach
02104Z9 Bypass Coronary Artery, One Site from Left Internal Mammary, Percutaneous Endoscopic Approach
02104ZC Bypass Coronary Artery, One Site from Thoracic Artery, Percutaneous Endoscopic Approach
36.16 Double internal mammary-coronary artery bypass 0211098 Bypass Coronary Artery, Two Sites from Right Internal Mammary with Autologous Venous Tissue, Open Approach
0211099 Bypass Coronary Artery, Two Sites from Left Internal Mammary with Autologous Venous Tissue, Open Approach
0211498 Bypass Coronary Artery, Two Sites from Right Internal Mammary with Autologous Venous Tissue, Percutaneous Endoscopic Approach
0211499 Bypass Coronary Artery, Two Sites from Left Internal Mammary with Autologous Venous Tissue, Percutaneous Endoscopic Approach
0212098 Bypass Coronary Artery, Three Sites from Right Internal Mammary with Autologous Venous Tissue, Open Approach
0212099 Bypass Coronary Artery, Three Sites from Left Internal Mammary with Autologous Venous Tissue, Open Approach
0212498 Bypass Coronary Artery, Three Sites from Right Internal Mammary with Autologous Venous Tissue, Percutaneous Endoscopic Approach
0212499 Bypass Coronary Artery, Three Sites from Left Internal Mammary with Autologous Venous Tissue, Percutaneous Endoscopic Approach
0213098 Bypass Coronary Artery, Four or More Sites from Right Internal Mammary with Autologous Venous Tissue, Open Approach
0213099 Bypass Coronary Artery, Four or More Sites from Left Internal Mammary with Autologous Venous Tissue, Open Approach
0213498 Bypass Coronary Artery, Four or More Sites from Right Internal Mammary with Autologous Venous Tissue, Percutaneous Endoscopic Approach
0213499 Bypass Coronary Artery, Four or More Sites from Left Internal Mammary with Autologous Venous Tissue, Percutaneous Endoscopic Approach
021109C Bypass Coronary Artery, Two Sites from Thoracic Artery with Autologous Venous Tissue, Open Approach
02110A8 Bypass Coronary Artery, Two Sites from Right Internal Mammary with Autologous Arterial Tissue, Open Approach
02110A9 Bypass Coronary Artery, Two Sites from Left Internal Mammary with Autologous Arterial Tissue, Open Approach
02110AC Bypass Coronary Artery, Two Sites from Thoracic Artery with Autologous Arterial Tissue, Open Approach
02110J8 Bypass Coronary Artery, Two Sites from Right Internal Mammary with Synthetic Substitute, Open Approach
02110J9 Bypass Coronary Artery, Two Sites from Left Internal Mammary with Synthetic Substitute, Open Approach
02110JC Bypass Coronary Artery, Two Sites from Thoracic Artery with Synthetic Substitute, Open Approach
02110K8 Bypass Coronary Artery, Two Sites from Right Internal Mammary with Nonautologous Tissue Substitute, Open Approach
02110K9 Bypass Coronary Artery, Two Sites from Left Internal Mammary with Nonautologous Tissue Substitute, Open Approach
02110KC Bypass Coronary Artery, Two Sites from Thoracic Artery with Nonautologous Tissue Substitute, Open Approach
02110Z8 Bypass Coronary Artery, Two Sites from Right Internal Mammary, Open Approach
02110Z9 Bypass Coronary Artery, Two Sites from Left Internal Mammary, Open Approach
02110ZC Bypass Coronary Artery, Two Sites from Thoracic Artery, Open Approach
021149C Bypass Coronary Artery, Two Sites from Thoracic Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach
02114A8 Bypass Coronary Artery, Two Sites from Right Internal Mammary with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
02114A9 Bypass Coronary Artery, Two Sites from Left Internal Mammary with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
02114AC Bypass Coronary Artery, Two Sites from Thoracic Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
02114J8 Bypass Coronary Artery, Two Sites from Right Internal Mammary with Synthetic Substitute, Percutaneous Endoscopic Approach
02114J9 Bypass Coronary Artery, Two Sites from Left Internal Mammary with Synthetic Substitute, Percutaneous Endoscopic Approach
02114JC Bypass Coronary Artery, Two Sites from Thoracic Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
02114K8 Bypass Coronary Artery, Two Sites from Right Internal Mammary with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02114K9 Bypass Coronary Artery, Two Sites from Left Internal Mammary with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02114KC Bypass Coronary Artery, Two Sites from Thoracic Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02114Z8 Bypass Coronary Artery, Two Sites from Right Internal Mammary, Percutaneous Endoscopic Approach
02114Z9 Bypass Coronary Artery, Two Sites from Left Internal Mammary, Percutaneous Endoscopic Approach
02114ZC Bypass Coronary Artery, Two Sites from Thoracic Artery, Percutaneous Endoscopic Approach
021209C Bypass Coronary Artery, Three Sites from Thoracic Artery with Autologous Venous Tissue, Open Approach
02120A8 Bypass Coronary Artery, Three Sites from Right Internal Mammary with Autologous Arterial Tissue, Open Approach
02120A9 Bypass Coronary Artery, Three Sites from Left Internal Mammary with Autologous Arterial Tissue, Open Approach
02120AC Bypass Coronary Artery, Three Sites from Thoracic Artery with Autologous Arterial Tissue, Open Approach
02120J8 Bypass Coronary Artery, Three Sites from Right Internal Mammary with Synthetic Substitute, Open Approach
02120J9 Bypass Coronary Artery, Three Sites from Left Internal Mammary with Synthetic Substitute, Open Approach
02120JC Bypass Coronary Artery, Three Sites from Thoracic Artery with Synthetic Substitute, Open Approach
02120K8 Bypass Coronary Artery, Three Sites from Right Internal Mammary with Nonautologous Tissue Substitute, Open Approach
02120K9 Bypass Coronary Artery, Three Sites from Left Internal Mammary with Nonautologous Tissue Substitute, Open Approach
02120KC Bypass Coronary Artery, Three Sites from Thoracic Artery with Nonautologous Tissue Substitute, Open Approach
02120Z8 Bypass Coronary Artery, Three Sites from Right Internal Mammary, Open Approach
02120Z9 Bypass Coronary Artery, Three Sites from Left Internal Mammary, Open Approach
02120ZC Bypass Coronary Artery, Three Sites from Thoracic Artery, Open Approach
021249C Bypass Coronary Artery, Three Sites from Thoracic Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach
02124A8 Bypass Coronary Artery, Three Sites from Right Internal Mammary with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
02124A9 Bypass Coronary Artery, Three Sites from Left Internal Mammary with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
02124AC Bypass Coronary Artery, Three Sites from Thoracic Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
02124J8 Bypass Coronary Artery, Three Sites from Right Internal Mammary with Synthetic Substitute, Percutaneous Endoscopic Approach
02124J9 Bypass Coronary Artery, Three Sites from Left Internal Mammary with Synthetic Substitute, Percutaneous Endoscopic Approach
02124JC Bypass Coronary Artery, Three Sites from Thoracic Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
02124K8 Bypass Coronary Artery, Three Sites from Right Internal Mammary with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02124K9 Bypass Coronary Artery, Three Sites from Left Internal Mammary with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02124KC Bypass Coronary Artery, Three Sites from Thoracic Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02124Z8 Bypass Coronary Artery, Three Sites from Right Internal Mammary, Percutaneous Endoscopic Approach
02124Z9 Bypass Coronary Artery, Three Sites from Left Internal Mammary, Percutaneous Endoscopic Approach
02124ZC Bypass Coronary Artery, Three Sites from Thoracic Artery, Percutaneous Endoscopic Approach
021309C Bypass Coronary Artery, Four or More Sites from Thoracic Artery with Autologous Venous Tissue, Open Approach
02130A8 Bypass Coronary Artery, Four or More Sites from Right Internal Mammary with Autologous Arterial Tissue, Open Approach
02130A9 Bypass Coronary Artery, Four or More Sites from Left Internal Mammary with Autologous Arterial Tissue, Open Approach
02130AC Bypass Coronary Artery, Four or More Sites from Thoracic Artery with Autologous Arterial Tissue, Open Approach
02130J8 Bypass Coronary Artery, Four or More Sites from Right Internal Mammary with Synthetic Substitute, Open Approach
02130J9 Bypass Coronary Artery, Four or More Sites from Left Internal Mammary with Synthetic Substitute, Open Approach
02130JC Bypass Coronary Artery, Four or More Sites from Thoracic Artery with Synthetic Substitute, Open Approach
02130K8 Bypass Coronary Artery, Four or More Sites from Right Internal Mammary with Nonautologous Tissue Substitute, Open Approach
02130K9 Bypass Coronary Artery, Four or More Sites from Left Internal Mammary with Nonautologous Tissue Substitute, Open Approach
02130KC Bypass Coronary Artery, Four or More Sites from Thoracic Artery with Nonautologous Tissue Substitute, Open Approach
02130Z8 Bypass Coronary Artery, Four or More Sites from Right Internal Mammary, Open Approach
02130Z9 Bypass Coronary Artery, Four or More Sites from Left Internal Mammary, Open Approach
02130ZC Bypass Coronary Artery, Four or More Sites from Thoracic Artery, Open Approach
021349C Bypass Coronary Artery, Four or More Sites from Thoracic Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach
02134A8 Bypass Coronary Artery, Four or More Sites from Right Internal Mammary with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
02134A9 Bypass Coronary Artery, Four or More Sites from Left Internal Mammary with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
02134AC Bypass Coronary Artery, Four or More Sites from Thoracic Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
02134J8 Bypass Coronary Artery, Four or More Sites from Right Internal Mammary with Synthetic Substitute, Percutaneous Endoscopic Approach
02134J9 Bypass Coronary Artery, Four or More Sites from Left Internal Mammary with Synthetic Substitute, Percutaneous Endoscopic Approach
02134JC Bypass Coronary Artery, Four or More Sites from Thoracic Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
02134K8 Bypass Coronary Artery, Four or More Sites from Right Internal Mammary with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02134K9 Bypass Coronary Artery, Four or More Sites from Left Internal Mammary with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02134KC Bypass Coronary Artery, Four or More Sites from Thoracic Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02134Z8 Bypass Coronary Artery, Four or More Sites from Right Internal Mammary, Percutaneous Endoscopic Approach
02134Z9 Bypass Coronary Artery, Four or More Sites from Left Internal Mammary, Percutaneous Endoscopic Approach
02134ZC Bypass Coronary Artery, Four or More Sites from Thoracic Artery, Percutaneous Endoscopic Approach
36.17 Abdominal-coronary artery bypass 021009F Bypass Coronary Artery, One Site from Abdominal Artery with Autologous Venous Tissue, Open Approach
02100AF Bypass Coronary Artery, One Site from Abdominal Artery with Autologous Arterial Tissue, Open Approach
02100JF Bypass Coronary Artery, One Site from Abdominal Artery with Synthetic Substitute, Open Approach
02100KF Bypass Coronary Artery, One Site from Abdominal Artery with Nonautologous Tissue Substitute, Open Approach
02100ZF Bypass Coronary Artery, One Site from Abdominal Artery, Open Approach
021049F Bypass Coronary Artery, One Site from Abdominal Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach
02104AF Bypass Coronary Artery, One Site from Abdominal Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
02104JF Bypass Coronary Artery, One Site from Abdominal Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
02104KF Bypass Coronary Artery, One Site from Abdominal Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02104ZF Bypass Coronary Artery, One Site from Abdominal Artery, Percutaneous Endoscopic Approach
021109F Bypass Coronary Artery, Two Sites from Abdominal Artery with Autologous Venous Tissue, Open Approach
02110AF Bypass Coronary Artery, Two Sites from Abdominal Artery with Autologous Arterial Tissue, Open Approach
02110JF Bypass Coronary Artery, Two Sites from Abdominal Artery with Synthetic Substitute, Open Approach
02110KF Bypass Coronary Artery, Two Sites from Abdominal Artery with Nonautologous Tissue Substitute, Open Approach
02110ZF Bypass Coronary Artery, Two Sites from Abdominal Artery, Open Approach
021149F Bypass Coronary Artery, Two Sites from Abdominal Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach
02114AF Bypass Coronary Artery, Two Sites from Abdominal Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
02114JF Bypass Coronary Artery, Two Sites from Abdominal Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
02114KF Bypass Coronary Artery, Two Sites from Abdominal Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02114ZF Bypass Coronary Artery, Two Sites from Abdominal Artery, Percutaneous Endoscopic Approach
021209F Bypass Coronary Artery, Three Sites from Abdominal Artery with Autologous Venous Tissue, Open Approach
02120AF Bypass Coronary Artery, Three Sites from Abdominal Artery with Autologous Arterial Tissue, Open Approach
02120JF Bypass Coronary Artery, Three Sites from Abdominal Artery with Synthetic Substitute, Open Approach
02120KF Bypass Coronary Artery, Three Sites from Abdominal Artery with Nonautologous Tissue Substitute, Open Approach
02120ZF Bypass Coronary Artery, Three Sites from Abdominal Artery, Open Approach
021249F Bypass Coronary Artery, Three Sites from Abdominal Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach
02124AF Bypass Coronary Artery, Three Sites from Abdominal Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
02124JF Bypass Coronary Artery, Three Sites from Abdominal Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
02124KF Bypass Coronary Artery, Three Sites from Abdominal Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02124ZF Bypass Coronary Artery, Three Sites from Abdominal Artery, Percutaneous Endoscopic Approach
021309F Bypass Coronary Artery, Four or More Sites from Abdominal Artery with Autologous Venous Tissue, Open Approach
02130AF Bypass Coronary Artery, Four or More Sites from Abdominal Artery with Autologous Arterial Tissue, Open Approach
02130JF Bypass Coronary Artery, Four or More Sites from Abdominal Artery with Synthetic Substitute, Open Approach
02130KF Bypass Coronary Artery, Four or More Sites from Abdominal Artery with Nonautologous Tissue Substitute, Open Approach
02130ZF Bypass Coronary Artery, Four or More Sites from Abdominal Artery, Open Approach
021349F Bypass Coronary Artery, Four or More Sites from Abdominal Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach
02134AF Bypass Coronary Artery, Four or More Sites from Abdominal Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
02134JF Bypass Coronary Artery, Four or More Sites from Abdominal Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
02134KF Bypass Coronary Artery, Four or More Sites from Abdominal Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02134ZF Bypass Coronary Artery, Four or More Sites from Abdominal Artery, Percutaneous Endoscopic Approach
36.19 Other bypass anastomosis for heart revascularization 0210093 Bypass Coronary Artery, One Site from Coronary Artery with Autologous Venous Tissue, Open Approach
0210493 Bypass Coronary Artery, One Site from Coronary Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach
0211093 Bypass Coronary Artery, Two Sites from Coronary Artery with Autologous Venous Tissue, Open Approach
0211493 Bypass Coronary Artery, Two Sites from Coronary Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach
0212093 Bypass Coronary Artery, Three Sites from Coronary Artery with Autologous Venous Tissue, Open Approach
0213493 Bypass Coronary Artery, Four or More Sites from Coronary Artery with Autologous Venous Tissue, Percutaneous Endoscopic Approach
02100A3 Bypass Coronary Artery, One Site from Coronary Artery with Autologous Arterial Tissue, Open Approach
02100J3 Bypass Coronary Artery, One Site from Coronary Artery with Synthetic Substitute, Open Approach
02100K3 Bypass Coronary Artery, One Site from Coronary Artery with Nonautologous Tissue Substitute, Open Approach
02100Z3 Bypass Coronary Artery, One Site from Coronary Artery, Open Approach
02104A3 Bypass Coronary Artery, One Site from Coronary Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
02104J3 Bypass Coronary Artery, One Site from Coronary Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
02104K3 Bypass Coronary Artery, One Site from Coronary Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02104Z3 Bypass Coronary Artery, One Site from Coronary Artery, Percutaneous Endoscopic Approach
02110A3 Bypass Coronary Artery, Two Sites from Coronary Artery with Autologous Arterial Tissue, Open Approach
02110J3 Bypass Coronary Artery, Two Sites from Coronary Artery with Synthetic Substitute, Open Approach
02110K3 Bypass Coronary Artery, Two Sites from Coronary Artery with Nonautologous Tissue Substitute, Open Approach
02110Z3 Bypass Coronary Artery, Two Sites from Coronary Artery, Open Approach
02114A3 Bypass Coronary Artery, Two Sites from Coronary Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
02114J3 Bypass Coronary Artery, Two Sites from Coronary Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
02114K3 Bypass Coronary Artery, Two Sites from Coronary Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02114Z3 Bypass Coronary Artery, Two Sites from Coronary Artery, Percutaneous Endoscopic Approach
02120A3 Bypass Coronary Artery, Three Sites from Coronary Artery with Autologous Arterial Tissue, Open Approach
02120J3 Bypass Coronary Artery, Three Sites from Coronary Artery with Synthetic Substitute, Open Approach
02120K3 Bypass Coronary Artery, Three Sites from Coronary Artery with Nonautologous Tissue Substitute, Open Approach
02120Z3 Bypass Coronary Artery, Three Sites from Coronary Artery, Open Approach
02124A3 Bypass Coronary Artery, Three Sites from Coronary Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
02124J3 Bypass Coronary Artery, Three Sites from Coronary Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
02124K3 Bypass Coronary Artery, Three Sites from Coronary Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02124Z3 Bypass Coronary Artery, Three Sites from Coronary Artery, Percutaneous Endoscopic Approach
02130A3 Bypass Coronary Artery, Four or More Sites from Coronary Artery with Autologous Arterial Tissue, Open Approach
02130J3 Bypass Coronary Artery, Four or More Sites from Coronary Artery with Synthetic Substitute, Open Approach
02130K3 Bypass Coronary Artery, Four or More Sites from Coronary Artery with Nonautologous Tissue Substitute, Open Approach
02130Z3 Bypass Coronary Artery, Four or More Sites from Coronary Artery, Open Approach
02134A3 Bypass Coronary Artery, Four or More Sites from Coronary Artery with Autologous Arterial Tissue, Percutaneous Endoscopic Approach
02134J3 Bypass Coronary Artery, Four or More Sites from Coronary Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
02134K3 Bypass Coronary Artery, Four or More Sites from Coronary Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
02134Z3 Bypass Coronary Artery, Four or More Sites from Coronary Artery, Percutaneous Endoscopic Approach
38.91 Arterial catheterization 02HP03Z Insertion of Infusion Device into Pulmonary Trunk, Open Approach
02HP33Z Insertion of Infusion Device into Pulmonary Trunk, Percutaneous Approach
02HP43Z Insertion of Infusion Device into Pulmonary Trunk, Percutaneous Endoscopic Approach
02HQ03Z Insertion of Infusion Device into Right Pulmonary Artery, Open Approach
02HQ33Z Insertion of Infusion Device into Right Pulmonary Artery, Percutaneous Approach
02HQ43Z Insertion of Infusion Device into Right Pulmonary Artery, Percutaneous Endoscopic Approach
02HR03Z Insertion of Infusion Device into Left Pulmonary Artery, Open Approach
02HR33Z Insertion of Infusion Device into Left Pulmonary Artery, Percutaneous Approach
02HR43Z Insertion of Infusion Device into Left Pulmonary Artery, Percutaneous Endoscopic Approach
02HW03Z Insertion of Infusion Device into Thoracic Aorta, Open Approach
02HW33Z Insertion of Infusion Device into Thoracic Aorta, Percutaneous Approach
02HW43Z Insertion of Infusion Device into Thoracic Aorta, Percutaneous Endoscopic Approach
03H003Z Insertion of Infusion Device into Right Internal Mammary Artery, Open Approach
03H033Z Insertion of Infusion Device into Right Internal Mammary Artery, Percutaneous Approach
03H043Z Insertion of Infusion Device into Right Internal Mammary Artery, Percutaneous Endoscopic Approach
03H103Z Insertion of Infusion Device into Left Internal Mammary Artery, Open Approach
03H133Z Insertion of Infusion Device into Left Internal Mammary Artery, Percutaneous Approach
03H143Z Insertion of Infusion Device into Left Internal Mammary Artery, Percutaneous Endoscopic Approach
03H203Z Insertion of Infusion Device into Innominate Artery, Open Approach
03H233Z Insertion of Infusion Device into Innominate Artery, Percutaneous Approach
03H243Z Insertion of Infusion Device into Innominate Artery, Percutaneous Endoscopic Approach
03H303Z Insertion of Infusion Device into Right Subclavian Artery, Open Approach
03H333Z Insertion of Infusion Device into Right Subclavian Artery, Percutaneous Approach
03H343Z Insertion of Infusion Device into Right Subclavian Artery, Percutaneous Endoscopic Approach
03H403Z Insertion of Infusion Device into Left Subclavian Artery, Open Approach
03H433Z Insertion of Infusion Device into Left Subclavian Artery, Percutaneous Approach
03H443Z Insertion of Infusion Device into Left Subclavian Artery, Percutaneous Endoscopic Approach
03H503Z Insertion of Infusion Device into Right Axillary Artery, Open Approach
03H533Z Insertion of Infusion Device into Right Axillary Artery, Percutaneous Approach
03H543Z Insertion of Infusion Device into Right Axillary Artery, Percutaneous Endoscopic Approach
03H603Z Insertion of Infusion Device into Left Axillary Artery, Open Approach
03H633Z Insertion of Infusion Device into Left Axillary Artery, Percutaneous Approach
03H643Z Insertion of Infusion Device into Left Axillary Artery, Percutaneous Endoscopic Approach
03H703Z Insertion of Infusion Device into Right Brachial Artery, Open Approach
03H733Z Insertion of Infusion Device into Right Brachial Artery, Percutaneous Approach
03H743Z Insertion of Infusion Device into Right Brachial Artery, Percutaneous Endoscopic Approach
03H803Z Insertion of Infusion Device into Left Brachial Artery, Open Approach
03H833Z Insertion of Infusion Device into Left Brachial Artery, Percutaneous Approach
03H843Z Insertion of Infusion Device into Left Brachial Artery, Percutaneous Endoscopic Approach
03H903Z Insertion of Infusion Device into Right Ulnar Artery, Open Approach
03H933Z Insertion of Infusion Device into Right Ulnar Artery, Percutaneous Approach
03H943Z Insertion of Infusion Device into Right Ulnar Artery, Percutaneous Endoscopic Approach
03HA03Z Insertion of Infusion Device into Left Ulnar Artery, Open Approach
03HA33Z Insertion of Infusion Device into Left Ulnar Artery, Percutaneous Approach
03HA43Z Insertion of Infusion Device into Left Ulnar Artery, Percutaneous Endoscopic Approach
03HB03Z Insertion of Infusion Device into Right Radial Artery, Open Approach
03HB33Z Insertion of Infusion Device into Right Radial Artery, Percutaneous Approach
03HB43Z Insertion of Infusion Device into Right Radial Artery, Percutaneous Endoscopic Approach
03HC03Z Insertion of Infusion Device into Left Radial Artery, Open Approach
03HC33Z Insertion of Infusion Device into Left Radial Artery, Percutaneous Approach
03HC43Z Insertion of Infusion Device into Left Radial Artery, Percutaneous Endoscopic Approach
03HD03Z Insertion of Infusion Device into Right Hand Artery, Open Approach
03HD33Z Insertion of Infusion Device into Right Hand Artery, Percutaneous Approach
03HD43Z Insertion of Infusion Device into Right Hand Artery, Percutaneous Endoscopic Approach
03HF03Z Insertion of Infusion Device into Left Hand Artery, Open Approach
03HF33Z Insertion of Infusion Device into Left Hand Artery, Percutaneous Approach
03HF43Z Insertion of Infusion Device into Left Hand Artery, Percutaneous Endoscopic Approach
03HG03Z Insertion of Infusion Device into Intracranial Artery, Open Approach
03HG33Z Insertion of Infusion Device into Intracranial Artery, Percutaneous Approach
03HG43Z Insertion of Infusion Device into Intracranial Artery, Percutaneous Endoscopic Approach
03HH03Z Insertion of Infusion Device into Right Common Carotid Artery, Open Approach
03HH33Z Insertion of Infusion Device into Right Common Carotid Artery, Percutaneous Approach
03HH43Z Insertion of Infusion Device into Right Common Carotid Artery, Percutaneous Endoscopic Approach
03HJ03Z Insertion of Infusion Device into Left Common Carotid Artery, Open Approach
03HJ33Z Insertion of Infusion Device into Left Common Carotid Artery, Percutaneous Approach
03HJ43Z Insertion of Infusion Device into Left Common Carotid Artery, Percutaneous Endoscopic Approach
03HK03Z Insertion of Infusion Device into Right Internal Carotid Artery, Open Approach
03HK33Z Insertion of Infusion Device into Right Internal Carotid Artery, Percutaneous Approach
03HK43Z Insertion of Infusion Device into Right Internal Carotid Artery, Percutaneous Endoscopic Approach
03HL03Z Insertion of Infusion Device into Left Internal Carotid Artery, Open Approach
03HL33Z Insertion of Infusion Device into Left Internal Carotid Artery, Percutaneous Approach
03HL43Z Insertion of Infusion Device into Left Internal Carotid Artery, Percutaneous Endoscopic Approach
03HM03Z Insertion of Infusion Device into Right External Carotid Artery, Open Approach
03HM33Z Insertion of Infusion Device into Right External Carotid Artery, Percutaneous Approach
03HM43Z Insertion of Infusion Device into Right External Carotid Artery, Percutaneous Endoscopic Approach
03HN03Z Insertion of Infusion Device into Left External Carotid Artery, Open Approach
03HN33Z Insertion of Infusion Device into Left External Carotid Artery, Percutaneous Approach
03HN43Z Insertion of Infusion Device into Left External Carotid Artery, Percutaneous Endoscopic Approach
03HP03Z Insertion of Infusion Device into Right Vertebral Artery, Open Approach
03HP33Z Insertion of Infusion Device into Right Vertebral Artery, Percutaneous Approach
03HP43Z Insertion of Infusion Device into Right Vertebral Artery, Percutaneous Endoscopic Approach
03HQ03Z Insertion of Infusion Device into Left Vertebral Artery, Open Approach
03HQ33Z Insertion of Infusion Device into Left Vertebral Artery, Percutaneous Approach
03HQ43Z Insertion of Infusion Device into Left Vertebral Artery, Percutaneous Endoscopic Approach
03HR03Z Insertion of Infusion Device into Face Artery, Open Approach
03HR33Z Insertion of Infusion Device into Face Artery, Percutaneous Approach
03HR43Z Insertion of Infusion Device into Face Artery, Percutaneous Endoscopic Approach
03HS03Z Insertion of Infusion Device into Right Temporal Artery, Open Approach
03HS33Z Insertion of Infusion Device into Right Temporal Artery, Percutaneous Approach
03HS43Z Insertion of Infusion Device into Right Temporal Artery, Percutaneous Endoscopic Approach
03HT03Z Insertion of Infusion Device into Left Temporal Artery, Open Approach
03HT33Z Insertion of Infusion Device into Left Temporal Artery, Percutaneous Approach
03HT43Z Insertion of Infusion Device into Left Temporal Artery, Percutaneous Endoscopic Approach
03HU03Z Insertion of Infusion Device into Right Thyroid Artery, Open Approach
03HU33Z Insertion of Infusion Device into Right Thyroid Artery, Percutaneous Approach
03HU43Z Insertion of Infusion Device into Right Thyroid Artery, Percutaneous Endoscopic Approach
03HV03Z Insertion of Infusion Device into Left Thyroid Artery, Open Approach
03HV33Z Insertion of Infusion Device into Left Thyroid Artery, Percutaneous Approach
03HV43Z Insertion of Infusion Device into Left Thyroid Artery, Percutaneous Endoscopic Approach
03HY03Z Insertion of Infusion Device into Upper Artery, Open Approach
03HY33Z Insertion of Infusion Device into Upper Artery, Percutaneous Approach
03HY43Z Insertion of Infusion Device into Upper Artery, Percutaneous Endoscopic Approach
04H003Z Insertion of Infusion Device into Abdominal Aorta, Open Approach
04H033Z Insertion of Infusion Device into Abdominal Aorta, Percutaneous Approach
04H043Z Insertion of Infusion Device into Abdominal Aorta, Percutaneous Endoscopic Approach
04H103Z Insertion of Infusion Device into Celiac Artery, Open Approach
04H133Z Insertion of Infusion Device into Celiac Artery, Percutaneous Approach
04H143Z Insertion of Infusion Device into Celiac Artery, Percutaneous Endoscopic Approach
04H203Z Insertion of Infusion Device into Gastric Artery, Open Approach
04H233Z Insertion of Infusion Device into Gastric Artery, Percutaneous Approach
04H243Z Insertion of Infusion Device into Gastric Artery, Percutaneous Endoscopic Approach
04H303Z Insertion of Infusion Device into Hepatic Artery, Open Approach
04H333Z Insertion of Infusion Device into Hepatic Artery, Percutaneous Approach
04H343Z Insertion of Infusion Device into Hepatic Artery, Percutaneous Endoscopic Approach
04H403Z Insertion of Infusion Device into Splenic Artery, Open Approach
04H433Z Insertion of Infusion Device into Splenic Artery, Percutaneous Approach
04H443Z Insertion of Infusion Device into Splenic Artery, Percutaneous Endoscopic Approach
04H503Z Insertion of Infusion Device into Superior Mesenteric Artery, Open Approach
04H533Z Insertion of Infusion Device into Superior Mesenteric Artery, Percutaneous Approach
04H543Z Insertion of Infusion Device into Superior Mesenteric Artery, Percutaneous Endoscopic Approach
04H603Z Insertion of Infusion Device into Right Colic Artery, Open Approach
04H633Z Insertion of Infusion Device into Right Colic Artery, Percutaneous Approach
04H643Z Insertion of Infusion Device into Right Colic Artery, Percutaneous Endoscopic Approach
04H703Z Insertion of Infusion Device into Left Colic Artery, Open Approach
04H733Z Insertion of Infusion Device into Left Colic Artery, Percutaneous Approach
04H743Z Insertion of Infusion Device into Left Colic Artery, Percutaneous Endoscopic Approach
04H803Z Insertion of Infusion Device into Middle Colic Artery, Open Approach
04H833Z Insertion of Infusion Device into Middle Colic Artery, Percutaneous Approach
04H843Z Insertion of Infusion Device into Middle Colic Artery, Percutaneous Endoscopic Approach
04H903Z Insertion of Infusion Device into Right Renal Artery, Open Approach
04H933Z Insertion of Infusion Device into Right Renal Artery, Percutaneous Approach
04H943Z Insertion of Infusion Device into Right Renal Artery, Percutaneous Endoscopic Approach
04HA33Z Insertion of Infusion Device into Left Renal Artery, Open Approach
02QJ4ZZ Insertion of Infusion Device into Left Renal Artery, Percutaneous Approach
04HA43Z Insertion of Infusion Device into Left Renal Artery, Percutaneous Endoscopic Approach
04HB03Z Insertion of Infusion Device into Inferior Mesenteric Artery, Open Approach
04HB33Z Insertion of Infusion Device into Inferior Mesenteric Artery, Percutaneous Approach
04HB43Z Insertion of Infusion Device into Inferior Mesenteric Artery, Percutaneous Endoscopic Approach
04HC03Z Insertion of Infusion Device into Right Common Iliac Artery, Open Approach
04HC33Z Insertion of Infusion Device into Right Common Iliac Artery, Percutaneous Approach
04HC43Z Insertion of Infusion Device into Right Common Iliac Artery, Percutaneous Endoscopic Approach
04HD03Z Insertion of Infusion Device into Left Common Iliac Artery, Open Approach
04HD33Z Insertion of Infusion Device into Left Common Iliac Artery, Percutaneous Approach
04HD43Z Insertion of Infusion Device into Left Common Iliac Artery, Percutaneous Endoscopic Approach
04HE03Z Insertion of Infusion Device into Right Internal Iliac Artery, Open Approach
04HE33Z Insertion of Infusion Device into Right Internal Iliac Artery, Percutaneous Approach
04HE43Z Insertion of Infusion Device into Right Internal Iliac Artery, Percutaneous Endoscopic Approach
04HF03Z Insertion of Infusion Device into Left Internal Iliac Artery, Open Approach
04HF33Z Insertion of Infusion Device into Left Internal Iliac Artery, Percutaneous Approach
04HF43Z Insertion of Infusion Device into Left Internal Iliac Artery, Percutaneous Endoscopic Approach
04HH03Z Insertion of Infusion Device into Right External Iliac Artery, Open Approach
04HH33Z Insertion of Infusion Device into Right External Iliac Artery, Percutaneous Approach
04HH43Z Insertion of Infusion Device into Right External Iliac Artery, Percutaneous Endoscopic Approach
04HJ03Z Insertion of Infusion Device into Left External Iliac Artery, Open Approach
04HJ33Z Insertion of Infusion Device into Left External Iliac Artery, Percutaneous Approach
04HJ43Z Insertion of Infusion Device into Left External Iliac Artery, Percutaneous Endoscopic Approach
04HK03Z Insertion of Infusion Device into Right Femoral Artery, Open Approach
04HK33Z Insertion of Infusion Device into Right Femoral Artery, Percutaneous Approach
04HK43Z Insertion of Infusion Device into Right Femoral Artery, Percutaneous Endoscopic Approach
04HL03Z Insertion of Infusion Device into Left Femoral Artery, Open Approach
04HL33Z Insertion of Infusion Device into Left Femoral Artery, Percutaneous Approach
04HL43Z Insertion of Infusion Device into Left Femoral Artery, Percutaneous Endoscopic Approach
04HM03Z Insertion of Infusion Device into Right Popliteal Artery, Open Approach
04HM33Z Insertion of Infusion Device into Right Popliteal Artery, Percutaneous Approach
04HM43Z Insertion of Infusion Device into Right Popliteal Artery, Percutaneous Endoscopic Approach
04HN03Z Insertion of Infusion Device into Left Popliteal Artery, Open Approach
04HN33Z Insertion of Infusion Device into Left Popliteal Artery, Percutaneous Approach
04HN43Z Insertion of Infusion Device into Left Popliteal Artery, Percutaneous Endoscopic Approach
04HP03Z Insertion of Infusion Device into Right Anterior Tibial Artery, Open Approach
04HP33Z Insertion of Infusion Device into Right Anterior Tibial Artery, Percutaneous Approach
04HP43Z Insertion of Infusion Device into Right Anterior Tibial Artery, Percutaneous Endoscopic Approach
04HQ03Z Insertion of Infusion Device into Left Anterior Tibial Artery, Open Approach
04HQ33Z Insertion of Infusion Device into Left Anterior Tibial Artery, Percutaneous Approach
04HQ43Z Insertion of Infusion Device into Left Anterior Tibial Artery, Percutaneous Endoscopic Approach
04HR03Z Insertion of Infusion Device into Right Posterior Tibial Artery, Open Approach
04HR33Z Insertion of Infusion Device into Right Posterior Tibial Artery, Percutaneous Approach
04HR43Z Insertion of Infusion Device into Right Posterior Tibial Artery, Percutaneous Endoscopic Approach
04HS03Z Insertion of Infusion Device into Left Posterior Tibial Artery, Open Approach
04HS33Z Insertion of Infusion Device into Left Posterior Tibial Artery, Percutaneous Approach
04HS43Z Insertion of Infusion Device into Left Posterior Tibial Artery, Percutaneous Endoscopic Approach
04HT03Z Insertion of Infusion Device into Right Peroneal Artery, Open Approach
04HT33Z Insertion of Infusion Device into Right Peroneal Artery, Percutaneous Approach
04HT43Z Insertion of Infusion Device into Right Peroneal Artery, Percutaneous Endoscopic Approach
04HU03Z Insertion of Infusion Device into Left Peroneal Artery, Open Approach
04HU33Z Insertion of Infusion Device into Left Peroneal Artery, Percutaneous Approach
04HU43Z Insertion of Infusion Device into Left Peroneal Artery, Percutaneous Endoscopic Approach
02NH3ZZ Release Pulmonary Valve, Percutaneous Approach
02NH4ZZ Release Pulmonary Valve, Percutaneous Endoscopic Approach
04HV03Z Insertion of Infusion Device into Right Foot Artery, Open Approach
04HV33Z Insertion of Infusion Device into Right Foot Artery, Percutaneous Approach
04HV43Z Insertion of Infusion Device into Right Foot Artery, Percutaneous Endoscopic Approach
04HW03Z Insertion of Infusion Device into Left Foot Artery, Open Approach
04HW33Z Insertion of Infusion Device into Left Foot Artery, Percutaneous Approach
04HW43Z Insertion of Infusion Device into Left Foot Artery, Percutaneous Endoscopic Approach
04HY03Z Insertion of Infusion Device into Lower Artery, Open Approach
04HY33Z Insertion of Infusion Device into Lower Artery, Percutaneous Approach
04HY43Z Insertion of Infusion Device into Lower Artery, Percutaneous Endoscopic Approach
39.61 Extracorporeal circulation auxiliary to open heart surgery 5A1221Z Performance of Cardiac Output, Continuous

REVENUE CODES7 AND HCPCS CODES

Revenue codes help hospitals categorize services provided by revenue center. Medicare utilizes revenue codes for cost reporting purposes. For Medicare, revenue codes must be included for each service on a CMS 1450 (UB-04) claim form. It may be appropriate for hospitals to capture the cost of products used for the procedures described above within Revenue Code 0278 (Medical/Surgical Supply – Other Implant) or Revenue Code 0360 (Operating Room Services - General). Health Care Common Procedural Coding System (HCPCS) codes include level I codes (CPT, described above) and level II codes (other products, supplies, and services not included in CPT). Level II HCPCS codes, including C codes, are not applicable to Edwards’ products utilized in the procedures described above. C codes are used in conjunction with the Medicare prospective payment system for outpatient procedures only.

DISCLAIMER

Reimbursement information provided by Edwards Lifesciences is gathered from third-party sources and is presented for informational purposes only. Edwards makes no representation, warranty or guarantee as to the timeliness, accuracy or completeness of the information and such information is not, and should not be construed as reimbursement, coding or legal advice. Any and all references to reimbursement codes are provided as examples only and are not intended to be a recommendation or advice as to the appropriate code for a particular patient, diagnosis, product or procedure or a guarantee or promise of coverage or payment, nor does Edwards Lifesciences warranty that codes listed are appropriate in all related clinical scenarios. It is the responsibility of the provider to determine if coverage exists and what requirements are necessary for submitting a proper claim for reimbursement to a health plan or payer, including the appropriate code(s) for products provided or services rendered. Laws, regulations, and payer policies concerning reimbursement are complex and change frequently; service providers are responsible for all decisions relating to coding and reimbursement submissions. Medicare’s Correct Coding Initiative and commercial payer policies are reviewed and updated several times each year. Accordingly, Edwards strongly recommends consultation with payers, reimbursement specialists and/or legal counsel regarding appropriate product or procedure codes, coverage, and reimbursement matters.

References
  1. Current Procedure Terminology (CPT) copyright 2015, American Medical Association (AMA). All rights reserved. CPT is a registered trademark of the AMA. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein. Applicable FARS/DFARS restrictions apply to government use.
  2. Not all codes provided are applicable for the clinical scenarios in which Edwards Lifesciences’ Heart Valve technologies are used. The provider is responsible for selecting the most appropriate code(s) for the patient’s clinical presentation. When diagnostic services are performed, it may be appropriate to add applicable codes according to the service provided following the correct coding guidelines. Services that are considered a component of another procedure may not always be coded and billed separately.
  3. For all Medicare payments for physician, hospital outpatient, and ASC services, the multiple procedure reduction rule may apply. Consult with coding and billing staff, and payer policy for further guidance. National average Medicare payment is calculated using the Conversion Factor of $35.8279 per the Medicare Physician Fee Schedule for Calendar Year 2016 Final Rule issued October 30, 2015. National average is based on factors such as geography, teaching vs. non-teaching hospital, rural vs. urban area, etc. and your payment may be different based on these factors. This payment will differ for commercial payers. Payments are effective January 1, 2016 through December 31, 2016.
  4. For Minimal Incision Valve Surgery procedures, multiple catheters and/or cannulae are typically used; therefore, the use of modifier -59 may be required. Check with internal billing staff and payer policies for clarification.
  5. Diagnostic procedures performed in the facility setting may require the use of modifier -26 to reflect the professional component of the service only. Check with internal billing staff and payer policies for clarification. Intraoperative Transesophageal echocardiography (TEE) is a non-covered service for many payers. Providers may wish to review Medicare’s Correct Coding Initiative when providing anesthesia services in conjunction with TEE. Consult payer policies and contracts for clarification.
  6. Centers for Medicare & Medicaid Services. FY 2017 Inpatient Prospective Payment System (IPPS) Final Rule issued August 2, 2016. Payments are effective October 1, 2016 through September 30, 2017.
  7. National Uniform Billing Committee, American Hospital Association
  8. Federal Register / Vol. 74, No. 11 / Friday, January 16, 2009 / Rules and Regulations: This final rule adopts modifications to two of the code set standards adopted in the Transactions and Code Sets final rule published in the Federal Register pursuant to certain provisions of the Administrative Simplification subtitle of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). Specifically, this final rule modifies the standard medical data code sets (hereinafter ‘‘code sets’’) for coding diagnoses and inpatient hospital procedures by concurrently adopting the International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) for diagnosis coding, including the Official ICD-10-CM Guidelines for Coding and Reporting, as maintained and distributed by the U.S. Department of Health and Human Services (HHS), hereinafter referred to as ICD-10-CM, and the International Classification of Diseases, 10th Revision, Procedure Coding System (ICD-10-PCS) for inpatient hospital procedure coding, including the Official ICD-10-PCS Guidelines for Coding and Reporting, as maintained and distributed by the HHS, hereinafter referred to as ICD-10-PCS. These new codes replace the International Classification of Diseases, 9th Revision, Clinical Modification, Volumes 1 and 2, including the Official ICD-9-CM Guidelines for Coding and Reporting, hereinafter referred to as ICD-9-CM Volumes 1 and 2, and the International Classification of Diseases, 9th Revision, Clinical Modification, Volume 3, including the Official ICD-9-CM Guidelines for Coding and Reporting, hereinafter referred to as ICD-9-CM Volume 3, for diagnosis and procedure codes, respectively. DATES: The effective date of this regulation is March 17, 2009. The effective date is the date that the policies herein take effect, and new policies are considered to be officially adopted. The compliance date, which is different than the effective date, is the date on which entities are required to have implemented the policies adopted in this rule. The compliance date for this regulation is October 1, 2015.
  9. International Classification of Diseases, 9th Revision, Clinical Modification 2015 ICD-9-CM for hospitals, volume 1, 2, & 3.
  10. International Classification of Diseases, 10th Revision, Procedure Coding System 2016 Draft.
Critical Care TECHNOLOGIES

2016 Facility and Physician Billing Guide

Clinicians use Current Procedural Terminology (CPT)1 codes to bill for procedures and services. Each CPT code is assigned unique relative value units (RVUs), which are used to determine payment by the Centers for Medicare & Medicaid Services (CMS). Some commonly billed CPT codes used to describe procedures related to Edwards Lifesciences’ Critical Care technologies (e.g. Swan-Ganz catheter, FloTrac sensor, PreSep and PediaSat and PediaSat oximetry catheters) are listed below.2 This list may not be comprehensive or complete. These procedures may be subject to the CMS multiple procedure reduction rule. When applicable, a payment reduction of 50% is applied to all payment amounts except the procedure with the greatest RVUs, which is paid at 100% unless exempt by CPT instructions or payer policy.

CPT Code Description Medicare National
Average Physician
Payment3
36555 Insertion of non-tunneled centrally inserted central venous catheter; younger than 5 years of age $124
36556 Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older $126
36620 Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous $53
93503 Insertion and placement of flow directed catheter (eg, Swan-Ganz) for monitoring purposes) $135
99221 Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of low complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the problem(s) requiring admission are of low severity. Typically, 30 minutes are spent at the bedside and on the patient's hospital floor or unit. $102
99222 Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the problem(s) requiring admission are of moderate severity. Typically, 50 minutes are spent at the bedside and on the patient's hospital floor or unit. $138
99223 Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the problem(s) requiring admission are of high severity. Typically, 70 minutes are spent at the bedside and on the patient's hospital floor or unit. $204
99231 Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or of low complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient is stable, recovering or improving. Typically, 15 minutes are spent at the bedside and on the patient's hospital floor or unit. $40
99232 Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient is responding inadequately to therapy or has developed a minor complication. Typically, 25 minutes are spent at the bedside and on the patient's hospital floor or unit. $73
99233 Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient is unstable or has developed a significant complication or a significant new problem. Typically, 35 minutes are spent at the bedside and on the patient's hospital floor or unit. $105
99291 Critical Care Evaluation and Management of the critically ill or critically injured, first 30-74 minutes $226
99292 Critical Care Evaluation and Management of the critically ill or critically injured, each additional 30 minutes (List separately in addition to code for primary service) $113

REVENUE CODES4 AND HCPCS CODES

Revenue codes help hospitals categorize services provided by revenue center. Medicare utilizes revenue codes for cost reporting purposes. It may be appropriate for hospitals to capture the cost for some of Edwards Lifesciences’ Critical Care technologies for payer reporting or cost accounting purposes as expenses within Revenue Code 0278 (Medical/Surgical – Other Implants) on the hospital’s UB-04 billing form. C codes do not apply to inpatient surgical procedures, but should be added to the hospital’s chargemaster to report device costs used in the outpatient setting. Medicare created C codes to track device cost information for future APC rate-setting purposes. No additional facility payment is associated with these codes. CMS may reject hospital claims if the appropriate code is not identified on the claim. C codes may not be recognized by commercial payers.

C Code Description
C1751 Catheter, infusion, inserted peripherally, centrally or midline, other than hemodialysis
C1769 Guide wire
C1894 Sheath introducer, other than guiding, other than Intracardiac electrophysiological, non-laser

Medicare inpatient hospital reimbursement is based upon the Medicare Severity-Diagnosis Related Group (MS-DRG) classification system, which assigns MS-DRGs based on ICD-9-CM diagnosis and procedure codes. Although the compliance date for mandatory use of ICD-10 codes is October 1, 20155, this guide is intended to provide the cross-over codes for testing purposes only. Given Medicare and other payers are encouraging the provider community to perform parallel coding and test the claims systems, this guide will provide the necessary conversion from ICD-9 codes to the appropriate ICD-10 codes.

ICD-9-CM Procedure Code6DescriptionICD-10-CM Procedure Code7Description
38.91 Arterial catheterization 02HP03Z Insertion of Infusion Device into Pulmonary Trunk, Open Approach
02HP33Z Insertion of Infusion Device into Pulmonary Trunk, Percutaneous Approach
02HP43Z Insertion of Infusion Device into Pulmonary Trunk, Percutaneous Endoscopic Approach
02HQ03Z Insertion of Infusion Device into Right Pulmonary Artery, Open Approach
02HQ33Z Insertion of Infusion Device into Right Pulmonary Artery, Percutaneous Approach
02HQ43Z Insertion of Infusion Device into Right Pulmonary Artery, Percutaneous Endoscopic Approach
02HR03Z Insertion of Infusion Device into Left Pulmonary Artery, Open Approach
02HR33Z Insertion of Infusion Device into Left Pulmonary Artery, Percutaneous Approach
02HR43Z Insertion of Infusion Device into Left Pulmonary Artery, Percutaneous Endoscopic Approach
02HW03Z Insertion of Infusion Device into Thoracic Aorta, Open Approach
02HW33Z Insertion of Infusion Device into Thoracic Aorta, Percutaneous Approach
02HW43Z Insertion of Infusion Device into Thoracic Aorta, Percutaneous Endoscopic Approach
03H003Z Insertion of Infusion Device into Right Internal Mammary Artery, Open Approach
03H033Z Insertion of Infusion Device into Right Internal Mammary Artery, Percutaneous Approach
03H043Z Insertion of Infusion Device into Right Internal Mammary Artery, Percutaneous Endoscopic Approach
03H103Z Insertion of Infusion Device into Left Internal Mammary Artery, Open Approach
03H133Z Insertion of Infusion Device into Left Internal Mammary Artery, Percutaneous Approach
03H143Z Insertion of Infusion Device into Left Internal Mammary Artery, Percutaneous Endoscopic Approach
03H203Z Insertion of Infusion Device into Innominate Artery, Open Approach
03H233Z Insertion of Infusion Device into Innominate Artery, Percutaneous Approach
03H243Z Insertion of Infusion Device into Innominate Artery, Percutaneous Endoscopic Approach
03H303Z Insertion of Infusion Device into Right Subclavian Artery, Open Approach
03H333Z Insertion of Infusion Device into Right Subclavian Artery, Percutaneous Approach
03H343Z Insertion of Infusion Device into Right Subclavian Artery, Percutaneous Endoscopic Approach
03H403Z Insertion of Infusion Device into Left Subclavian Artery, Open Approach
03H433Z Insertion of Infusion Device into Left Subclavian Artery, Percutaneous Approach
03H443Z Insertion of Infusion Device into Left Subclavian Artery, Percutaneous Endoscopic Approach
03H503Z Insertion of Infusion Device into Right Axillary Artery, Open Approach
03H533Z Insertion of Infusion Device into Right Axillary Artery, Percutaneous Approach
03H543Z Insertion of Infusion Device into Right Axillary Artery, Percutaneous Endoscopic Approach
03H603Z Insertion of Infusion Device into Left Axillary Artery, Open Approach
03H633Z Insertion of Infusion Device into Left Axillary Artery, Percutaneous Approach
03H643Z Insertion of Infusion Device into Left Axillary Artery, Percutaneous Endoscopic Approach
03H703Z Insertion of Infusion Device into Right Brachial Artery, Open Approach
03H733Z Insertion of Infusion Device into Right Brachial Artery, Percutaneous Approach
03H743Z Insertion of Infusion Device into Right Brachial Artery, Percutaneous Endoscopic Approach
03H803Z Insertion of Infusion Device into Left Brachial Artery, Open Approach
03H833Z Insertion of Infusion Device into Left Brachial Artery, Percutaneous Approach
03H843Z Insertion of Infusion Device into Left Brachial Artery, Percutaneous Endoscopic Approach
03H903Z Insertion of Infusion Device into Right Ulnar Artery, Open Approach
03H933Z Insertion of Infusion Device into Right Ulnar Artery, Percutaneous Approach
03H943Z Insertion of Infusion Device into Right Ulnar Artery, Percutaneous Endoscopic Approach
03HA03Z Insertion of Infusion Device into Left Ulnar Artery, Open Approach
03HA33Z Insertion of Infusion Device into Left Ulnar Artery, Percutaneous Approach
03HA43Z Insertion of Infusion Device into Left Ulnar Artery, Percutaneous Endoscopic Approach
03HB03Z Insertion of Infusion Device into Right Radial Artery, Open Approach
03HB33Z Insertion of Infusion Device into Right Radial Artery, Percutaneous Approach
03HB43Z Insertion of Infusion Device into Right Radial Artery, Percutaneous Endoscopic Approach
03HC03Z Insertion of Infusion Device into Left Radial Artery, Open Approach
03HC33Z Insertion of Infusion Device into Left Radial Artery, Percutaneous Approach
03HC43Z Insertion of Infusion Device into Left Radial Artery, Percutaneous Endoscopic Approach
03HD03Z Insertion of Infusion Device into Right Hand Artery, Open Approach
03HD33Z Insertion of Infusion Device into Right Hand Artery, Percutaneous Approach
03HD43Z Insertion of Infusion Device into Right Hand Artery, Percutaneous Endoscopic Approach
03HF03Z Insertion of Infusion Device into Left Hand Artery, Open Approach
03HF33Z Insertion of Infusion Device into Left Hand Artery, Percutaneous Approach
03HF43Z Insertion of Infusion Device into Left Hand Artery, Percutaneous Endoscopic Approach
03HG03Z Insertion of Infusion Device into Intracranial Artery, Open Approach
03HG33Z Insertion of Infusion Device into Intracranial Artery, Percutaneous Approach
03HG43Z Insertion of Infusion Device into Intracranial Artery, Percutaneous Endoscopic Approach
03HH03Z Insertion of Infusion Device into Right Common Carotid Artery, Open Approach
03HH33Z Insertion of Infusion Device into Right Common Carotid Artery, Percutaneous Approach
03HH43Z Insertion of Infusion Device into Right Common Carotid Artery, Percutaneous Endoscopic Approach
03HJ03Z Insertion of Infusion Device into Left Common Carotid Artery, Open Approach
03HJ33Z Insertion of Infusion Device into Left Common Carotid Artery, Percutaneous Approach
03HJ43Z Insertion of Infusion Device into Left Common Carotid Artery, Percutaneous Endoscopic Approach
03HK03Z Insertion of Infusion Device into Right Internal Carotid Artery, Open Approach
03HK33Z Insertion of Infusion Device into Right Internal Carotid Artery, Percutaneous Approach
03HK43Z Insertion of Infusion Device into Right Internal Carotid Artery, Percutaneous Endoscopic Approach
03HL03Z Insertion of Infusion Device into Left Internal Carotid Artery, Open Approach
03HL33Z Insertion of Infusion Device into Left Internal Carotid Artery, Percutaneous Approach
03HL43Z Insertion of Infusion Device into Left Internal Carotid Artery, Percutaneous Endoscopic Approach
03HM03Z Insertion of Infusion Device into Right External Carotid Artery, Open Approach
03HM33Z Insertion of Infusion Device into Right External Carotid Artery, Percutaneous Approach
03HM43Z Insertion of Infusion Device into Right External Carotid Artery, Percutaneous Endoscopic Approach
03HN03Z Insertion of Infusion Device into Left External Carotid Artery, Open Approach
03HN33Z Insertion of Infusion Device into Left External Carotid Artery, Percutaneous Approach
03HN43Z Insertion of Infusion Device into Left External Carotid Artery, Percutaneous Endoscopic Approach
03HP03Z Insertion of Infusion Device into Right Vertebral Artery, Open Approach
03HP33Z Insertion of Infusion Device into Right Vertebral Artery, Percutaneous Approach
03HP43Z Insertion of Infusion Device into Right Vertebral Artery, Percutaneous Endoscopic Approach
03HQ03Z Insertion of Infusion Device into Left Vertebral Artery, Open Approach
03HQ33Z Insertion of Infusion Device into Left Vertebral Artery, Percutaneous Approach
03HQ43Z Insertion of Infusion Device into Left Vertebral Artery, Percutaneous Endoscopic Approach
03HR03Z Insertion of Infusion Device into Face Artery, Open Approach
03HR33Z Insertion of Infusion Device into Face Artery, Percutaneous Approach
03HR43Z Insertion of Infusion Device into Face Artery, Percutaneous Endoscopic Approach
03HS03Z Insertion of Infusion Device into Right Temporal Artery, Open Approach
03HS33Z Insertion of Infusion Device into Right Temporal Artery, Percutaneous Approach
03HS43Z Insertion of Infusion Device into Right Temporal Artery, Percutaneous Endoscopic Approach
03HT03Z Insertion of Infusion Device into Left Temporal Artery, Open Approach
03HT33Z Insertion of Infusion Device into Left Temporal Artery, Percutaneous Approach
03HT43Z Insertion of Infusion Device into Left Temporal Artery, Percutaneous Endoscopic Approach
03HU03Z Insertion of Infusion Device into Right Thyroid Artery, Open Approach
03HU33Z Insertion of Infusion Device into Right Thyroid Artery, Percutaneous Approach
03HU43Z Insertion of Infusion Device into Right Thyroid Artery, Percutaneous Endoscopic Approach
03HV03Z Insertion of Infusion Device into Left Thyroid Artery, Open Approach
03HV33Z Insertion of Infusion Device into Left Thyroid Artery, Percutaneous Approach
03HV43Z Insertion of Infusion Device into Left Thyroid Artery, Percutaneous Endoscopic Approach
03HY03Z Insertion of Infusion Device into Upper Artery, Open Approach
03HY33Z Insertion of Infusion Device into Upper Artery, Percutaneous Approach
03HY43Z Insertion of Infusion Device into Upper Artery, Percutaneous Endoscopic Approach
04H003Z Insertion of Infusion Device into Abdominal Aorta, Open Approach
04H033Z Insertion of Infusion Device into Abdominal Aorta, Percutaneous Approach
04H043Z Insertion of Infusion Device into Abdominal Aorta, Percutaneous Endoscopic Approach
04H103Z Insertion of Infusion Device into Celiac Artery, Open Approach
04H133Z Insertion of Infusion Device into Celiac Artery, Percutaneous Approach
04H143Z Insertion of Infusion Device into Celiac Artery, Percutaneous Endoscopic Approach
04H203Z Insertion of Infusion Device into Gastric Artery, Open Approach
04H233Z Insertion of Infusion Device into Gastric Artery, Percutaneous Approach
04H243Z Insertion of Infusion Device into Gastric Artery, Percutaneous Endoscopic Approach
04H303Z Insertion of Infusion Device into Hepatic Artery, Open Approach
04H333Z Insertion of Infusion Device into Hepatic Artery, Percutaneous Approach
04H343Z Insertion of Infusion Device into Hepatic Artery, Percutaneous Endoscopic Approach
04H403Z Insertion of Infusion Device into Splenic Artery, Open Approach
04H433Z Insertion of Infusion Device into Splenic Artery, Percutaneous Approach
04H443Z Insertion of Infusion Device into Splenic Artery, Percutaneous Endoscopic Approach
04H503Z Insertion of Infusion Device into Superior Mesenteric Artery, Open Approach
04H533Z Insertion of Infusion Device into Superior Mesenteric Artery, Percutaneous Approach
04H543Z Insertion of Infusion Device into Superior Mesenteric Artery, Percutaneous Endoscopic Approach
04H603Z Insertion of Infusion Device into Right Colic Artery, Open Approach
04H633Z Insertion of Infusion Device into Right Colic Artery, Percutaneous Approach
04H643Z Insertion of Infusion Device into Right Colic Artery, Percutaneous Endoscopic Approach
04H703Z Insertion of Infusion Device into Left Colic Artery, Open Approach
04H733Z Insertion of Infusion Device into Left Colic Artery, Percutaneous Approach
04H743Z Insertion of Infusion Device into Left Colic Artery, Percutaneous Endoscopic Approach
04H803Z Insertion of Infusion Device into Middle Colic Artery, Open Approach
04H833Z Insertion of Infusion Device into Middle Colic Artery, Percutaneous Approach
04H843Z Insertion of Infusion Device into Middle Colic Artery, Percutaneous Endoscopic Approach
04H903Z Insertion of Infusion Device into Right Renal Artery, Open Approach
04H933Z Insertion of Infusion Device into Right Renal Artery, Percutaneous Approach
04H943Z Insertion of Infusion Device into Right Renal Artery, Percutaneous Endoscopic Approach
04HA33Z Insertion of Infusion Device into Left Renal Artery, Open Approach
02QJ4ZZ Insertion of Infusion Device into Left Renal Artery, Percutaneous Approach
04HA43Z Insertion of Infusion Device into Left Renal Artery, Percutaneous Endoscopic Approach
04HB03Z Insertion of Infusion Device into Inferior Mesenteric Artery, Open Approach
04HB33Z Insertion of Infusion Device into Inferior Mesenteric Artery, Percutaneous Approach
04HB43Z Insertion of Infusion Device into Inferior Mesenteric Artery, Percutaneous Endoscopic Approach
04HC03Z Insertion of Infusion Device into Right Common Iliac Artery, Open Approach
04HC33Z Insertion of Infusion Device into Right Common Iliac Artery, Percutaneous Approach
04HC43Z Insertion of Infusion Device into Right Common Iliac Artery, Percutaneous Endoscopic Approach
04HD03Z Insertion of Infusion Device into Left Common Iliac Artery, Open Approach
04HD33Z Insertion of Infusion Device into Left Common Iliac Artery, Percutaneous Approach
04HD43Z Insertion of Infusion Device into Left Common Iliac Artery, Percutaneous Endoscopic Approach
04HE03Z Insertion of Infusion Device into Right Internal Iliac Artery, Open Approach
04HE33Z Insertion of Infusion Device into Right Internal Iliac Artery, Percutaneous Approach
04HE43Z Insertion of Infusion Device into Right Internal Iliac Artery, Percutaneous Endoscopic Approach
04HF03Z Insertion of Infusion Device into Left Internal Iliac Artery, Open Approach
04HF33Z Insertion of Infusion Device into Left Internal Iliac Artery, Percutaneous Approach
04HF43Z Insertion of Infusion Device into Left Internal Iliac Artery, Percutaneous Endoscopic Approach
04HH03Z Insertion of Infusion Device into Right External Iliac Artery, Open Approach
04HH33Z Insertion of Infusion Device into Right External Iliac Artery, Percutaneous Approach
04HH43Z Insertion of Infusion Device into Right External Iliac Artery, Percutaneous Endoscopic Approach
04HJ03Z Insertion of Infusion Device into Left External Iliac Artery, Open Approach
04HJ33Z Insertion of Infusion Device into Left External Iliac Artery, Percutaneous Approach
04HJ43Z Insertion of Infusion Device into Left External Iliac Artery, Percutaneous Endoscopic Approach
04HK03Z Insertion of Infusion Device into Right Femoral Artery, Open Approach
04HK33Z Insertion of Infusion Device into Right Femoral Artery, Percutaneous Approach
04HK43Z Insertion of Infusion Device into Right Femoral Artery, Percutaneous Endoscopic Approach
04HL03Z Insertion of Infusion Device into Left Femoral Artery, Open Approach
04HL33Z Insertion of Infusion Device into Left Femoral Artery, Percutaneous Approach
04HL43Z Insertion of Infusion Device into Left Femoral Artery, Percutaneous Endoscopic Approach
04HM03Z Insertion of Infusion Device into Right Popliteal Artery, Open Approach
04HM33Z Insertion of Infusion Device into Right Popliteal Artery, Percutaneous Approach
04HM43Z Insertion of Infusion Device into Right Popliteal Artery, Percutaneous Endoscopic Approach
04HN03Z Insertion of Infusion Device into Left Popliteal Artery, Open Approach
04HN33Z Insertion of Infusion Device into Left Popliteal Artery, Percutaneous Approach
04HN43Z Insertion of Infusion Device into Left Popliteal Artery, Percutaneous Endoscopic Approach
04HP03Z Insertion of Infusion Device into Right Anterior Tibial Artery, Open Approach
04HP33Z Insertion of Infusion Device into Right Anterior Tibial Artery, Percutaneous Approach
04HP43Z Insertion of Infusion Device into Right Anterior Tibial Artery, Percutaneous Endoscopic Approach
04HQ03Z Insertion of Infusion Device into Left Anterior Tibial Artery, Open Approach
04HQ33Z Insertion of Infusion Device into Left Anterior Tibial Artery, Percutaneous Approach
04HQ43Z Insertion of Infusion Device into Left Anterior Tibial Artery, Percutaneous Endoscopic Approach
04HR03Z Insertion of Infusion Device into Right Posterior Tibial Artery, Open Approach
04HR33Z Insertion of Infusion Device into Right Posterior Tibial Artery, Percutaneous Approach
04HR43Z Insertion of Infusion Device into Right Posterior Tibial Artery, Percutaneous Endoscopic Approach
04HS03Z Insertion of Infusion Device into Left Posterior Tibial Artery, Open Approach
04HS33Z Insertion of Infusion Device into Left Posterior Tibial Artery, Percutaneous Approach
04HS43Z Insertion of Infusion Device into Left Posterior Tibial Artery, Percutaneous Endoscopic Approach
04HT03Z Insertion of Infusion Device into Right Peroneal Artery, Open Approach
04HT33Z Insertion of Infusion Device into Right Peroneal Artery, Percutaneous Approach
04HT43Z Insertion of Infusion Device into Right Peroneal Artery, Percutaneous Endoscopic Approach
04HU03Z Insertion of Infusion Device into Left Peroneal Artery, Open Approach
04HU33Z Insertion of Infusion Device into Left Peroneal Artery, Percutaneous Approach
04HU43Z Insertion of Infusion Device into Left Peroneal Artery, Percutaneous Endoscopic Approach
02NH3ZZ Release Pulmonary Valve, Percutaneous Approach
02NH4ZZ Release Pulmonary Valve, Percutaneous Endoscopic Approach
04HV03Z Insertion of Infusion Device into Right Foot Artery, Open Approach
04HV33Z Insertion of Infusion Device into Right Foot Artery, Percutaneous Approach
04HV43Z Insertion of Infusion Device into Right Foot Artery, Percutaneous Endoscopic Approach
04HW03Z Insertion of Infusion Device into Left Foot Artery, Open Approach
04HW33Z Insertion of Infusion Device into Left Foot Artery, Percutaneous Approach
04HW43Z Insertion of Infusion Device into Left Foot Artery, Percutaneous Endoscopic Approach
04HY03Z Insertion of Infusion Device into Lower Artery, Open Approach
04HY33Z Insertion of Infusion Device into Lower Artery, Percutaneous Approach
04HY43Z Insertion of Infusion Device into Lower Artery, Percutaneous Endoscopic Approach
38.93 Venous catheterization, not elsewhere classified 02H633Z Insertion of Infusion Device into Right Atrium, Percutaneous Approach
02HK33Z Insertion of Infusion Device into Right Ventricle, Percutaneous Approach
02HS03Z Insertion of Infusion Device into Right Pulmonary Vein, Open Approach
02HS33Z Insertion of Infusion Device into Right Pulmonary Vein, Percutaneous Approach
02HS43Z Insertion of Infusion Device into Right Pulmonary Vein, Percutaneous Endoscopic Approach
02HT03Z Insertion of Infusion Device into Left Pulmonary Vein, Open Approach
02HT33Z Insertion of Infusion Device into Left Pulmonary Vein, Percutaneous Approach
02HT43Z Insertion of Infusion Device into Left Pulmonary Vein, Percutaneous Endoscopic Approach
02HV03Z Insertion of Infusion Device into Superior Vena Cava, Open Approach
02HV33Z Insertion of Infusion Device into Superior Vena Cava, Percutaneous Approach
02HV43Z Insertion of Infusion Device into Superior Vena Cava, Percutaneous Endoscopic Approach
05H003Z Insertion of Infusion Device into Azygos Vein, Open Approach
05H033Z Insertion of Infusion Device into Azygos Vein, Percutaneous Approach
05H043Z Insertion of Infusion Device into Azygos Vein, Percutaneous Endoscopic Approach
05H103Z Insertion of Infusion Device into Hemiazygos Vein, Open Approach
05H133Z Insertion of Infusion Device into Hemiazygos Vein, Percutaneous Approach
05H143Z Insertion of Infusion Device into Hemiazygos Vein, Percutaneous Endoscopic Approach
05H303Z Insertion of Infusion Device into Right Innominate Vein, Open Approach
05H333Z Insertion of Infusion Device into Right Innominate Vein, Percutaneous Approach
05H343Z Insertion of Infusion Device into Right Innominate Vein, Percutaneous Endoscopic Approach
05H403Z Insertion of Infusion Device into Left Innominate Vein, Open Approach
05H433Z Insertion of Infusion Device into Left Innominate Vein, Percutaneous Approach
05H443Z Insertion of Infusion Device into Left Innominate Vein, Percutaneous Endoscopic Approach
05H503Z Insertion of Infusion Device into Right Subclavian Vein, Open Approach
05H533Z Insertion of Infusion Device into Right Subclavian Vein, Percutaneous Approach
05H543Z Insertion of Infusion Device into Right Subclavian Vein, Percutaneous Endoscopic Approach
05H603Z Insertion of Infusion Device into Left Subclavian Vein, Open Approach
05H633Z Insertion of Infusion Device into Left Subclavian Vein, Percutaneous Approach
05H643Z Insertion of Infusion Device into Left Subclavian Vein, Percutaneous Endoscopic Approach
05H703Z Insertion of Infusion Device into Right Axillary Vein, Open Approach
05H733Z Insertion of Infusion Device into Right Axillary Vein, Percutaneous Approach
05H743Z Insertion of Infusion Device into Right Axillary Vein, Percutaneous Endoscopic Approach
05H803Z Insertion of Infusion Device into Left Axillary Vein, Open Approach
05H833Z Insertion of Infusion Device into Left Axillary Vein, Percutaneous Approach
05H843Z Insertion of Infusion Device into Left Axillary Vein, Percutaneous Endoscopic Approach
05H903Z Insertion of Infusion Device into Right Brachial Vein, Open Approach
05H933Z Insertion of Infusion Device into Right Brachial Vein, Percutaneous Approach
05H943Z Insertion of Infusion Device into Right Brachial Vein, Percutaneous Endoscopic Approach
05HA03Z Insertion of Infusion Device into Left Brachial Vein, Open Approach
05HA33Z Insertion of Infusion Device into Left Brachial Vein, Percutaneous Approach
05HA43Z Insertion of Infusion Device into Left Brachial Vein, Percutaneous Endoscopic Approach
05HB03Z Insertion of Infusion Device into Right Basilic Vein, Open Approach
05HB33Z Insertion of Infusion Device into Right Basilic Vein, Percutaneous Approach
05HB43Z Insertion of Infusion Device into Right Basilic Vein, Percutaneous Endoscopic Approach
05HC03Z Insertion of Infusion Device into Left Basilic Vein, Open Approach
05HC33Z Insertion of Infusion Device into Left Basilic Vein, Percutaneous Approach
05HC43Z Insertion of Infusion Device into Left Basilic Vein, Percutaneous Endoscopic Approach
05HD03Z Insertion of Infusion Device into Right Cephalic Vein, Open Approach
05HD33Z Insertion of Infusion Device into Right Cephalic Vein, Percutaneous Approach
05HD43Z Insertion of Infusion Device into Right Cephalic Vein, Percutaneous Endoscopic Approach
05HF03Z Insertion of Infusion Device into Left Cephalic Vein, Open Approach
05HF33Z Insertion of Infusion Device into Left Cephalic Vein, Percutaneous Approach
05HF43Z Insertion of Infusion Device into Left Cephalic Vein, Percutaneous Endoscopic Approach
05HG03Z Insertion of Infusion Device into Right Hand Vein, Open Approach
05HG33Z Insertion of Infusion Device into Right Hand Vein, Percutaneous Approach
05HG43Z Insertion of Infusion Device into Right Hand Vein, Percutaneous Endoscopic Approach
05HH03Z Insertion of Infusion Device into Left Hand Vein, Open Approach
05HH33Z Insertion of Infusion Device into Left Hand Vein, Percutaneous Approach
05HH43Z Insertion of Infusion Device into Left Hand Vein, Percutaneous Endoscopic Approach
05HL03Z Insertion of Infusion Device into Intracranial Vein, Open Approach
05HL33Z Insertion of Infusion Device into Intracranial Vein, Percutaneous Approach
05HL43Z Insertion of Infusion Device into Intracranial Vein, Percutaneous Endoscopic Approach
05HM03Z Insertion of Infusion Device into Right Internal Jugular Vein, Open Approach
05HM33Z Insertion of Infusion Device into Right Internal Jugular Vein, Percutaneous Approach
05HM43Z Insertion of Infusion Device into Right Internal Jugular Vein, Percutaneous Endoscopic Approach
05HN03Z Insertion of Infusion Device into Left Internal Jugular Vein, Open Approach
05HN33Z Insertion of Infusion Device into Left Internal Jugular Vein, Percutaneous Approach
05HN43Z Insertion of Infusion Device into Left Internal Jugular Vein, Percutaneous Endoscopic Approach
05HP03Z Insertion of Infusion Device into Right External Jugular Vein, Open Approach
05HP33Z Insertion of Infusion Device into Right External Jugular Vein, Percutaneous Approach
05HP43Z Insertion of Infusion Device into Right External Jugular Vein, Percutaneous Endoscopic Approach
05HQ03Z Insertion of Infusion Device into Left External Jugular Vein, Open Approach
05HQ33Z Insertion of Infusion Device into Left External Jugular Vein, Percutaneous Approach
05HQ43Z Insertion of Infusion Device into Left External Jugular Vein, Percutaneous Endoscopic Approach
05HR03Z Insertion of Infusion Device into Right Vertebral Vein, Open Approach
05HR33Z Insertion of Infusion Device into Right Vertebral Vein, Percutaneous Approach
05HR43Z Insertion of Infusion Device into Right Vertebral Vein, Percutaneous Endoscopic Approach
05HS03Z Insertion of Infusion Device into Left Vertebral Vein, Open Approach
05HS33Z Insertion of Infusion Device into Left Vertebral Vein, Percutaneous Approach
05HS43Z Insertion of Infusion Device into Left Vertebral Vein, Percutaneous Endoscopic Approach
05HT03Z Insertion of Infusion Device into Right Face Vein, Open Approach
05HT33Z Insertion of Infusion Device into Right Face Vein, Percutaneous Approach
05HT43Z Insertion of Infusion Device into Right Face Vein, Percutaneous Endoscopic Approach
05HV03Z Insertion of Infusion Device into Left Face Vein, Open Approach
05HV33Z Insertion of Infusion Device into Left Face Vein, Percutaneous Approach
05HV43Z Insertion of Infusion Device into Left Face Vein, Percutaneous Endoscopic Approach
05HY03Z Insertion of Infusion Device into Upper Vein, Open Approach
05HY33Z Insertion of Infusion Device into Upper Vein, Percutaneous Approach
05HY43Z Insertion of Infusion Device into Upper Vein, Percutaneous Endoscopic Approach
06H003Z Insertion of Infusion Device into Inferior Vena Cava, Open Approach
06H033Z Insertion of Infusion Device into Inferior Vena Cava, Percutaneous Approach
06H043Z Insertion of Infusion Device into Inferior Vena Cava, Percutaneous Endoscopic Approach
06H103Z Insertion of Infusion Device into Splenic Vein, Open Approach
06H133Z Insertion of Infusion Device into Splenic Vein, Percutaneous Approach
06H143Z Insertion of Infusion Device into Splenic Vein, Percutaneous Endoscopic Approach
06H203Z Insertion of Infusion Device into Gastric Vein, Open Approach
06H233Z Insertion of Infusion Device into Gastric Vein, Percutaneous Approach
06H243Z Insertion of Infusion Device into Gastric Vein, Percutaneous Endoscopic Approach
06H303Z Insertion of Infusion Device into Esophageal Vein, Open Approach
06H333Z Insertion of Infusion Device into Esophageal Vein, Percutaneous Approach
06H343Z Insertion of Infusion Device into Esophageal Vein, Percutaneous Endoscopic Approach
06H403Z Insertion of Infusion Device into Hepatic Vein, Open Approach
06H433Z Insertion of Infusion Device into Hepatic Vein, Percutaneous Approach
06H443Z Insertion of Infusion Device into Hepatic Vein, Percutaneous Endoscopic Approach
06H503Z Insertion of Infusion Device into Superior Mesenteric Vein, Open Approach
06H533Z Insertion of Infusion Device into Superior Mesenteric Vein, Percutaneous Approach
06H543Z Insertion of Infusion Device into Superior Mesenteric Vein, Percutaneous Endoscopic Approach
06H603Z Insertion of Infusion Device into Inferior Mesenteric Vein, Open Approach
06H633Z Insertion of Infusion Device into Inferior Mesenteric Vein, Percutaneous Approach
06H643Z Insertion of Infusion Device into Inferior Mesenteric Vein, Percutaneous Endoscopic Approach
06H703Z Insertion of Infusion Device into Colic Vein, Open Approach
06H733Z Insertion of Infusion Device into Colic Vein, Percutaneous Approach
06H743Z Insertion of Infusion Device into Colic Vein, Percutaneous Endoscopic Approach
06H803Z Insertion of Infusion Device into Portal Vein, Open Approach
06H833Z Insertion of Infusion Device into Portal Vein, Percutaneous Approach
06H843Z Insertion of Infusion Device into Portal Vein, Percutaneous Endoscopic Approach
06H903Z Insertion of Infusion Device into Right Renal Vein, Open Approach
06H933Z Insertion of Infusion Device into Right Renal Vein, Percutaneous Approach
06H943Z Insertion of Infusion Device into Right Renal Vein, Percutaneous Endoscopic Approach
06HB03Z Insertion of Infusion Device into Left Renal Vein, Open Approach
06HB33Z Insertion of Infusion Device into Left Renal Vein, Percutaneous Approach
06HB43Z Insertion of Infusion Device into Left Renal Vein, Percutaneous Endoscopic Approach
06HC03Z Insertion of Infusion Device into Right Common Iliac Vein, Open Approach
06HC33Z Insertion of Infusion Device into Right Common Iliac Vein, Percutaneous Approach
06HC43Z Insertion of Infusion Device into Right Common Iliac Vein, Percutaneous Endoscopic Approach
06HD03Z Insertion of Infusion Device into Left Common Iliac Vein, Open Approach
06HD33Z Insertion of Infusion Device into Left Common Iliac Vein, Percutaneous Approach
06HD43Z Insertion of Infusion Device into Left Common Iliac Vein, Percutaneous Endoscopic Approach
06HF03Z Insertion of Infusion Device into Right External Iliac Vein, Open Approach
06HF33Z Insertion of Infusion Device into Right External Iliac Vein, Percutaneous Approach
06HF43Z Insertion of Infusion Device into Right External Iliac Vein, Percutaneous Endoscopic Approach
06HG03Z Insertion of Infusion Device into Left External Iliac Vein, Open Approach
06HG33Z Insertion of Infusion Device into Left External Iliac Vein, Percutaneous Approach
06HG43Z Insertion of Infusion Device into Left External Iliac Vein, Percutaneous Endoscopic Approach
06HH03Z Insertion of Infusion Device into Right Hypogastric Vein, Open Approach
06HH33Z Insertion of Infusion Device into Right Hypogastric Vein, Percutaneous Approach
06HH43Z Insertion of Infusion Device into Right Hypogastric Vein, Percutaneous Endoscopic Approach
06HJ03Z Insertion of Infusion Device into Left Hypogastric Vein, Open Approach
06HJ33Z Insertion of Infusion Device into Left Hypogastric Vein, Percutaneous Approach
06HJ43Z Insertion of Infusion Device into Left Hypogastric Vein, Percutaneous Endoscopic Approach
06HM03Z Insertion of Infusion Device into Right Femoral Vein, Open Approach
06HM33Z Insertion of Infusion Device into Right Femoral Vein, Percutaneous Approach
06HM43Z Insertion of Infusion Device into Right Femoral Vein, Percutaneous Endoscopic Approach
06HN03Z Insertion of Infusion Device into Left Femoral Vein, Open Approach
06HN33Z Insertion of Infusion Device into Left Femoral Vein, Percutaneous Approach
06HN43Z Insertion of Infusion Device into Left Femoral Vein, Percutaneous Endoscopic Approach
06HP03Z Insertion of Infusion Device into Right Greater Saphenous Vein, Open Approach
06HP33Z Insertion of Infusion Device into Right Greater Saphenous Vein, Percutaneous Approach
06HP43Z Insertion of Infusion Device into Right Greater Saphenous Vein, Percutaneous Endoscopic Approach
06HQ03Z Insertion of Infusion Device into Left Greater Saphenous Vein, Open Approach
06HQ33Z Insertion of Infusion Device into Left Greater Saphenous Vein, Percutaneous Approach
06HQ43Z Insertion of Infusion Device into Left Greater Saphenous Vein, Percutaneous Endoscopic Approach
06HR03Z Insertion of Infusion Device into Right Lesser Saphenous Vein, Open Approach
06HR33Z Insertion of Infusion Device into Right Lesser Saphenous Vein, Percutaneous Approach
06HR43Z Insertion of Infusion Device into Right Lesser Saphenous Vein, Percutaneous Endoscopic Approach
06HS03Z Insertion of Infusion Device into Left Lesser Saphenous Vein, Open Approach
06HS33Z Insertion of Infusion Device into Left Lesser Saphenous Vein, Percutaneous Approach
06HS43Z Insertion of Infusion Device into Left Lesser Saphenous Vein, Percutaneous Endoscopic Approach
06HT03Z Insertion of Infusion Device into Right Foot Vein, Open Approach
06HT33Z Insertion of Infusion Device into Right Foot Vein, Percutaneous Approach
06HT43Z Supplement Pulmonary Valve with Synthetic Substitute, Percutaneous Approach
06HV03Z Insertion of Infusion Device into Right Foot Vein, Percutaneous Endoscopic Approach
02UH47Z Insertion of Infusion Device into Left Foot Vein, Open Approach
06HV33Z Insertion of Infusion Device into Left Foot Vein, Percutaneous Approach
06HV43Z Insertion of Infusion Device into Left Foot Vein, Percutaneous Endoscopic Approach
06HY03Z Insertion of Infusion Device into Lower Vein, Open Approach
06HY33Z Insertion of Infusion Device into Lower Vein, Percutaneous Approach
06HY43Z Insertion of Infusion Device into Lower Vein, Percutaneous Endoscopic Approach
0JH60XZ Insertion of Vascular Access Device into Chest Subcutaneous Tissue and Fascia, Open Approach
0JH63XZ Insertion of Vascular Access Device into Chest Subcutaneous Tissue and Fascia, Percutaneous Approach
0JH80XZ Insertion of Vascular Access Device into Abdomen Subcutaneous Tissue and Fascia, Open Approach
0JH83XZ Insertion of Vascular Access Device into Abdomen Subcutaneous Tissue and Fascia, Percutaneous Approach
0JHD0XZ Insertion of Vascular Access Device into Right Upper Arm Subcutaneous Tissue and Fascia, Open Approach
0JHD3XZ Insertion of Vascular Access Device into Right Upper Arm Subcutaneous Tissue and Fascia, Percutaneous Approach
0JHF0XZ Insertion of Vascular Access Device into Left Upper Arm Subcutaneous Tissue and Fascia, Open Approach
0JHF3XZ Insertion of Vascular Access Device into Left Upper Arm Subcutaneous Tissue and Fascia, Percutaneous Approach
0JHG0XZ Insertion of Vascular Access Device into Right Lower Arm Subcutaneous Tissue and Fascia, Open Approach
0JHG3XZ Insertion of Vascular Access Device into Right Lower Arm Subcutaneous Tissue and Fascia, Percutaneous Approach
0JHH0XZ Insertion of Vascular Access Device into Left Lower Arm Subcutaneous Tissue and Fascia, Open Approach
0JHH3XZ Insertion of Vascular Access Device into Left Lower Arm Subcutaneous Tissue and Fascia, Percutaneous Approach
0JHL0XZ Insertion of Vascular Access Device into Right Upper Leg Subcutaneous Tissue and Fascia, Open Approach
0JHL3XZ Insertion of Vascular Access Device into Right Upper Leg Subcutaneous Tissue and Fascia, Percutaneous Approach
0JHM0XZ Insertion of Vascular Access Device into Left Upper Leg Subcutaneous Tissue and Fascia, Open Approach
0JHM3XZ Insertion of Vascular Access Device into Left Upper Leg Subcutaneous Tissue and Fascia, Percutaneous Approach
0JHN0XZ Insertion of Vascular Access Device into Right Lower Leg Subcutaneous Tissue and Fascia, Open Approach
0JHN3XZ Insertion of Vascular Access Device into Right Lower Leg Subcutaneous Tissue and Fascia, Percutaneous Approach
0JHP0XZ Insertion of Vascular Access Device into Left Lower Leg Subcutaneous Tissue and Fascia, Open Approach
0JHP3XZ Insertion of Vascular Access Device into Left Lower Leg Subcutaneous Tissue and Fascia, Percutaneous Approach
89.62 Central venous pressure monitoring 4A04XB1 Measurement of Venous Pressure, Peripheral, External Approach
4A14XB1 Monitoring of Venous Pressure, Peripheral, External Approach
89.64 Pulmonary artery wedge monitoring 02HP00Z Insertion of Pressure Sensor Monitoring Device into Pulmonary Trunk, Open Approach
02HP02Z Insertion of Monitoring Device into Pulmonary Trunk, Open Approach
02HP30Z Insertion of Pressure Sensor Monitoring Device into Pulmonary Trunk, Percutaneous Approach
02HP32Z Insertion of Monitoring Device into Pulmonary Trunk, Percutaneous Approach
02HP40Z Insertion of Pressure Sensor Monitoring Device into Pulmonary Trunk, Percutaneous Endoscopic Approach
02HP42Z Insertion of Monitoring Device into Pulmonary Trunk, Percutaneous Endoscopic Approach
02HQ00Z Insertion of Pressure Sensor Monitoring Device into Right Pulmonary Artery, Open Approach
02HQ02Z Insertion of Monitoring Device into Right Pulmonary Artery, Open Approach
02HQ30Z Insertion of Pressure Sensor Monitoring Device into Right Pulmonary Artery, Percutaneous Approach
02HQ32Z Insertion of Monitoring Device into Right Pulmonary Artery, Percutaneous Approach
02HQ40Z Insertion of Pressure Sensor Monitoring Device into Right Pulmonary Artery, Percutaneous Endoscopic Approach
02HQ42Z Insertion of Monitoring Device into Right Pulmonary Artery, Percutaneous Endoscopic Approach
02HR00Z Insertion of Pressure Sensor Monitoring Device into Left Pulmonary Artery, Open Approach
02HR02Z Insertion of Monitoring Device into Left Pulmonary Artery, Open Approach
02HR30Z Insertion of Pressure Sensor Monitoring Device into Left Pulmonary Artery, Percutaneous Approach
02HR32Z Insertion of Monitoring Device into Left Pulmonary Artery, Percutaneous Approach
02HR40Z Insertion of Pressure Sensor Monitoring Device into Left Pulmonary Artery, Percutaneous Endoscopic Approach
02HR42Z Insertion of Monitoring Device into Left Pulmonary Artery, Percutaneous Endoscopic Approach
4A0239Z Measurement of Cardiac Output, Percutaneous Approach
4A1239Z Monitoring of Cardiac Output, Percutaneous Approach
89.68 Monitoring of cardiac output by other technique 4A030JC Measurement of Arterial Pulse, Coronary, Open Approach
4A033JC Measurement of Arterial Pulse, Coronary, Percutaneous Approach
4A1209Z Monitoring of Cardiac Output, Open Approach
4A12X9Z Monitoring of Cardiac Output, External Approach
4A030JC Measurement of Arterial Pulse, Coronary, Open Approach
4A033JC Measurement of Arterial Pulse, Coronary, Percutaneous Approach
4A1209Z Monitoring of Cardiac Output, Open Approach
4A12X9Z Monitoring of Cardiac Output, External Approach
DISCLAIMER

Reimbursement information provided by Edwards Lifesciences is gathered from third-party sources and is presented for informational purposes only. Edwards makes no representation, warranty or guarantee as to the timeliness, accuracy or completeness of the information and such information is not, and should not be construed as reimbursement, coding or legal advice. Any and all references to reimbursement codes are provided as examples only and are not intended to be a recommendation or advice as to the appropriate code for the a particular patient, diagnosis, product or procedure or a guarantee or promise of coverage or payment, nor does Edwards Lifesciences warranty that codes listed are appropriate in all related clinical scenarios. It is the responsibility of the provider to determine if coverage exists and what requirements are necessary for submitting a proper claim for reimbursement to a health plan or payer, including the appropriate code(s) for products provided or services rendered. Laws, regulations, and payer policies concerning reimbursement are complex and change frequently; service providers are responsible for all decisions relating to coding and reimbursement submissions. Medicare’s Correct Coding Initiative and commercial payer policies are reviewed and updated several times each year. Accordingly, Edwards strongly recommends consultation with payers, reimbursement specialists and/or legal counsel regarding appropriate product or procedure codes, coverage, and reimbursement matters.

References
  1. Current Procedural Terminology (CPT) copyright 2015, American Medical Association (AMA). All rights reserved. CPT is a registered trademark of the AMA. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein. Applicable FARS/DFARS restrictions apply to government use.
  2. Not all codes provided are applicable for the clinical scenarios in which Edwards Lifesciences’ Critical Care technologies are used. The provider is responsible for selecting the most appropriate code(s) for the patient’s clinical presentation. When radiologic guidance is used for catheter placement, it may be appropriate to add applicable codes according to the service provided following correct coding guidelines. Services that are considered a component of another procedure may not always be coded and billed separately.
  3. For all Medicare payments for physician, hospital outpatient, and ASC services, the multiple procedure reduction rule may apply. Consult with coding and billing staff, and payer policy for further guidance. National average Medicare payment is calculated using the Conversion Factor of $35.8279 per the Medicare Physician Fee Schedule for Calendar Year 2016 Final Rule issued October 30, 2015. National average is based on factors such as geography, teaching vs. non-teaching hospital, rural vs. urban area, etc. and your payment may be different based on these factors. This payment will differ for commercial payers. Payments are effective January 1, 2016 through December 31, 2016.
  4. National Uniform Billing Committee, American Hospital Association.
  5. Federal Register / Vol. 74, No. 11 / Friday, January 16, 2009 / Rules and Regulations: This final rule adopts modifications to two of the code set standards adopted in the Transactions and Code Sets final rule published in the Federal Register pursuant to certain provisions of the Administrative Simplification subtitle of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). Specifically, this final rule modifies the standard medical data code sets (hereinafter ‘‘code sets’’) for coding diagnoses and inpatient hospital procedures by concurrently adopting the International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) for diagnosis coding, including the Official ICD-10-CM Guidelines for Coding and Reporting, as maintained and distributed by the U.S. Department of Health and Human Services (HHS), hereinafter referred to as ICD-10-CM, and the International Classification of Diseases, 10th Revision, Procedure Coding System (ICD-10-PCS) for inpatient hospital procedure coding, including the Official ICD-10-PCS Guidelines for Coding and Reporting, as maintained and distributed by the HHS, hereinafter referred to as ICD-10-PCS. These new codes replace the International Classification of Diseases, 9th Revision, Clinical Modification, Volumes 1 and 2, including the Official ICD-9-CM Guidelines for Coding and Reporting, hereinafter referred to as ICD-9-CM Volumes 1 and 2, and the International Classification of Diseases, 9th Revision, Clinical Modification, Volume 3, including the Official ICD-9-CM Guidelines for Coding and Reporting, hereinafter referred to as ICD-9-CM Volume 3, for diagnosis and procedure codes, respectively. DATES: The effective date of this regulation is March 17, 2009. The effective date is the date that the policies herein take effect, and new policies are considered to be officially adopted. The compliance date, which is different than the effective date, is the date on which entities are required to have implemented the policies adopted in this rule. The compliance date for this regulation is October 1, 2015.
  6. International Classification of Diseases, 9th Revision, Clinical Modification 2015 ICD-9-CM for hospitals, volume 1, 2, & 3.
  7. International Classification of Diseases, 10th Revision, Procedure Coding System 2015 Draft.
Vascular TECHNOLOGIES

2016 Facility and Physician Billing Guide

Clinicians and outpatient facilities use Current Procedural Terminology (CPT1) codes to bill for procedures and services. Each CPT code is assigned unique relative value units (RVUs), which are used to determine payment by the Centers for Medicare & Medicaid Services (CMS). Some commonly billed CPT codes used to describe procedures related to Edwards Lifesciences’ Vascular technologies (e.g. Fogarty catheters) are listed below.2 This list may not be comprehensive or complete. These procedures may be subject to the CMS multiple procedure reduction rule. When applicable, a payment reduction of 50% is applied to all payment amounts except the procedure with the greatest RVUs, which is paid at 100% unless exempt by CPT instructions or payer policy. This rule does not normally apply to radiologic procedures.

Procedures related to the use of Edwards Lifesciences’ technologies (e.g. Fogarty catheters) are often performed in a facility setting, including an outpatient hospital department (OPPS, Place of Service (POS) code 22), Ambulatory Surgery Center (ASC, POS code 24), or a Vascular Access Center (which can be licensed as POS 11, 22, or 24). Reimbursement is determined based upon services rendered and varies by place of service. The following are commonly billed codes and associated national average Medicare payment amounts. This list may not be comprehensive and complete.

Interventional Procedures3

Medicare
National Average Physician Payment4
Medicare
National Average Facility Payment
CPT Code Description Facility Setting (Various POSs) Non-Facility Setting (Including POS 11) Outpatient Hospital5 (POS 22) ASC (POS 24)
35301 Thromboendarterectomy, including patch graft, if performed; carotid, vertebral, subclavian, by neck incision $1,198 Facility Only n/a n/a n/a
35390 Reoperation, carotid, thromboendarterectomy, more than 1 month after original operation (list separately in addition to code for primary procedure) $167 Facility Only n/a n/a n/a
361476 Introduction of needle and/or catheter, arteriovenous shunt created for dialysis (graft/fistula); initial access with complete radiological evaluation of dialysis access, including fluoroscopy, image documentation and report (includes access of shunt, injection(s) of contrast, and all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava) $194 $853 APC
0668
$863 $482
361487 Introduction of needle and/or catheter, arteriovenous shunt created for dialysis (graft/fistula); additional access for therapeutic intervention (List separately in addition to code for primary procedure) $51 $267 n/a n/a n/a
36831 Thrombectomy, open, arteriovenous fistula without revision, autogenous or non-autogenous dialysis graft (separate procedure) $654 Facility Only APC
5182
$2,247 $1,257
36833 Revision, open, arteriovenous fistula; with thrombectomy, autogenous or non-autogenous dialysis graft (separate procedure) $858 Facility Only APC
5183
$3,795 $2,122
36870 Thrombectomy, percutaneous, arteriovenous fistula; autogenous or nonautogenous graft (includes mechanical thrombus extraction and intra-graft thrombolysis) $312 $1,867 APC
5191
$4,592 $2,288
37211 Transcatheter therapy, arterial infusion for thrombolysis other than coronary, any method, including radiological supervision and interpretation, initial treatment day $419 Facility Only APC
5183
$3,795 $2,122
37212 Transcatheter therapy, venous infusion for thrombolysis, any method, including radiological supervision and interpretation, initial treatment day $368 Facility Only APC
5181
$862 $482
37213 Transcatheter therapy, arterial or venous infusion for thrombolysis other than coronary, any method, including radiological supervision and interpretation, continued treatment on subsequent day during course of thrombolytic therapy, including follow-up catheter contrast injection, position change, or exchange, when performed $259 Facility Only APC
5182
$2,247 n/a
37214 Transcatheter therapy, arterial or venous infusion for thrombolysis other than coronary, any method, including radiological supervision and interpretation, continued treatment on subsequent day during course of thrombolytic therapy, including follow-up catheter contrast injection, position change, or exchange, when performed; cessation of thrombolysis including removal of catheter and vessel closure by any method $142 Facility Only APC
5182
$2,247 n/a

REVENUE CODES 8 AND HCPCS CODES

Revenue codes help hospitals categorize services provided by revenue center. Medicare utilizes revenue codes for cost reporting purposes. It may be appropriate for hospitals to capture the cost of products used for these procedures for payer reporting or cost accounting purposes as expenses within Revenue Code 0278 (Medical/Surgical Supply – Other Implants) on the hospital UB-04 billing form. CMS uses C-codes under the Outpatient Prospective Payment System (OPPS) to track device cost information for future APC rate-setting purposes. No additional facility payment is associated with these codes. CMS may reject hospital claims if the appropriate C codes used to report device costs are not identified on the claim. Edwards Lifesciences’ Vascular technologies can be used in both the inpatient and outpatient setting. C codes which may apply to the use of these products in the outpatient setting are listed below. Procedure codes associated with these products are not necessarily included within this document.

C CodeDescriptionEdwards Product Examples
C1757 Thrombectomy/ Embolectomy Catheter Fogarty and Fogarty Fortis thrombectomy and embolectomy catheters: 120403F-120807F, 12A0403F-12A1004F, NL2EMB40-NL7EMB80, 12TLW403F-12TLW807F, 140806-1408010, 160245F, 160245F, 160246F, 320806F-32080810F
C2628 Catheter, occlusion 620403F, 620404F, 620405F, 62080814F, 62080822F

Medicare inpatient hospital reimbursement is based upon the Medicare Severity-Diagnostic Related Group (MS-DRG) classification system, which assigns MS-DRGs based on ICD-9-CM diagnosis and procedure codes. Although the compliance date for mandatory use of ICD-10 codes is October 1, 20159, this guide is intended to provide the cross-over codes for testing purposes only. Given Medicare and other payers are encouraging the provider community to perform parallel coding and test the claims systems, this guide will provide the necessary conversion from ICD-9 codes to the appropriate ICD-10 codes.

ICD-9-CM Procedure Code10DescriptionICD-10-CM Procedure Code11Description
38.12 Endarterectomy, other vessels of head and neck 03CH0ZZ Extirpation of Matter from Right Common Carotid Artery, Open Approach
03CH4ZZ Extirpation of Matter from Right Common Carotid Artery, Percutaneous Endoscopic Approach
03CJ0ZZ Extirpation of Matter from Left Common Carotid Artery, Open Approach
03CJ4ZZ Extirpation of Matter from Left Common Carotid Artery, Percutaneous Endoscopic Approach
03CK0ZZ Extirpation of Matter from Right Internal Carotid Artery, Open Approach
03CK4ZZ Extirpation of Matter from Right Internal Carotid Artery, Percutaneous Endoscopic Approach
03CL0ZZ Extirpation of Matter from Left Internal Carotid Artery, Open Approach
03CL4ZZ Extirpation of Matter from Left Internal Carotid Artery, Percutaneous Endoscopic Approach
03CM0ZZ Extirpation of Matter from Right External Carotid Artery, Open Approach
03CM4ZZ Extirpation of Matter from Right External Carotid Artery, Percutaneous Endoscopic Approach
03CN0ZZ Extirpation of Matter from Left External Carotid Artery, Open Approach
03CN4ZZ Extirpation of Matter from Left External Carotid Artery, Percutaneous Endoscopic Approach
03CP0ZZ Extirpation of Matter from Right Vertebral Artery, Open Approach
03CP4ZZ Extirpation of Matter from Right Vertebral Artery, Percutaneous Endoscopic Approach
03CQ0ZZ Extirpation of Matter from Left Vertebral Artery, Open Approach
03CQ4ZZ Extirpation of Matter from Left Vertebral Artery, Percutaneous Endoscopic Approach
03CR0ZZ Extirpation of Matter from Face Artery, Open Approach
03CR3ZZ Extirpation of Matter from Face Artery, Percutaneous Approach
03CR4ZZ Extirpation of Matter from Face Artery, Percutaneous Endoscopic Approach
03CS0ZZ Extirpation of Matter from Right Temporal Artery, Open Approach
03CS3ZZ Extirpation of Matter from Right Temporal Artery, Percutaneous Approach
03CS4ZZ Extirpation of Matter from Right Temporal Artery, Percutaneous Endoscopic Approach
03CT0ZZ Extirpation of Matter from Left Temporal Artery, Open Approach
03CT3ZZ Extirpation of Matter from Left Temporal Artery, Percutaneous Approach
03CT4ZZ Extirpation of Matter from Left Temporal Artery, Percutaneous Endoscopic Approach
03CU0ZZ Extirpation of Matter from Right Thyroid Artery, Open Approach
03CU3ZZ Extirpation of Matter from Right Thyroid Artery, Percutaneous Approach
03CU4ZZ Extirpation of Matter from Right Thyroid Artery, Percutaneous Endoscopic Approach
03CV0ZZ Extirpation of Matter from Left Thyroid Artery, Open Approach
03CV3ZZ Extirpation of Matter from Left Thyroid Artery, Percutaneous Approach
03CV4ZZ Extirpation of Matter from Left Thyroid Artery, Percutaneous Endoscopic Approach
38.32 Resection of other vessels of head and neck with anastomosis 03BH0ZZ Excision of Right Common Carotid Artery, Open Approach
03BH4ZZ Excision of Right Common Carotid Artery, Percutaneous Endoscopic Approach
03BJ0ZZ Excision of Left Common Carotid Artery, Open Approach
03BJ4ZZ Excision of Left Common Carotid Artery, Percutaneous Endoscopic Approach
03BK0ZZ Excision of Right Internal Carotid Artery, Open Approach
03BK4ZZ Excision of Right Internal Carotid Artery, Percutaneous Endoscopic Approach
03BL0ZZ Excision of Left Internal Carotid Artery, Open Approach
03BL4ZZ Excision of Left Internal Carotid Artery, Percutaneous Endoscopic Approach
03BM0ZZ Excision of Right External Carotid Artery, Open Approach
03BM4ZZ Excision of Right External Carotid Artery, Percutaneous Endoscopic Approach
03BN0ZZ Excision of Left External Carotid Artery, Open Approach
03BN4ZZ Excision of Left External Carotid Artery, Percutaneous Endoscopic Approach
03BP0ZZ Excision of Right Vertebral Artery, Open Approach
03BP4ZZ Excision of Right Vertebral Artery, Percutaneous Endoscopic Approach
03BQ0ZZ Excision of Left Vertebral Artery, Open Approach
03BQ4ZZ Excision of Left Vertebral Artery, Percutaneous Endoscopic Approach
03BR0ZZ Excision of Face Artery, Open Approach
03BR4ZZ Excision of Face Artery, Percutaneous Endoscopic Approach
03BS0ZZ Excision of Right Temporal Artery, Open Approach
03BS4ZZ Excision of Right Temporal Artery, Percutaneous Endoscopic Approach
03BT0ZZ Excision of Left Temporal Artery, Open Approach
03BT4ZZ Excision of Left Temporal Artery, Percutaneous Endoscopic Approach
03BU0ZZ Excision of Right Thyroid Artery, Open Approach
03BU4ZZ Excision of Right Thyroid Artery, Percutaneous Endoscopic Approach
03BV0ZZ Excision of Left Thyroid Artery, Open Approach
03BV4ZZ Excision of Left Thyroid Artery, Percutaneous Endoscopic Approach
05BM0ZZ Excision of Right Internal Jugular Vein, Open Approach
05BM4ZZ Excision of Right Internal Jugular Vein, Percutaneous Endoscopic Approach
05BN0ZZ Excision of Left Internal Jugular Vein, Open Approach
05BN4ZZ Excision of Left Internal Jugular Vein, Percutaneous Endoscopic Approach
05BP0ZZ Excision of Right External Jugular Vein, Open Approach
05BP4ZZ Excision of Right External Jugular Vein, Percutaneous Endoscopic Approach
05BQ0ZZ Excision of Left External Jugular Vein, Open Approach
05BQ4ZZ Excision of Left External Jugular Vein, Percutaneous Endoscopic Approach
05BR0ZZ Excision of Right Vertebral Vein, Open Approach
05BR4ZZ Excision of Right Vertebral Vein, Percutaneous Endoscopic Approach
05BS0ZZ Excision of Left Vertebral Vein, Open Approach
05BS4ZZ Excision of Left Vertebral Vein, Percutaneous Endoscopic Approach
05BT0ZZ Excision of Right Face Vein, Open Approach
05BT4ZZ Excision of Right Face Vein, Percutaneous Endoscopic Approach
05BV0ZZ Excision of Left Face Vein, Open Approach
05BV4ZZ Excision of Left Face Vein, Percutaneous Endoscopic Approach
38.42 Resection of other vessel of head and neck replacement; carotid artery (common) (external) (internal), jugular vein (external) (internal) 03RH07Z Replacement of Right Common Carotid Artery with Autologous Tissue Substitute, Open Approach
03RH0JZ Replacement of Right Common Carotid Artery with Synthetic Substitute, Open Approach
03RH0KZ Replacement of Right Common Carotid Artery with Nonautologous Tissue Substitute, Open Approach
03RH47Z Replacement of Right Common Carotid Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
03RH4JZ Replacement of Right Common Carotid Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
03RH4KZ Replacement of Right Common Carotid Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
03RJ07Z Replacement of Left Common Carotid Artery with Autologous Tissue Substitute, Open Approach
03RJ0JZ Replacement of Left Common Carotid Artery with Synthetic Substitute, Open Approach
03RJ0KZ Replacement of Left Common Carotid Artery with Nonautologous Tissue Substitute, Open Approach
03RJ47Z Replacement of Left Common Carotid Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
03RJ4JZ Replacement of Left Common Carotid Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
03RJ4KZ Replacement of Left Common Carotid Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
03RK07Z Replacement of Right Internal Carotid Artery with Autologous Tissue Substitute, Open Approach
03RK0JZ Replacement of Right Internal Carotid Artery with Synthetic Substitute, Open Approach
03RK0KZ Replacement of Right Internal Carotid Artery with Nonautologous Tissue Substitute, Open Approach
03RK47Z Replacement of Right Internal Carotid Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
03RK4JZ Replacement of Right Internal Carotid Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
03RK4KZ Replacement of Right Internal Carotid Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
03RL07Z Replacement of Left Internal Carotid Artery with Autologous Tissue Substitute, Open Approach
03RL0JZ Replacement of Left Internal Carotid Artery with Synthetic Substitute, Open Approach
03RL0KZ Replacement of Left Internal Carotid Artery with Nonautologous Tissue Substitute, Open Approach
03RL47Z Replacement of Left Internal Carotid Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
03RL4JZ Replacement of Left Internal Carotid Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
03RL4KZ Replacement of Left Internal Carotid Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
03RM07Z Replacement of Right External Carotid Artery with Autologous Tissue Substitute, Open Approach
03RM0JZ Replacement of Right External Carotid Artery with Synthetic Substitute, Open Approach
03RM0KZ Replacement of Right External Carotid Artery with Nonautologous Tissue Substitute, Open Approach
03RM47Z Replacement of Right External Carotid Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
03RM4JZ Replacement of Right External Carotid Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
03RM4KZ Replacement of Right External Carotid Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
03RN07Z Replacement of Left External Carotid Artery with Autologous Tissue Substitute, Open Approach
03RN0JZ Replacement of Left External Carotid Artery with Synthetic Substitute, Open Approach
03RN0KZ Replacement of Left External Carotid Artery with Nonautologous Tissue Substitute, Open Approach
03RN47Z Replacement of Left External Carotid Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
03RN4JZ Replacement of Left External Carotid Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
03RN4KZ Replacement of Left External Carotid Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
03RP07Z Replacement of Right Vertebral Artery with Autologous Tissue Substitute, Open Approach
03RP0JZ Replacement of Right Vertebral Artery with Synthetic Substitute, Open Approach
03RP0KZ Replacement of Right Vertebral Artery with Nonautologous Tissue Substitute, Open Approach
03RP47Z Replacement of Right Vertebral Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
03RP4JZ Replacement of Right Vertebral Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
03RP4KZ Replacement of Right Vertebral Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
03RQ07Z Replacement of Left Vertebral Artery with Autologous Tissue Substitute, Open Approach
03RQ0JZ Replacement of Left Vertebral Artery with Synthetic Substitute, Open Approach
03RQ0KZ Replacement of Left Vertebral Artery with Nonautologous Tissue Substitute, Open Approach
03RQ47Z Replacement of Left Vertebral Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
03RQ4JZ Replacement of Left Vertebral Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
03RQ4KZ Replacement of Left Vertebral Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
03RR07Z Replacement of Face Artery with Autologous Tissue Substitute, Open Approach
03RR0JZ Replacement of Face Artery with Synthetic Substitute, Open Approach
03RR0KZ Replacement of Face Artery with Nonautologous Tissue Substitute, Open Approach
03RR47Z Replacement of Face Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
03RR4JZ Replacement of Face Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
03RR4KZ Replacement of Face Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
03RS07Z Replacement of Right Temporal Artery with Autologous Tissue Substitute, Open Approach
03RS0JZ Replacement of Right Temporal Artery with Synthetic Substitute, Open Approach
03RS0KZ Replacement of Right Temporal Artery with Nonautologous Tissue Substitute, Open Approach
03RS47Z Replacement of Right Temporal Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
03RS4JZ Replacement of Right Temporal Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
03RS4KZ Replacement of Right Temporal Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
03RT07Z Replacement of Left Temporal Artery with Autologous Tissue Substitute, Open Approach
03RT0JZ Replacement of Left Temporal Artery with Synthetic Substitute, Open Approach
03RT0KZ Replacement of Left Temporal Artery with Nonautologous Tissue Substitute, Open Approach
03RT47Z Replacement of Left Temporal Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
03RT4JZ Replacement of Left Temporal Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
03RT4KZ Replacement of Left Temporal Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
03RU07Z Replacement of Right Thyroid Artery with Autologous Tissue Substitute, Open Approach
03RU0JZ Replacement of Right Thyroid Artery with Synthetic Substitute, Open Approach
03RU0KZ Replacement of Right Thyroid Artery with Nonautologous Tissue Substitute, Open Approach
03RU47Z Replacement of Right Thyroid Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
03RU4JZ Replacement of Right Thyroid Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
03RU4KZ Replacement of Right Thyroid Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
03RV07Z Replacement of Left Thyroid Artery with Autologous Tissue Substitute, Open Approach
03RV0JZ Replacement of Left Thyroid Artery with Synthetic Substitute, Open Approach
03RV0KZ Replacement of Left Thyroid Artery with Nonautologous Tissue Substitute, Open Approach
03RV47Z Replacement of Left Thyroid Artery with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
03RV4JZ Replacement of Left Thyroid Artery with Synthetic Substitute, Percutaneous Endoscopic Approach
03RV4KZ Replacement of Left Thyroid Artery with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
05RM07Z Replacement of Right Internal Jugular Vein with Autologous Tissue Substitute, Open Approach
05RM0JZ Replacement of Right Internal Jugular Vein with Synthetic Substitute, Open Approach
05RM0KZ Replacement of Right Internal Jugular Vein with Nonautologous Tissue Substitute, Open Approach
05RM47Z Replacement of Right Internal Jugular Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
05RM4JZ Replacement of Right Internal Jugular Vein with Synthetic Substitute, Percutaneous Endoscopic Approach
05RM4KZ Replacement of Right Internal Jugular Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
05RN07Z Replacement of Left Internal Jugular Vein with Autologous Tissue Substitute, Open Approach
05RN0JZ Replacement of Left Internal Jugular Vein with Synthetic Substitute, Open Approach
05RN0KZ Replacement of Left Internal Jugular Vein with Nonautologous Tissue Substitute, Open Approach
05RN47Z Replacement of Left Internal Jugular Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
05RN4JZ Replacement of Left Internal Jugular Vein with Synthetic Substitute, Percutaneous Endoscopic Approach
05RN4KZ Replacement of Left Internal Jugular Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
05RP07Z Replacement of Right External Jugular Vein with Autologous Tissue Substitute, Open Approach
05RP0JZ Replacement of Right External Jugular Vein with Synthetic Substitute, Open Approach
05RP0KZ Replacement of Right External Jugular Vein with Nonautologous Tissue Substitute, Open Approach
05RP47Z Replacement of Right External Jugular Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
05RP4JZ Replacement of Right External Jugular Vein with Synthetic Substitute, Percutaneous Endoscopic Approach
05RP4KZ Replacement of Right External Jugular Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
05RQ07Z Replacement of Left External Jugular Vein with Autologous Tissue Substitute, Open Approach
05RQ0JZ Replacement of Left External Jugular Vein with Synthetic Substitute, Open Approach
05RQ0KZ Replacement of Left External Jugular Vein with Nonautologous Tissue Substitute, Open Approach
05RQ47Z Replacement of Left External Jugular Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
05RQ4JZ Replacement of Left External Jugular Vein with Synthetic Substitute, Percutaneous Endoscopic Approach
05RQ4KZ Replacement of Left External Jugular Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
05RR07Z Replacement of Right Vertebral Vein with Autologous Tissue Substitute, Open Approach
05RR0JZ Replacement of Right Vertebral Vein with Synthetic Substitute, Open Approach
05RR0KZ Replacement of Right Vertebral Vein with Nonautologous Tissue Substitute, Open Approach
05RR47Z Replacement of Right Vertebral Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
05RR4JZ Replacement of Right Vertebral Vein with Synthetic Substitute, Percutaneous Endoscopic Approach
05RR4KZ Replacement of Right Vertebral Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
05RS07Z Replacement of Left Vertebral Vein with Autologous Tissue Substitute, Open Approach
05RS0JZ Replacement of Left Vertebral Vein with Synthetic Substitute, Open Approach
05RS0KZ Replacement of Left Vertebral Vein with Nonautologous Tissue Substitute, Open Approach
05RS47Z Replacement of Left Vertebral Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
05RS4JZ Replacement of Left Vertebral Vein with Synthetic Substitute, Percutaneous Endoscopic Approach
05RS4KZ Replacement of Left Vertebral Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
05RT07Z Replacement of Right Face Vein with Autologous Tissue Substitute, Open Approach
05RT0JZ Replacement of Right Face Vein with Synthetic Substitute, Open Approach
05RT0KZ Replacement of Right Face Vein with Nonautologous Tissue Substitute, Open Approach
05RT47Z Replacement of Right Face Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
05RT4JZ Replacement of Right Face Vein with Synthetic Substitute, Percutaneous Endoscopic Approach
05RT4KZ Replacement of Right Face Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
05RV07Z Replacement of Left Face Vein with Autologous Tissue Substitute, Open Approach
05RV0JZ Replacement of Left Face Vein with Synthetic Substitute, Open Approach
05RV0KZ Replacement of Left Face Vein with Nonautologous Tissue Substitute, Open Approach
05RV47Z Replacement of Left Face Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
05RV4JZ Replacement of Left Face Vein with Synthetic Substitute, Percutaneous Endoscopic Approach
05RV4KZ Replacement of Left Face Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
06R307Z Replacement of Esophageal Vein with Autologous Tissue Substitute, Open Approach
06R30JZ Replacement of Esophageal Vein with Synthetic Substitute, Open Approach
06R30KZ Replacement of Esophageal Vein with Nonautologous Tissue Substitute, Open Approach
06R347Z Replacement of Esophageal Vein with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
06R34JZ Replacement of Esophageal Vein with Synthetic Substitute, Percutaneous Endoscopic Approach
06R34KZ Replacement of Esophageal Vein with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
38.91 Arterial catheterization 02HP03Z Insertion of Infusion Device into Pulmonary Trunk, Open Approach
02HP33Z Insertion of Infusion Device into Pulmonary Trunk, Percutaneous Approach
02HP43Z Insertion of Infusion Device into Pulmonary Trunk, Percutaneous Endoscopic Approach
02HQ03Z Insertion of Infusion Device into Right Pulmonary Artery, Open Approach
02HQ33Z Insertion of Infusion Device into Right Pulmonary Artery, Percutaneous Approach
02HQ43Z Insertion of Infusion Device into Right Pulmonary Artery, Percutaneous Endoscopic Approach
02HR03Z Insertion of Infusion Device into Left Pulmonary Artery, Open Approach
02HR33Z Insertion of Infusion Device into Left Pulmonary Artery, Percutaneous Approach
02HR43Z Insertion of Infusion Device into Left Pulmonary Artery, Percutaneous Endoscopic Approach
02HW03Z Insertion of Infusion Device into Thoracic Aorta, Open Approach
02HW33Z Insertion of Infusion Device into Thoracic Aorta, Percutaneous Approach
02HW43Z Insertion of Infusion Device into Thoracic Aorta, Percutaneous Endoscopic Approach
03H003Z Insertion of Infusion Device into Right Internal Mammary Artery, Open Approach
03H033Z Insertion of Infusion Device into Right Internal Mammary Artery, Percutaneous Approach
03H043Z Insertion of Infusion Device into Right Internal Mammary Artery, Percutaneous Endoscopic Approach
03H103Z Insertion of Infusion Device into Left Internal Mammary Artery, Open Approach
03H133Z Insertion of Infusion Device into Left Internal Mammary Artery, Percutaneous Approach
03H143Z Insertion of Infusion Device into Left Internal Mammary Artery, Percutaneous Endoscopic Approach
03H203Z Insertion of Infusion Device into Innominate Artery, Open Approach
03H233Z Insertion of Infusion Device into Innominate Artery, Percutaneous Approach
03H243Z Insertion of Infusion Device into Innominate Artery, Percutaneous Endoscopic Approach
03H303Z Insertion of Infusion Device into Right Subclavian Artery, Open Approach
03H333Z Insertion of Infusion Device into Right Subclavian Artery, Percutaneous Approach
03H343Z Insertion of Infusion Device into Right Subclavian Artery, Percutaneous Endoscopic Approach
03H403Z Insertion of Infusion Device into Left Subclavian Artery, Open Approach
03H433Z Insertion of Infusion Device into Left Subclavian Artery, Percutaneous Approach
03H443Z Insertion of Infusion Device into Left Subclavian Artery, Percutaneous Endoscopic Approach
03H503Z Insertion of Infusion Device into Right Axillary Artery, Open Approach
03H533Z Insertion of Infusion Device into Right Axillary Artery, Percutaneous Approach
03H543Z Insertion of Infusion Device into Right Axillary Artery, Percutaneous Endoscopic Approach
03H603Z Insertion of Infusion Device into Left Axillary Artery, Open Approach
03H633Z Insertion of Infusion Device into Left Axillary Artery, Percutaneous Approach
03H643Z Insertion of Infusion Device into Left Axillary Artery, Percutaneous Endoscopic Approach
03H703Z Insertion of Infusion Device into Right Brachial Artery, Open Approach
03H733Z Insertion of Infusion Device into Right Brachial Artery, Percutaneous Approach
03H743Z Insertion of Infusion Device into Right Brachial Artery, Percutaneous Endoscopic Approach
03H803Z Insertion of Infusion Device into Left Brachial Artery, Open Approach
03H833Z Insertion of Infusion Device into Left Brachial Artery, Percutaneous Approach
03H843Z Insertion of Infusion Device into Left Brachial Artery, Percutaneous Endoscopic Approach
03H903Z Insertion of Infusion Device into Right Ulnar Artery, Open Approach
03H933Z Insertion of Infusion Device into Right Ulnar Artery, Percutaneous Approach
03H943Z Insertion of Infusion Device into Right Ulnar Artery, Percutaneous Endoscopic Approach
03HA03Z Insertion of Infusion Device into Left Ulnar Artery, Open Approach
03HA33Z Insertion of Infusion Device into Left Ulnar Artery, Percutaneous Approach
03HA43Z Insertion of Infusion Device into Left Ulnar Artery, Percutaneous Endoscopic Approach
03HB03Z Insertion of Infusion Device into Right Radial Artery, Open Approach
03HB33Z Insertion of Infusion Device into Right Radial Artery, Percutaneous Approach
03HB43Z Insertion of Infusion Device into Right Radial Artery, Percutaneous Endoscopic Approach
03HC03Z Insertion of Infusion Device into Left Radial Artery, Open Approach
03HC33Z Insertion of Infusion Device into Left Radial Artery, Percutaneous Approach
03HC43Z Insertion of Infusion Device into Left Radial Artery, Percutaneous Endoscopic Approach
03HD03Z Insertion of Infusion Device into Right Hand Artery, Open Approach
03HD33Z Insertion of Infusion Device into Right Hand Artery, Percutaneous Approach
03HD43Z Insertion of Infusion Device into Right Hand Artery, Percutaneous Endoscopic Approach
03HF03Z Insertion of Infusion Device into Left Hand Artery, Open Approach
03HF33Z Insertion of Infusion Device into Left Hand Artery, Percutaneous Approach
03HF43Z Insertion of Infusion Device into Left Hand Artery, Percutaneous Endoscopic Approach
03HG03Z Insertion of Infusion Device into Intracranial Artery, Open Approach
03HG33Z Insertion of Infusion Device into Intracranial Artery, Percutaneous Approach
03HG43Z Insertion of Infusion Device into Intracranial Artery, Percutaneous Endoscopic Approach
03HH03Z Insertion of Infusion Device into Right Common Carotid Artery, Open Approach
03HH33Z Insertion of Infusion Device into Right Common Carotid Artery, Percutaneous Approach
03HH43Z Insertion of Infusion Device into Right Common Carotid Artery, Percutaneous Endoscopic Approach
03HJ03Z Insertion of Infusion Device into Left Common Carotid Artery, Open Approach
03HJ33Z Insertion of Infusion Device into Left Common Carotid Artery, Percutaneous Approach
03HJ43Z Insertion of Infusion Device into Left Common Carotid Artery, Percutaneous Endoscopic Approach
03HK03Z Insertion of Infusion Device into Right Internal Carotid Artery, Open Approach
03HK33Z Insertion of Infusion Device into Right Internal Carotid Artery, Percutaneous Approach
03HK43Z Insertion of Infusion Device into Right Internal Carotid Artery, Percutaneous Endoscopic Approach
03HL03Z Insertion of Infusion Device into Left Internal Carotid Artery, Open Approach
03HL33Z Insertion of Infusion Device into Left Internal Carotid Artery, Percutaneous Approach
03HL43Z Insertion of Infusion Device into Left Internal Carotid Artery, Percutaneous Endoscopic Approach
03HM03Z Insertion of Infusion Device into Right External Carotid Artery, Open Approach
03HM33Z Insertion of Infusion Device into Right External Carotid Artery, Percutaneous Approach
03HM43Z Insertion of Infusion Device into Right External Carotid Artery, Percutaneous Endoscopic Approach
03HN03Z Insertion of Infusion Device into Left External Carotid Artery, Open Approach
03HN33Z Insertion of Infusion Device into Left External Carotid Artery, Percutaneous Approach
03HN43Z Insertion of Infusion Device into Left External Carotid Artery, Percutaneous Endoscopic Approach
03HP03Z Insertion of Infusion Device into Right Vertebral Artery, Open Approach
03HP33Z Insertion of Infusion Device into Right Vertebral Artery, Percutaneous Approach
03HP43Z Insertion of Infusion Device into Right Vertebral Artery, Percutaneous Endoscopic Approach
03HQ03Z Insertion of Infusion Device into Left Vertebral Artery, Open Approach
03HQ33Z Insertion of Infusion Device into Left Vertebral Artery, Percutaneous Approach
03HQ43Z Insertion of Infusion Device into Left Vertebral Artery, Percutaneous Endoscopic Approach
03HR03Z Insertion of Infusion Device into Face Artery, Open Approach
03HR33Z Insertion of Infusion Device into Face Artery, Percutaneous Approach
03HR43Z Insertion of Infusion Device into Face Artery, Percutaneous Endoscopic Approach
03HS03Z Insertion of Infusion Device into Right Temporal Artery, Open Approach
03HS33Z Insertion of Infusion Device into Right Temporal Artery, Percutaneous Approach
03HS43Z Insertion of Infusion Device into Right Temporal Artery, Percutaneous Endoscopic Approach
03HT03Z Insertion of Infusion Device into Left Temporal Artery, Open Approach
03HT33Z Insertion of Infusion Device into Left Temporal Artery, Percutaneous Approach
03HT43Z Insertion of Infusion Device into Left Temporal Artery, Percutaneous Endoscopic Approach
03HU03Z Insertion of Infusion Device into Right Thyroid Artery, Open Approach
03HU33Z Insertion of Infusion Device into Right Thyroid Artery, Percutaneous Approach
03HU43Z Insertion of Infusion Device into Right Thyroid Artery, Percutaneous Endoscopic Approach
03HV03Z Insertion of Infusion Device into Left Thyroid Artery, Open Approach
03HV33Z Insertion of Infusion Device into Left Thyroid Artery, Percutaneous Approach
03HV43Z Insertion of Infusion Device into Left Thyroid Artery, Percutaneous Endoscopic Approach
03HY03Z Insertion of Infusion Device into Upper Artery, Open Approach
03HY33Z Insertion of Infusion Device into Upper Artery, Percutaneous Approach
03HY43Z Insertion of Infusion Device into Upper Artery, Percutaneous Endoscopic Approach
04H003Z Insertion of Infusion Device into Abdominal Aorta, Open Approach
04H033Z Insertion of Infusion Device into Abdominal Aorta, Percutaneous Approach
04H043Z Insertion of Infusion Device into Abdominal Aorta, Percutaneous Endoscopic Approach
04H103Z Insertion of Infusion Device into Celiac Artery, Open Approach
04H133Z Insertion of Infusion Device into Celiac Artery, Percutaneous Approach
04H143Z Insertion of Infusion Device into Celiac Artery, Percutaneous Endoscopic Approach
04H203Z Insertion of Infusion Device into Gastric Artery, Open Approach
04H233Z Insertion of Infusion Device into Gastric Artery, Percutaneous Approach
04H243Z Insertion of Infusion Device into Gastric Artery, Percutaneous Endoscopic Approach
04H303Z Insertion of Infusion Device into Hepatic Artery, Open Approach
04H333Z Insertion of Infusion Device into Hepatic Artery, Percutaneous Approach
04H343Z Insertion of Infusion Device into Hepatic Artery, Percutaneous Endoscopic Approach
04H403Z Insertion of Infusion Device into Splenic Artery, Open Approach
04H433Z Insertion of Infusion Device into Splenic Artery, Percutaneous Approach
04H443Z Insertion of Infusion Device into Splenic Artery, Percutaneous Endoscopic Approach
04H503Z Insertion of Infusion Device into Superior Mesenteric Artery, Open Approach
04H533Z Insertion of Infusion Device into Superior Mesenteric Artery, Percutaneous Approach
04H543Z Insertion of Infusion Device into Superior Mesenteric Artery, Percutaneous Endoscopic Approach
04H603Z Insertion of Infusion Device into Right Colic Artery, Open Approach
04H633Z Insertion of Infusion Device into Right Colic Artery, Percutaneous Approach
04H643Z Insertion of Infusion Device into Right Colic Artery, Percutaneous Endoscopic Approach
04H703Z Insertion of Infusion Device into Left Colic Artery, Open Approach
04H733Z Insertion of Infusion Device into Left Colic Artery, Percutaneous Approach
04H743Z Insertion of Infusion Device into Left Colic Artery, Percutaneous Endoscopic Approach
04H803Z Insertion of Infusion Device into Middle Colic Artery, Open Approach
04H833Z Insertion of Infusion Device into Middle Colic Artery, Percutaneous Approach
04H843Z Insertion of Infusion Device into Middle Colic Artery, Percutaneous Endoscopic Approach
04H903Z Insertion of Infusion Device into Right Renal Artery, Open Approach
04H933Z Insertion of Infusion Device into Right Renal Artery, Percutaneous Approach
04H943Z Insertion of Infusion Device into Right Renal Artery, Percutaneous Endoscopic Approach
04HA33Z Insertion of Infusion Device into Left Renal Artery, Open Approach
02QJ4ZZ Insertion of Infusion Device into Left Renal Artery, Percutaneous Approach
04HA43Z Insertion of Infusion Device into Left Renal Artery, Percutaneous Endoscopic Approach
04HB03Z Insertion of Infusion Device into Inferior Mesenteric Artery, Open Approach
04HB33Z Insertion of Infusion Device into Inferior Mesenteric Artery, Percutaneous Approach
04HB43Z Insertion of Infusion Device into Inferior Mesenteric Artery, Percutaneous Endoscopic Approach
04HC03Z Insertion of Infusion Device into Right Common Iliac Artery, Open Approach
04HC33Z Insertion of Infusion Device into Right Common Iliac Artery, Percutaneous Approach
04HC43Z Insertion of Infusion Device into Right Common Iliac Artery, Percutaneous Endoscopic Approach
04HD03Z Insertion of Infusion Device into Left Common Iliac Artery, Open Approach
04HD33Z Insertion of Infusion Device into Left Common Iliac Artery, Percutaneous Approach
04HD43Z Insertion of Infusion Device into Left Common Iliac Artery, Percutaneous Endoscopic Approach
04HE03Z Insertion of Infusion Device into Right Internal Iliac Artery, Open Approach
04HE33Z Insertion of Infusion Device into Right Internal Iliac Artery, Percutaneous Approach
04HE43Z Insertion of Infusion Device into Right Internal Iliac Artery, Percutaneous Endoscopic Approach
04HF03Z Insertion of Infusion Device into Left Internal Iliac Artery, Open Approach
04HF33Z Insertion of Infusion Device into Left Internal Iliac Artery, Percutaneous Approach
04HF43Z Insertion of Infusion Device into Left Internal Iliac Artery, Percutaneous Endoscopic Approach
04HH03Z Insertion of Infusion Device into Right External Iliac Artery, Open Approach
04HH33Z Insertion of Infusion Device into Right External Iliac Artery, Percutaneous Approach
04HH43Z Insertion of Infusion Device into Right External Iliac Artery, Percutaneous Endoscopic Approach
04HJ03Z Insertion of Infusion Device into Left External Iliac Artery, Open Approach
04HJ33Z Insertion of Infusion Device into Left External Iliac Artery, Percutaneous Approach
04HJ43Z Insertion of Infusion Device into Left External Iliac Artery, Percutaneous Endoscopic Approach
04HK03Z Insertion of Infusion Device into Right Femoral Artery, Open Approach
04HK33Z Insertion of Infusion Device into Right Femoral Artery, Percutaneous Approach
04HK43Z Insertion of Infusion Device into Right Femoral Artery, Percutaneous Endoscopic Approach
04HL03Z Insertion of Infusion Device into Left Femoral Artery, Open Approach
04HL33Z Insertion of Infusion Device into Left Femoral Artery, Percutaneous Approach
04HL43Z Insertion of Infusion Device into Left Femoral Artery, Percutaneous Endoscopic Approach
04HM03Z Insertion of Infusion Device into Right Popliteal Artery, Open Approach
04HM33Z Insertion of Infusion Device into Right Popliteal Artery, Percutaneous Approach
04HM43Z Insertion of Infusion Device into Right Popliteal Artery, Percutaneous Endoscopic Approach
04HN03Z Insertion of Infusion Device into Left Popliteal Artery, Open Approach
04HN33Z Insertion of Infusion Device into Left Popliteal Artery, Percutaneous Approach
04HN43Z Insertion of Infusion Device into Left Popliteal Artery, Percutaneous Endoscopic Approach
04HP03Z Insertion of Infusion Device into Right Anterior Tibial Artery, Open Approach
04HP33Z Insertion of Infusion Device into Right Anterior Tibial Artery, Percutaneous Approach
04HP43Z Insertion of Infusion Device into Right Anterior Tibial Artery, Percutaneous Endoscopic Approach
04HQ03Z Insertion of Infusion Device into Left Anterior Tibial Artery, Open Approach
04HQ33Z Insertion of Infusion Device into Left Anterior Tibial Artery, Percutaneous Approach
04HQ43Z Insertion of Infusion Device into Left Anterior Tibial Artery, Percutaneous Endoscopic Approach
04HR03Z Insertion of Infusion Device into Right Posterior Tibial Artery, Open Approach
04HR33Z Insertion of Infusion Device into Right Posterior Tibial Artery, Percutaneous Approach
04HR43Z Insertion of Infusion Device into Right Posterior Tibial Artery, Percutaneous Endoscopic Approach
04HS03Z Insertion of Infusion Device into Left Posterior Tibial Artery, Open Approach
04HS33Z Insertion of Infusion Device into Left Posterior Tibial Artery, Percutaneous Approach
04HS43Z Insertion of Infusion Device into Left Posterior Tibial Artery, Percutaneous Endoscopic Approach
04HT03Z Insertion of Infusion Device into Right Peroneal Artery, Open Approach
04HT33Z Insertion of Infusion Device into Right Peroneal Artery, Percutaneous Approach
04HT43Z Insertion of Infusion Device into Right Peroneal Artery, Percutaneous Endoscopic Approach
04HU03Z Insertion of Infusion Device into Left Peroneal Artery, Open Approach
04HU33Z Insertion of Infusion Device into Left Peroneal Artery, Percutaneous Approach
04HU43Z Insertion of Infusion Device into Left Peroneal Artery, Percutaneous Endoscopic Approach
02NH3ZZ Release Pulmonary Valve, Percutaneous Approach
02NH4ZZ Release Pulmonary Valve, Percutaneous Endoscopic Approach
04HV03Z Insertion of Infusion Device into Right Foot Artery, Open Approach
04HV33Z Insertion of Infusion Device into Right Foot Artery, Percutaneous Approach
04HV43Z Insertion of Infusion Device into Right Foot Artery, Percutaneous Endoscopic Approach
04HW03Z Insertion of Infusion Device into Left Foot Artery, Open Approach
04HW33Z Insertion of Infusion Device into Left Foot Artery, Percutaneous Approach
04HW43Z Insertion of Infusion Device into Left Foot Artery, Percutaneous Endoscopic Approach
04HY03Z Insertion of Infusion Device into Lower Artery, Open Approach
04HY33Z Insertion of Infusion Device into Lower Artery, Percutaneous Approach
04HY43Z Insertion of Infusion Device into Lower Artery, Percutaneous Endoscopic Approach
38.93 Venous catheterization, not elsewhere classified 02H633Z Insertion of Infusion Device into Right Atrium, Percutaneous Approach
02HK33Z Insertion of Infusion Device into Right Ventricle, Percutaneous Approach
02HS03Z Insertion of Infusion Device into Right Pulmonary Vein, Open Approach
02HS33Z Insertion of Infusion Device into Right Pulmonary Vein, Percutaneous Approach
02HS43Z Insertion of Infusion Device into Right Pulmonary Vein, Percutaneous Endoscopic Approach
02HT03Z Insertion of Infusion Device into Left Pulmonary Vein, Open Approach
02HT33Z Insertion of Infusion Device into Left Pulmonary Vein, Percutaneous Approach
02HT43Z Insertion of Infusion Device into Left Pulmonary Vein, Percutaneous Endoscopic Approach
02HV03Z Insertion of Infusion Device into Superior Vena Cava, Open Approach
02HV33Z Insertion of Infusion Device into Superior Vena Cava, Percutaneous Approach
02HV43Z Insertion of Infusion Device into Superior Vena Cava, Percutaneous Endoscopic Approach
05H003Z Insertion of Infusion Device into Azygos Vein, Open Approach
05H033Z Insertion of Infusion Device into Azygos Vein, Percutaneous Approach
05H043Z Insertion of Infusion Device into Azygos Vein, Percutaneous Endoscopic Approach
05H103Z Insertion of Infusion Device into Hemiazygos Vein, Open Approach
05H133Z Insertion of Infusion Device into Hemiazygos Vein, Percutaneous Approach
05H143Z Insertion of Infusion Device into Hemiazygos Vein, Percutaneous Endoscopic Approach
05H303Z Insertion of Infusion Device into Right Innominate Vein, Open Approach
05H333Z Insertion of Infusion Device into Right Innominate Vein, Percutaneous Approach
05H343Z Insertion of Infusion Device into Right Innominate Vein, Percutaneous Endoscopic Approach
05H403Z Insertion of Infusion Device into Left Innominate Vein, Open Approach
05H433Z Insertion of Infusion Device into Left Innominate Vein, Percutaneous Approach
05H443Z Insertion of Infusion Device into Left Innominate Vein, Percutaneous Endoscopic Approach
05H503Z Insertion of Infusion Device into Right Subclavian Vein, Open Approach
05H533Z Insertion of Infusion Device into Right Subclavian Vein, Percutaneous Approach
05H543Z Insertion of Infusion Device into Right Subclavian Vein, Percutaneous Endoscopic Approach
05H603Z Insertion of Infusion Device into Left Subclavian Vein, Open Approach
05H633Z Insertion of Infusion Device into Left Subclavian Vein, Percutaneous Approach
05H643Z Insertion of Infusion Device into Left Subclavian Vein, Percutaneous Endoscopic Approach
05H703Z Insertion of Infusion Device into Right Axillary Vein, Open Approach
05H733Z Insertion of Infusion Device into Right Axillary Vein, Percutaneous Approach
05H743Z Insertion of Infusion Device into Right Axillary Vein, Percutaneous Endoscopic Approach
05H803Z Insertion of Infusion Device into Left Axillary Vein, Open Approach
05H833Z Insertion of Infusion Device into Left Axillary Vein, Percutaneous Approach
05H843Z Insertion of Infusion Device into Left Axillary Vein, Percutaneous Endoscopic Approach
05H903Z Insertion of Infusion Device into Right Brachial Vein, Open Approach
05H933Z Insertion of Infusion Device into Right Brachial Vein, Percutaneous Approach
05H943Z Insertion of Infusion Device into Right Brachial Vein, Percutaneous Endoscopic Approach
05HA03Z Insertion of Infusion Device into Left Brachial Vein, Open Approach
05HA33Z Insertion of Infusion Device into Left Brachial Vein, Percutaneous Approach
05HA43Z Insertion of Infusion Device into Left Brachial Vein, Percutaneous Endoscopic Approach
05HB03Z Insertion of Infusion Device into Right Basilic Vein, Open Approach
05HB33Z Insertion of Infusion Device into Right Basilic Vein, Percutaneous Approach
05HB43Z Insertion of Infusion Device into Right Basilic Vein, Percutaneous Endoscopic Approach
05HC03Z Insertion of Infusion Device into Left Basilic Vein, Open Approach
05HC33Z Insertion of Infusion Device into Left Basilic Vein, Percutaneous Approach
05HC43Z Insertion of Infusion Device into Left Basilic Vein, Percutaneous Endoscopic Approach
05HD03Z Insertion of Infusion Device into Right Cephalic Vein, Open Approach
05HD33Z Insertion of Infusion Device into Right Cephalic Vein, Percutaneous Approach
05HD43Z Insertion of Infusion Device into Right Cephalic Vein, Percutaneous Endoscopic Approach
05HF03Z Insertion of Infusion Device into Left Cephalic Vein, Open Approach
05HF33Z Insertion of Infusion Device into Left Cephalic Vein, Percutaneous Approach
05HF43Z Insertion of Infusion Device into Left Cephalic Vein, Percutaneous Endoscopic Approach
05HG03Z Insertion of Infusion Device into Right Hand Vein, Open Approach
05HG33Z Insertion of Infusion Device into Right Hand Vein, Percutaneous Approach
05HG43Z Insertion of Infusion Device into Right Hand Vein, Percutaneous Endoscopic Approach
05HH03Z Insertion of Infusion Device into Left Hand Vein, Open Approach
05HH33Z Insertion of Infusion Device into Left Hand Vein, Percutaneous Approach
05HH43Z Insertion of Infusion Device into Left Hand Vein, Percutaneous Endoscopic Approach
05HL03Z Insertion of Infusion Device into Intracranial Vein, Open Approach
05HL33Z Insertion of Infusion Device into Intracranial Vein, Percutaneous Approach
05HL43Z Insertion of Infusion Device into Intracranial Vein, Percutaneous Endoscopic Approach
05HM03Z Insertion of Infusion Device into Right Internal Jugular Vein, Open Approach
05HM33Z Insertion of Infusion Device into Right Internal Jugular Vein, Percutaneous Approach
05HM43Z Insertion of Infusion Device into Right Internal Jugular Vein, Percutaneous Endoscopic Approach
05HN03Z Insertion of Infusion Device into Left Internal Jugular Vein, Open Approach
05HN33Z Insertion of Infusion Device into Left Internal Jugular Vein, Percutaneous Approach
05HN43Z Insertion of Infusion Device into Left Internal Jugular Vein, Percutaneous Endoscopic Approach
05HP03Z Insertion of Infusion Device into Right External Jugular Vein, Open Approach
05HP33Z Insertion of Infusion Device into Right External Jugular Vein, Percutaneous Approach
05HP43Z Insertion of Infusion Device into Right External Jugular Vein, Percutaneous Endoscopic Approach
05HQ03Z Insertion of Infusion Device into Left External Jugular Vein, Open Approach
05HQ33Z Insertion of Infusion Device into Left External Jugular Vein, Percutaneous Approach
05HQ43Z Insertion of Infusion Device into Left External Jugular Vein, Percutaneous Endoscopic Approach
05HR03Z Insertion of Infusion Device into Right Vertebral Vein, Open Approach
05HR33Z Insertion of Infusion Device into Right Vertebral Vein, Percutaneous Approach
05HR43Z Insertion of Infusion Device into Right Vertebral Vein, Percutaneous Endoscopic Approach
05HS03Z Insertion of Infusion Device into Left Vertebral Vein, Open Approach
05HS33Z Insertion of Infusion Device into Left Vertebral Vein, Percutaneous Approach
05HS43Z Insertion of Infusion Device into Left Vertebral Vein, Percutaneous Endoscopic Approach
05HT03Z Insertion of Infusion Device into Right Face Vein, Open Approach
05HT33Z Insertion of Infusion Device into Right Face Vein, Percutaneous Approach
05HT43Z Insertion of Infusion Device into Right Face Vein, Percutaneous Endoscopic Approach
05HV03Z Insertion of Infusion Device into Left Face Vein, Open Approach
05HV33Z Insertion of Infusion Device into Left Face Vein, Percutaneous Approach
05HV43Z Insertion of Infusion Device into Left Face Vein, Percutaneous Endoscopic Approach
05HY03Z Insertion of Infusion Device into Upper Vein, Open Approach
05HY33Z Insertion of Infusion Device into Upper Vein, Percutaneous Approach
05HY43Z Insertion of Infusion Device into Upper Vein, Percutaneous Endoscopic Approach
06H003Z Insertion of Infusion Device into Inferior Vena Cava, Open Approach
06H033Z Insertion of Infusion Device into Inferior Vena Cava, Percutaneous Approach
06H043Z Insertion of Infusion Device into Inferior Vena Cava, Percutaneous Endoscopic Approach
06H103Z Insertion of Infusion Device into Splenic Vein, Open Approach
06H133Z Insertion of Infusion Device into Splenic Vein, Percutaneous Approach
06H143Z Insertion of Infusion Device into Splenic Vein, Percutaneous Endoscopic Approach
06H203Z Insertion of Infusion Device into Gastric Vein, Open Approach
06H233Z Insertion of Infusion Device into Gastric Vein, Percutaneous Approach
06H243Z Insertion of Infusion Device into Gastric Vein, Percutaneous Endoscopic Approach
06H303Z Insertion of Infusion Device into Esophageal Vein, Open Approach
06H333Z Insertion of Infusion Device into Esophageal Vein, Percutaneous Approach
06H343Z Insertion of Infusion Device into Esophageal Vein, Percutaneous Endoscopic Approach
06H403Z Insertion of Infusion Device into Hepatic Vein, Open Approach
06H433Z Insertion of Infusion Device into Hepatic Vein, Percutaneous Approach
06H443Z Insertion of Infusion Device into Hepatic Vein, Percutaneous Endoscopic Approach
06H503Z Insertion of Infusion Device into Superior Mesenteric Vein, Open Approach
06H533Z Insertion of Infusion Device into Superior Mesenteric Vein, Percutaneous Approach
06H543Z Insertion of Infusion Device into Superior Mesenteric Vein, Percutaneous Endoscopic Approach
06H603Z Insertion of Infusion Device into Inferior Mesenteric Vein, Open Approach
06H633Z Insertion of Infusion Device into Inferior Mesenteric Vein, Percutaneous Approach
06H643Z Insertion of Infusion Device into Inferior Mesenteric Vein, Percutaneous Endoscopic Approach
06H703Z Insertion of Infusion Device into Colic Vein, Open Approach
06H733Z Insertion of Infusion Device into Colic Vein, Percutaneous Approach
06H743Z Insertion of Infusion Device into Colic Vein, Percutaneous Endoscopic Approach
06H803Z Insertion of Infusion Device into Portal Vein, Open Approach
06H833Z Insertion of Infusion Device into Portal Vein, Percutaneous Approach
06H843Z Insertion of Infusion Device into Portal Vein, Percutaneous Endoscopic Approach
06H903Z Insertion of Infusion Device into Right Renal Vein, Open Approach
06H933Z Insertion of Infusion Device into Right Renal Vein, Percutaneous Approach
06H943Z Insertion of Infusion Device into Right Renal Vein, Percutaneous Endoscopic Approach
06HB03Z Insertion of Infusion Device into Left Renal Vein, Open Approach
06HB33Z Insertion of Infusion Device into Left Renal Vein, Percutaneous Approach
06HB43Z Insertion of Infusion Device into Left Renal Vein, Percutaneous Endoscopic Approach
06HC03Z Insertion of Infusion Device into Right Common Iliac Vein, Open Approach
06HC33Z Insertion of Infusion Device into Right Common Iliac Vein, Percutaneous Approach
06HC43Z Insertion of Infusion Device into Right Common Iliac Vein, Percutaneous Endoscopic Approach
06HD03Z Insertion of Infusion Device into Left Common Iliac Vein, Open Approach
06HD33Z Insertion of Infusion Device into Left Common Iliac Vein, Percutaneous Approach
06HD43Z Insertion of Infusion Device into Left Common Iliac Vein, Percutaneous Endoscopic Approach
06HF03Z Insertion of Infusion Device into Right External Iliac Vein, Open Approach
06HF33Z Insertion of Infusion Device into Right External Iliac Vein, Percutaneous Approach
06HF43Z Insertion of Infusion Device into Right External Iliac Vein, Percutaneous Endoscopic Approach
06HG03Z Insertion of Infusion Device into Left External Iliac Vein, Open Approach
06HG33Z Insertion of Infusion Device into Left External Iliac Vein, Percutaneous Approach
06HG43Z Insertion of Infusion Device into Left External Iliac Vein, Percutaneous Endoscopic Approach
06HH03Z Insertion of Infusion Device into Right Hypogastric Vein, Open Approach
06HH33Z Insertion of Infusion Device into Right Hypogastric Vein, Percutaneous Approach
06HH43Z Insertion of Infusion Device into Right Hypogastric Vein, Percutaneous Endoscopic Approach
06HJ03Z Insertion of Infusion Device into Left Hypogastric Vein, Open Approach
06HJ33Z Insertion of Infusion Device into Left Hypogastric Vein, Percutaneous Approach
06HJ43Z Insertion of Infusion Device into Left Hypogastric Vein, Percutaneous Endoscopic Approach
06HM03Z Insertion of Infusion Device into Right Femoral Vein, Open Approach
06HM33Z Insertion of Infusion Device into Right Femoral Vein, Percutaneous Approach
06HM43Z Insertion of Infusion Device into Right Femoral Vein, Percutaneous Endoscopic Approach
06HN03Z Insertion of Infusion Device into Left Femoral Vein, Open Approach
06HN33Z Insertion of Infusion Device into Left Femoral Vein, Percutaneous Approach
06HN43Z Insertion of Infusion Device into Left Femoral Vein, Percutaneous Endoscopic Approach
06HP03Z Insertion of Infusion Device into Right Greater Saphenous Vein, Open Approach
06HP33Z Insertion of Infusion Device into Right Greater Saphenous Vein, Percutaneous Approach
06HP43Z Insertion of Infusion Device into Right Greater Saphenous Vein, Percutaneous Endoscopic Approach
06HQ03Z Insertion of Infusion Device into Left Greater Saphenous Vein, Open Approach
06HQ33Z Insertion of Infusion Device into Left Greater Saphenous Vein, Percutaneous Approach
06HQ43Z Insertion of Infusion Device into Left Greater Saphenous Vein, Percutaneous Endoscopic Approach
06HR03Z Insertion of Infusion Device into Right Lesser Saphenous Vein, Open Approach
06HR33Z Insertion of Infusion Device into Right Lesser Saphenous Vein, Percutaneous Approach
06HR43Z Insertion of Infusion Device into Right Lesser Saphenous Vein, Percutaneous Endoscopic Approach
06HS03Z Insertion of Infusion Device into Left Lesser Saphenous Vein, Open Approach
06HS33Z Insertion of Infusion Device into Left Lesser Saphenous Vein, Percutaneous Approach
06HS43Z Insertion of Infusion Device into Left Lesser Saphenous Vein, Percutaneous Endoscopic Approach
06HT03Z Insertion of Infusion Device into Right Foot Vein, Open Approach
06HT33Z Insertion of Infusion Device into Right Foot Vein, Percutaneous Approach
06HT43Z Insertion of Infusion Device into Right Foot Vein, Percutaneous Endoscopic Approach
06HV03Z Insertion of Infusion Device into Left Foot Vein, Open Approach
06HV33Z Insertion of Infusion Device into Left Foot Vein, Percutaneous Approach
06HV43Z Insertion of Infusion Device into Left Foot Vein, Percutaneous Endoscopic Approach
06HY03Z Insertion of Infusion Device into Lower Vein, Open Approach
06HY33Z Insertion of Infusion Device into Lower Vein, Percutaneous Approach
06HY43Z Insertion of Infusion Device into Lower Vein, Percutaneous Endoscopic Approach
0JH60XZ Insertion of Vascular Access Device into Chest Subcutaneous Tissue and Fascia, Open Approach
0JH63XZ Insertion of Vascular Access Device into Chest Subcutaneous Tissue and Fascia, Percutaneous Approach
0JH80XZ Insertion of Vascular Access Device into Abdomen Subcutaneous Tissue and Fascia, Open Approach
0JH83XZ Insertion of Vascular Access Device into Abdomen Subcutaneous Tissue and Fascia, Percutaneous Approach
0JHD0XZ Insertion of Vascular Access Device into Right Upper Arm Subcutaneous Tissue and Fascia, Open Approach
0JHD3XZ Insertion of Vascular Access Device into Right Upper Arm Subcutaneous Tissue and Fascia, Percutaneous Approach
0JHF0XZ Insertion of Vascular Access Device into Left Upper Arm Subcutaneous Tissue and Fascia, Open Approach
0JHF3XZ Insertion of Vascular Access Device into Left Upper Arm Subcutaneous Tissue and Fascia, Percutaneous Approach
0JHG0XZ Insertion of Vascular Access Device into Right Lower Arm Subcutaneous Tissue and Fascia, Open Approach
0JHG3XZ Insertion of Vascular Access Device into Right Lower Arm Subcutaneous Tissue and Fascia, Percutaneous Approach
0JHH0XZ Insertion of Vascular Access Device into Left Lower Arm Subcutaneous Tissue and Fascia, Open Approach
0JHH3XZ Insertion of Vascular Access Device into Left Lower Arm Subcutaneous Tissue and Fascia, Percutaneous Approach
0JHL0XZ Insertion of Vascular Access Device into Right Upper Leg Subcutaneous Tissue and Fascia, Open Approach
0JHL3XZ Insertion of Vascular Access Device into Right Upper Leg Subcutaneous Tissue and Fascia, Percutaneous Approach
0JHM0XZ Insertion of Vascular Access Device into Left Upper Leg Subcutaneous Tissue and Fascia, Open Approach
0JHM3XZ Insertion of Vascular Access Device into Left Upper Leg Subcutaneous Tissue and Fascia, Percutaneous Approach
0JHN0XZ Insertion of Vascular Access Device into Right Lower Leg Subcutaneous Tissue and Fascia, Open Approach
0JHN3XZ Insertion of Vascular Access Device into Right Lower Leg Subcutaneous Tissue and Fascia, Percutaneous Approach
0JHP0XZ Insertion of Vascular Access Device into Left Lower Leg Subcutaneous Tissue and Fascia, Open Approach
0JHP3XZ Insertion of Vascular Access Device into Left Lower Leg Subcutaneous Tissue and Fascia, Percutaneous Approach
39.42 Revision of arteriovenous shunt for renal dialysis 031209D Bypass Innominate Artery to Upper Arm Vein with Autologous Venous Tissue, Open Approach
031209F Bypass Innominate Artery to Lower Arm Vein with Autologous Venous Tissue, Open Approach
03120AD Bypass Innominate Artery to Upper Arm Vein with Autologous Arterial Tissue, Open Approach
03120AF Bypass Innominate Artery to Lower Arm Vein with Autologous Arterial Tissue, Open Approach
03120JD Bypass Innominate Artery to Upper Arm Vein with Synthetic Substitute, Open Approach
03120JF Bypass Innominate Artery to Lower Arm Vein with Synthetic Substitute, Open Approach
03120KD Bypass Innominate Artery to Upper Arm Vein with Nonautologous Tissue Substitute, Open Approach
03120KF Bypass Innominate Artery to Lower Arm Vein with Nonautologous Tissue Substitute, Open Approach
03120ZD Bypass Innominate Artery to Upper Arm Vein, Open Approach
03120ZF Bypass Innominate Artery to Lower Arm Vein, Open Approach
031309D Bypass Right Subclavian Artery to Upper Arm Vein with Autologous Venous Tissue, Open Approach
031309F Bypass Right Subclavian Artery to Lower Arm Vein with Autologous Venous Tissue, Open Approach
03130AD Bypass Right Subclavian Artery to Upper Arm Vein with Autologous Arterial Tissue, Open Approach
03130AF Bypass Right Subclavian Artery to Lower Arm Vein with Autologous Arterial Tissue, Open Approach
03130JD Bypass Right Subclavian Artery to Upper Arm Vein with Synthetic Substitute, Open Approach
03130JF Bypass Right Subclavian Artery to Lower Arm Vein with Synthetic Substitute, Open Approach
03130KD Bypass Right Subclavian Artery to Upper Arm Vein with Nonautologous Tissue Substitute, Open Approach
03130KF Bypass Right Subclavian Artery to Lower Arm Vein with Nonautologous Tissue Substitute, Open Approach
03130ZD Bypass Right Subclavian Artery to Upper Arm Vein, Open Approach
03130ZF Bypass Right Subclavian Artery to Lower Arm Vein, Open Approach
031409D Bypass Left Subclavian Artery to Upper Arm Vein with Autologous Venous Tissue, Open Approach
031409F Bypass Left Subclavian Artery to Lower Arm Vein with Autologous Venous Tissue, Open Approach
03140AD Bypass Left Subclavian Artery to Upper Arm Vein with Autologous Arterial Tissue, Open Approach
03140AF Bypass Left Subclavian Artery to Lower Arm Vein with Autologous Arterial Tissue, Open Approach
03140JD Bypass Left Subclavian Artery to Upper Arm Vein with Synthetic Substitute, Open Approach
03140JF Bypass Left Subclavian Artery to Lower Arm Vein with Synthetic Substitute, Open Approach
03140KD Bypass Left Subclavian Artery to Upper Arm Vein with Nonautologous Tissue Substitute, Open Approach
03140KF Bypass Left Subclavian Artery to Lower Arm Vein with Nonautologous Tissue Substitute, Open Approach
03140ZD Bypass Left Subclavian Artery to Upper Arm Vein, Open Approach
03140ZF Bypass Left Subclavian Artery to Lower Arm Vein, Open Approach
031509D Bypass Right Axillary Artery to Upper Arm Vein with Autologous Venous Tissue, Open Approach
031509F Bypass Right Axillary Artery to Lower Arm Vein with Autologous Venous Tissue, Open Approach
03150AD Bypass Right Axillary Artery to Upper Arm Vein with Autologous Arterial Tissue, Open Approach
03150AF Bypass Right Axillary Artery to Lower Arm Vein with Autologous Arterial Tissue, Open Approach
03150JD Bypass Right Axillary Artery to Upper Arm Vein with Synthetic Substitute, Open Approach
03150JF Bypass Right Axillary Artery to Lower Arm Vein with Synthetic Substitute, Open Approach
03150KD Bypass Right Axillary Artery to Upper Arm Vein with Nonautologous Tissue Substitute, Open Approach
03150KF Bypass Right Axillary Artery to Lower Arm Vein with Nonautologous Tissue Substitute, Open Approach
03150ZD Bypass Right Axillary Artery to Upper Arm Vein, Open Approach
03150ZF Bypass Right Axillary Artery to Lower Arm Vein, Open Approach
031609D Bypass Left Axillary Artery to Upper Arm Vein with Autologous Venous Tissue, Open Approach
031609F Bypass Left Axillary Artery to Lower Arm Vein with Autologous Venous Tissue, Open Approach
03160AD Bypass Left Axillary Artery to Upper Arm Vein with Autologous Arterial Tissue, Open Approach
03160AF Bypass Left Axillary Artery to Lower Arm Vein with Autologous Arterial Tissue, Open Approach
03160JD Bypass Left Axillary Artery to Upper Arm Vein with Synthetic Substitute, Open Approach
03160JF Bypass Left Axillary Artery to Lower Arm Vein with Synthetic Substitute, Open Approach
03160KD Bypass Left Axillary Artery to Upper Arm Vein with Nonautologous Tissue Substitute, Open Approach
03160KF Bypass Left Axillary Artery to Lower Arm Vein with Nonautologous Tissue Substitute, Open Approach
03160ZD Bypass Left Axillary Artery to Upper Arm Vein, Open Approach
03160ZF Bypass Left Axillary Artery to Lower Arm Vein, Open Approach
031709D Bypass Right Brachial Artery to Upper Arm Vein with Autologous Venous Tissue, Open Approach
031709F Bypass Right Brachial Artery to Lower Arm Vein with Autologous Venous Tissue, Open Approach
03170AD Bypass Right Brachial Artery to Upper Arm Vein with Autologous Arterial Tissue, Open Approach
03170AF Bypass Right Brachial Artery to Lower Arm Vein with Autologous Arterial Tissue, Open Approach
03170JD Bypass Right Brachial Artery to Upper Arm Vein with Synthetic Substitute, Open Approach
03170JF Bypass Right Brachial Artery to Lower Arm Vein with Synthetic Substitute, Open Approach
03170KD Bypass Right Brachial Artery to Upper Arm Vein with Nonautologous Tissue Substitute, Open Approach
03170KF Bypass Right Brachial Artery to Lower Arm Vein with Nonautologous Tissue Substitute, Open Approach
03170ZD Bypass Right Brachial Artery to Upper Arm Vein, Open Approach
03170ZF Bypass Right Brachial Artery to Lower Arm Vein, Open Approach
031809D Bypass Left Brachial Artery to Upper Arm Vein with Autologous Venous Tissue, Open Approach
031809F Bypass Left Brachial Artery to Lower Arm Vein with Autologous Venous Tissue, Open Approach
03180AD Bypass Left Brachial Artery to Upper Arm Vein with Autologous Arterial Tissue, Open Approach
03180AF Bypass Left Brachial Artery to Lower Arm Vein with Autologous Arterial Tissue, Open Approach
03180JD Bypass Left Brachial Artery to Upper Arm Vein with Synthetic Substitute, Open Approach
03180JF Bypass Left Brachial Artery to Lower Arm Vein with Synthetic Substitute, Open Approach
03180KD Bypass Left Brachial Artery to Upper Arm Vein with Nonautologous Tissue Substitute, Open Approach
03180KF Bypass Left Brachial Artery to Lower Arm Vein with Nonautologous Tissue Substitute, Open Approach
03180ZD Bypass Left Brachial Artery to Upper Arm Vein, Open Approach
03180ZF Bypass Left Brachial Artery to Lower Arm Vein, Open Approach
031909F Bypass Right Ulnar Artery to Lower Arm Vein with Autologous Venous Tissue, Open Approach
03190AF Bypass Right Ulnar Artery to Lower Arm Vein with Autologous Arterial Tissue, Open Approach
03190JF Bypass Right Ulnar Artery to Lower Arm Vein with Synthetic Substitute, Open Approach
03190KF Bypass Right Ulnar Artery to Lower Arm Vein with Nonautologous Tissue Substitute, Open Approach
03190ZF Bypass Right Ulnar Artery to Lower Arm Vein, Open Approach
031A09F Bypass Left Ulnar Artery to Lower Arm Vein with Autologous Venous Tissue, Open Approach
031A0AF Bypass Left Ulnar Artery to Lower Arm Vein with Autologous Arterial Tissue, Open Approach
031A0JF Bypass Left Ulnar Artery to Lower Arm Vein with Synthetic Substitute, Open Approach
031A0KF Bypass Left Ulnar Artery to Lower Arm Vein with Nonautologous Tissue Substitute, Open Approach
031A0ZF Bypass Left Ulnar Artery to Lower Arm Vein, Open Approach
031B09F Bypass Right Radial Artery to Lower Arm Vein with Autologous Venous Tissue, Open Approach
031B0AF Bypass Right Radial Artery to Lower Arm Vein with Autologous Arterial Tissue, Open Approach
031B0JF Bypass Right Radial Artery to Lower Arm Vein with Synthetic Substitute, Open Approach
031B0KF Bypass Right Radial Artery to Lower Arm Vein with Nonautologous Tissue Substitute, Open Approach
031B0ZF Bypass Right Radial Artery to Lower Arm Vein, Open Approach
031C09F Bypass Left Radial Artery to Lower Arm Vein with Autologous Venous Tissue, Open Approach
031C0AF Bypass Left Radial Artery to Lower Arm Vein with Autologous Arterial Tissue, Open Approach
031C0JF Bypass Left Radial Artery to Lower Arm Vein with Synthetic Substitute, Open Approach
031C0KF Bypass Left Radial Artery to Lower Arm Vein with Nonautologous Tissue Substitute, Open Approach
031C0ZF Bypass Left Radial Artery to Lower Arm Vein, Open Approach
39.49 Other revisions of vascular procedure 03CY0ZZ Extirpation of Matter from Upper Artery, Open Approach
03CY3ZZ Extirpation of Matter from Upper Artery, Percutaneous Approach
03CY4ZZ Extirpation of Matter from Upper Artery, Percutaneous Endoscopic Approach
03QY0ZZ Repair Upper Artery, Open Approach
03QY3ZZ Repair Upper Artery, Percutaneous Approach
03QY4ZZ Repair Upper Artery, Percutaneous Endoscopic Approach
04CY0ZZ Extirpation of Matter from Lower Artery, Open Approach
04CY3ZZ Extirpation of Matter from Lower Artery, Percutaneous Approach
04CY4ZZ Extirpation of Matter from Lower Artery, Percutaneous Endoscopic Approach
04QY0ZZ Repair Lower Artery, Open Approach
04QY3ZZ Repair Lower Artery, Percutaneous Approach
04QY4ZZ Repair Lower Artery, Percutaneous Endoscopic Approach
05CY0ZZ Extirpation of Matter from Upper Vein, Open Approach
05CY3ZZ Extirpation of Matter from Upper Vein, Percutaneous Approach
05CY4ZZ Extirpation of Matter from Upper Vein, Percutaneous Endoscopic Approach
05QY0ZZ Repair Upper Vein, Open Approach
05QY3ZZ Repair Upper Vein, Percutaneous Approach
05QY4ZZ Repair Upper Vein, Percutaneous Endoscopic Approach
06CY0ZZ Extirpation of Matter from Lower Vein, Open Approach
06CY3ZZ Extirpation of Matter from Lower Vein, Percutaneous Approach
06CY4ZZ Extirpation of Matter from Lower Vein, Percutaneous Endoscopic Approach
06QY0ZZ Repair Lower Vein, Open Approach
06QY3ZZ Repair Lower Vein, Percutaneous Approach
06QY4ZZ Repair Lower Vein, Percutaneous Endoscopic Approach
39.94 Replacement of vessel-to-vessel cannula 031B0JF Bypass Right Radial Artery to Lower Arm Vein with Synthetic Substitute, Open Approach
031C0JF Bypass Left Radial Artery to Lower Arm Vein with Synthetic Substitute, Open Approach
03PY0JZ Removal of Synthetic Substitute from Upper Artery, Open Approach
03PY3JZ Removal of Synthetic Substitute from Upper Artery, Percutaneous Approach
03PY4JZ Removal of Synthetic Substitute from Upper Artery, Percutaneous Endoscopic Approach
03WY0JZ Revision of Synthetic Substitute in Upper Artery, Open Approach
03WY3JZ Revision of Synthetic Substitute in Upper Artery, Percutaneous Approach
03WY4JZ Revision of Synthetic Substitute in Upper Artery, Percutaneous Endoscopic Approach
03WYXJZ Revision of Synthetic Substitute in Upper Artery, External Approach
DISCLAIMER

Reimbursement information provided by Edwards Lifesciences is gathered from third-party sources and is presented for informational purposes only. Edwards makes no representation, warranty or guarantee as to the timeliness, accuracy or completeness of the information and such information is not, and should not be construed as reimbursement, coding or legal advice. Any and all references to reimbursement codes are provided as examples only and are not intended to be a recommendation or advice as to the appropriate code for the a particular patient, diagnosis, product or procedure or a guarantee or promise of coverage or payment, nor does Edwards Lifesciences warranty that codes listed are appropriate in all related clinical scenarios. It is the responsibility of the provider to determine if coverage exists and what requirements are necessary for submitting a proper claim for reimbursement to a health plan or payer, including the appropriate code(s) for products provided or services rendered. Laws, regulations, and payer policies concerning reimbursement are complex and change frequently; service providers are responsible for all decisions relating to coding and reimbursement submissions. Medicare’s Correct Coding Initiative and commercial payer policies are reviewed and updated several times each year. Accordingly, Edwards strongly recommends consultation with payers, reimbursement specialists and/or legal counsel regarding appropriate product or procedure codes, coverage, and reimbursement matters.

References
  1. Current Procedural Terminology (CPT) copyright 2015, American Medical Association (AMA). All rights reserved. CPT is a registered trademark of the AMA. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein. Applicable FARS/DFARS restrictions apply to government use.
  2. Not all codes provided are applicable for the clinical scenarios in which Edwards Lifesciences’ Vascular technologies are used. The provider is responsible for selecting the most appropriate code(s) for the patient’s clinical presentation. When radiologic guidance is used for catheter placement, it may be appropriate to add applicable codes according to the service provided following correct coding guidelines. Services that are considered a component of another procedure may not always be coded and billed separately.
  3. Where applicable, a physician may be required to report CPT codes for radiological supervision and interpretation with CPT codes for interventional procedures. The use of modifier-26 may be required with various radiological supervision and interpretation CPT codes unless radiological equipment is owned by the physician performing these services. Radiological services are often packaged and do not qualify for separate payment by Medicare when performed in conjunction with interventional procedures. Consult with coding and billing staff, as well as payer policy for further guidance.
  4. For all Medicare payments for physician, hospital outpatient, and ASC services, the multiple procedure reduction rule may apply. Consult with coding and billing staff, and payer policy for further guidance. National average Medicare payment is calculated using the Conversion Factor of $35.8279 per the Medicare Physician Fee Schedule for Calendar Year 2016 Final Rule issued October 30, 2015. National average is based on factors such as geography, teaching vs. non-teaching hospital, rural vs. urban area, etc. and your payment may be different based on these factors. This payment will differ for commercial payers. Payments are effective January 1, 2016 through December 31, 2016.
  5. Various radiological services are often packaged in APC payments and do not qualify for separate payment by Medicare when performed in conjunction with the interventional procedure. For Medicare claims submission and processing, applicable device-related C codes must also be reported.
  6. CPT code 36147 should not be used in conjunction with 75791.
  7. CPT code 36148 may be used in conjunction with 36147.
  8. National Uniform Billing Committee, American Hospital Association.
  9. Federal Register / Vol. 74, No. 11 / Friday, January 16, 2009 / Rules and Regulations: This final rule adopts modifications to two of the code set standards adopted in the Transactions and Code Sets final rule published in the Federal Register pursuant to certain provisions of the Administrative Simplification subtitle of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). Specifically, this final rule modifies the standard medical data code sets (hereinafter ‘‘code sets’’) for coding diagnoses and inpatient hospital procedures by concurrently adopting the International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) for diagnosis coding, including the Official ICD-10-CM Guidelines for Coding and Reporting, as maintained and distributed by the U.S. Department of Health and Human Services (HHS), hereinafter referred to as ICD-10-CM, and the International Classification of Diseases, 10th Revision, Procedure Coding System (ICD-10-PCS) for inpatient hospital procedure coding, including the Official ICD-10-PCS Guidelines for Coding and Reporting, as maintained and distributed by the HHS, hereinafter referred to as ICD-10-PCS. These new codes replace the International Classification of Diseases, 9th Revision, Clinical Modification, Volumes 1 and 2, including the Official ICD-9-CM Guidelines for Coding and Reporting, hereinafter referred to as ICD-9-CM Volumes 1 and 2, and the International Classification of Diseases, 9th Revision, Clinical Modification, Volume 3, including the Official ICD-9-CM Guidelines for Coding and Reporting, hereinafter referred to as ICD-9-CM Volume 3, for diagnosis and procedure codes, respectively. DATES: The effective date of this regulation is March 17, 2009. The effective date is the date that the policies herein take effect, and new policies are considered to be officially adopted. The compliance date, which is different than the effective date, is the date on which entities are required to have implemented the policies adopted in this rule. The compliance date for this regulation is October 1, 2015.
  10. International Classification of Diseases, 9th Revision, Clinical Modification 2015 ICD-9-CM for hospitals, volume 1, 2, & 3.
  11. International Classification of Diseases, 10th Revision, Procedure Coding System 2015 Draft.
DISCLAIMER
Reimbursement information provided by Edwards Lifesciences is gathered from third-party sources and is presented for informational purposes only. Edwards makes no representation, warranty or guarantee as to the timeliness, accuracy or completeness of the information and such information is not, and should not be construed as reimbursement, coding or legal advice. Any and all references to reimbursement codes are provided as examples only and are not intended to be a recommendation or advice as to the appropriate code for the a particular patient, diagnosis, product or procedure or a guarantee or promise of coverage or payment, nor does Edwards Lifesciences warranty that codes listed are appropriate in all related clinical scenarios. It is the responsibility of the provider to determine if coverage exists and what requirements are necessary for submitting a proper claim for reimbursement to a health plan or payer, including the appropriate code(s) for products provided or services rendered. Laws, regulations, and payer policies concerning reimbursement are complex and change frequently; service providers are responsible for all decisions relating to coding and reimbursement submissions. Medicare’s Correct Coding Initiative and commercial payer policies are reviewed and updated several times each year. Accordingly, Edwards strongly recommends consultation with payers, reimbursement specialists and/or legal counsel regarding appropriate product or procedure codes, coverage, and reimbursement matters.

Important Safety Information

CAUTION: Federal (United States) law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions and adverse events.

Important Safety Information

CAUTION: Federal (United States) law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions and adverse events.

Please update your browser

Please update to a current version of your preferred browser, this site will perform effectively on the following:

Unable to update your browser?

If you are on a computer, that is maintained by an admin and you cannot install a new browser, ask your admin about it. If you can't change your browser because of compatibility issues, think about installing a second browser for browsing and keep this old one for compatibility